syndrome	score	normalized_score
CONGENITAL TOTAL PULMONARY VENOUS RETURN ANOMALY	4.0	100.0
DRAVET SYNDROME	3.0613517	76.5337925
CHILDHOOD ABSENCE EPILEPSY	1.64574085	41.14352125
MYOCLONIC-ASTASTIC EPILEPSY	1.2192351539999997	30.480878849999993
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.193694	29.84235
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	1.1528726900000001	28.821817250000002
CRANIO-CERVICAL DYSTONIA WITH LARYNGEAL AND UPPER-LIMB INVOLVEMENT	1.1455937999999999	28.639844999999998
SPINOCEREBELLAR ATAXIA TYPE 20	1.1227388999999999	28.0684725
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	1.045156429	26.128910724999997
RING CHROMOSOME 12 SYNDROME	1.0146700439999998	25.366751099999995
PETERS PLUS SYNDROME	1.011379724	25.2844931
RADIAL HEMIMELIA	1.0	25.0
ATRESIA OF SMALL INTESTINE	1.0	25.0
PAROXYSMAL KINESIGENIC DYSKINESIA	1.0	25.0
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.0	25.0
BNAR SYNDROME	1.0	25.0
UROFACIAL SYNDROME	1.0	25.0
MYOCLONIC EPILEPSY OF LAFORA	0.93788904	23.447226
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.7841270000000001	19.603175000000004
LAFORA DISEASE	0.7715289599999999	19.288224
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.7706171	19.2654275
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.750583814	18.76459535
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.748578964	18.7144741
EARLY MYOCLONIC ENCEPHALOPATHY	0.7087289139999999	17.718222849999997
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.59617784	14.904445999999998
ROLANDIC EPILEPSY	0.5906213	14.7655325
PLACENTAL INSUFFICIENCY	0.583333	14.583325
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.551281154	13.78202885
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.55092596	13.773149000000002
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.5333330000000001	13.333325000000002
ISOTRETINOIN-LIKE SYNDROME	0.53301453	13.325363249999999
TREMOR, HEREDITARY ESSENTIAL, 5; ETM5	0.5324612	13.31153
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.530315884	13.2578971
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.527027	13.175675
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.5202834940000001	13.007087350000003
SPINOCEREBELLAR ATAXIA TYPE 42	0.5184699	12.961747500000001
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.512173454	12.80433635
EPILEPSY, BENIGN NEONATAL, 2	0.50704225	12.67605625
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.503989699	12.599742475000001
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.5018434030000001	12.546085075000002
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.5018434030000001	12.546085075000002
BRANCHIOOTORENAL SYNDROME 1	0.5	12.5
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	12.5
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.5	12.5
CREST SYNDROME	0.5	12.5
PAROXYSMAL HEMICRANIA	0.5	12.5
INHALATIONAL ANTHRAX	0.5	12.5
ALVEOLAR CAPILLARY DYSPLASIA WITH MISALIGNMENT OF PULMONARY VEINS; ACDMPV	0.5	12.5
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.5	12.5
GLOMUVENOUS MALFORMATION	0.492857	12.321425
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.47192672	11.798168
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.42149728000000003	10.537432
SPINOCEREBELLAR ATAXIA TYPE 10	0.4205192	10.512979999999999
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.415887734	10.39719335
PERIORAL MYOCLONIA WITH ABSENCES	0.39904270999999997	9.976067749999999
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.39775455000000004	9.94386375
CANAVAN DISEASE	0.37037	9.25925
ATYPICAL PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.36781579999999997	9.195395
SPINOCEREBELLAR ATAXIA TYPE 12	0.3657942	9.144855
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.3655911	9.1397775
POSTENCEPHALITIC PARKINSONISM	0.362445819	9.061145475
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.35751765999999996	8.937941499999999
EPILEPSY, JUVENILE ABSENCE	0.35751765999999996	8.937941499999999
CENTRALOPATHIC EPILEPSY	0.35470090000000004	8.867522500000002
KAPOSI SARCOMA	0.35	8.75
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.34845636399999996	8.7114091
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.347032319	8.675807975
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.346468173	8.661704325
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.346047873	8.651196825
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.345372854	8.63432135
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.3448273	8.620682500000001
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.34381167999999995	8.595291999999999
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.34259226	8.5648065
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.341450519	8.536262975
PELVIS-SHOULDER DYSPLASIA	0.3411455	8.5286375
FOCAL DERMAL HYPOPLASIA	0.34068593999999996	8.5171485
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.33882751	8.47068775
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.337901203	8.447530075
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	0.33676943	8.41923575
COG4-CDG	0.33463498399999997	8.3658746
ACITRETIN/ETRETINATE EMBRYOPATHY	0.33408942999999997	8.352235749999998
EPIDERMAL NEVUS SYNDROME	0.333878554	8.34696385
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.333874419	8.346860475
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.333874419	8.346860475
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.333874419	8.346860475
OROFACIODIGITAL SYNDROME TYPE 3	0.333333	8.333325
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.333333	8.333325
SCHIZOPHRENIA 10	0.333333	8.333325
CLEFT LIP AND ALVEOLUS	0.333333	8.333325
TEMPI SYNDROME	0.333333	8.333325
LYMPHEDEMA-DISTICHIASIS SYNDROME	0.333333	8.333325
NEUROMYELITIS OPTICA	0.333333	8.333325
SPINOCEREBELLAR ATAXIA TYPE 25	0.333333	8.333325
ROLANDIC EPILEPSY-PAROXYSMAL EXERCISE-INDUCED DYSTONIA-WRITER'S CRAMP SYNDROME	0.333333	8.333325
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.30128141399999997	7.532035349999999
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.275267114	6.881677849999999
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.27163705000000005	6.790926250000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.26767815400000006	6.691953850000002
LENNOX-GASTAUT SYNDROME	0.26705410999999996	6.676352749999999
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.26676428399999996	6.669107099999999
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.26659164400000007	6.664791100000002
OROFACIODIGITAL SYNDROME I; OFD1	0.264665909	6.616647724999999
PALLISTER-HALL SYNDROME	0.257898494	6.4474623499999995
AL KAISSI SYNDROME; ALKAS	0.257398963	6.4349740749999995
KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	0.25549451	6.38736275
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.254026784	6.3506696
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.25184340299999997	6.296085074999999
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.251086973	6.277174325
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.25075643	6.268910749999999
DYSPLASTIC CORTICAL HYPEROSTOSIS	0.25075643	6.268910749999999
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.25075643	6.268910749999999
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.250541419	6.263535474999999
CORTICOSTEROID-SENSITIVE ASEPTIC ABSCESS SYNDROME	0.25	6.25
HYPERPARATHYROIDISM 2	0.25	6.25
ATAXIA-OCULOMOTOR APRAXIA TYPE 4	0.25	6.25
TUBERCULOSIS	0.25	6.25
HYPEREKPLEXIA 1; HKPX1	0.25	6.25
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25	6.25
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	6.25
CAUDAL APPENDAGE-DEAFNESS SYNDROME	0.25	6.25
HYPOTRICHOSIS WITH JUVENILE MACULAR DEGENERATION	0.25	6.25
DYSTONIA 6, TORSION	0.25	6.25
SPINOCEREBELLAR ATAXIA TYPE 18	0.24545450000000002	6.136362500000001
ADULT-ONSET CERVICAL DYSTONIA, DYT23 TYPE	0.24545450000000002	6.136362500000001
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.24520084000000003	6.130021000000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.243045154	6.07612885
UNDIFFERENTIATED PLEOMORPHIC SARCOMA	0.242857	6.071425
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.234614804	5.8653701
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.22814826000000002	5.703706500000001
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.22592915000000002	5.64822875
TREMOR, HEREDITARY ESSENTIAL, 2; ETM2	0.22222199999999998	5.555549999999999
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.217603494	5.440087350000001
ANGELMAN SYNDROME	0.213135173	5.328379325
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.212929884	5.323247100000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.212796284	5.3199071
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.20688471	5.17211775
6P22 MICRODELETION SYNDROME	0.20555556	5.138889
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.2051883	5.129707499999999
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.20419286	5.1048215
SPINOCEREBELLAR ATAXIA TYPE 13	0.201086973	5.027174325
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.20054555400000001	5.01363885
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.20054555400000001	5.01363885
BETA-THALASSEMIA	0.2	5.0
JUVENILE HYALINE FIBROMATOSIS	0.2	5.0
MALARIA	0.2	5.0
BENIGN SCHWANNOMA	0.2	5.0
POLYARTERITIS NODOSA	0.2	5.0
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.2	5.0
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.2	5.0
DIFFUSE NEONATAL HEMANGIOMATOSIS	0.2	5.0
INFANTILE MYOFIBROMATOSIS	0.2	5.0
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.19789361	4.94734025
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.19756121999999998	4.939030499999999
SAGLIKER SYNDROME	0.1909091	4.7727275
JUVENILE MYOCLONIC EPILEPSY	0.18297529999999998	4.5743825
MYOCLONIC EPILEPSY OF INFANCY	0.181285814	4.5321453499999995
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.181285814	4.5321453499999995
UNILATERAL POLYMICROGYRIA	0.17616554	4.4041385
MUCOLIPIDOSIS TYPE II	0.17407441	4.3518602500000005
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.17120225300000003	4.280056325
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.17118598399999999	4.2796496
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.16973429999999998	4.243357499999999
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.167208419	4.180210475
CEREBROOCULONASAL SYNDROME	0.166667	4.166675000000001
DERMATOLEUKODYSTROPHY	0.166667	4.166675000000001
CHRONIC INTESTINAL PSEUDOOBSTRUCTION	0.166667	4.166675000000001
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.16636041399999998	4.15901035
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.16636041399999998	4.15901035
FREE SIALIC ACID STORAGE DISEASE	0.16167795299999999	4.0419488249999995
TRISOMY 18	0.160125484	4.0031371
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.15950570000000003	3.9876425000000006
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.15950570000000003	3.9876425000000006
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.158444684	3.9611171
SPINOCEREBELLAR ATAXIA TYPE 28	0.1565655	3.9141375
SPINOCEREBELLAR ATAXIA TYPE 15/16	0.1565655	3.9141375
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.15173494999999998	3.7933737499999993
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.1515915	3.7897874999999996
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.15077670999999998	3.7694177499999997
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.15075135899999997	3.7687839749999994
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.14880960000000001	3.7202400000000004
TUBEROUS SCLEROSIS COMPLEX	0.1484533	3.7113325
PRIMARY DYSTONIA, DYT13 TYPE	0.1458333	3.6458325
FAMILIAL MULTIPLE NEVI FLAMMEI	0.14339841899999997	3.5849604749999995
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.14285699999999998	3.5714249999999996
DELAYED ENCEPHALOPATHY DUE TO CARBON MONOXIDE POISONING	0.14285699999999998	3.5714249999999996
COMBINED SAPOSIN DEFICIENCY	0.14285699999999998	3.5714249999999996
LIPODYSTROPHY DUE TO PEPTIDIC GROWTH FACTORS DEFICIENCY	0.14285699999999998	3.5714249999999996
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.14162570000000002	3.5406425000000006
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.13756670399999998	3.4391675999999998
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.13754538400000002	3.4386346000000003
DYSTONIA 16; DYT16	0.13539257999999998	3.3848144999999996
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.1324787	3.3119675
SPINOCEREBELLAR ATAXIA TYPE 2	0.1319443	3.2986074999999997
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.13076913999999998	3.2692284999999996
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.12879732	3.2199329999999997
AUTOSOMAL DOMINANT SPASTIC ATAXIA TYPE 1	0.12843643	3.2109107499999996
PROGRESSIVE SUPRANUCLEAR PALSY-CORTICOBASAL SYNDROME	0.12843643	3.2109107499999996
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.126301984	3.1575496000000003
HUNTINGTON DISEASE-LIKE 1	0.125541419	3.138535475
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.12536701000000003	3.1341752500000006
OCULAR MOTOR APRAXIA	0.125	3.125
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.1231672	3.07918
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.12315085399999999	3.07877135
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.120915814	3.0228953499999998
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.119765924	2.9941481
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.118509963	2.962749075
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.11815324999999999	2.9538312499999995
PRIMARY DYSTONIA, DYT4 TYPE	0.11455927999999999	2.8639819999999996
TREMOR, HEREDITARY ESSENTIAL, AND IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS	0.11455927999999999	2.8639819999999996
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.112954403	2.823860075
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.112954403	2.823860075
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.112412984	2.8103246
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.11240884899999999	2.810221225
DESMOSTEROLOSIS	0.11225073	2.80626825
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.11219797299999999	2.804949325
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.11165655399999999	2.7914138499999996
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.11165655399999999	2.7914138499999996
OGDEN SYNDROME	0.11165655399999999	2.7914138499999996
HUNTINGTON DISEASE-LIKE 3	0.11165241899999999	2.7913104749999995
FRAGILE X MENTAL RETARDATION SYNDROME	0.11165241899999999	2.7913104749999995
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.11165241899999999	2.7913104749999995
TRISOMY 18P	0.11144574000000002	2.7861435000000006
CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 6; CHTD6	0.11111099999999999	2.7777749999999997
PRIMARY DYSTONIA, DYT27 TYPE	0.11111099999999999	2.7777749999999997
DIAMOND-BLACKFAN ANEMIA 20; DBA20	0.11111099999999999	2.7777749999999997
BENIGN PAROXYSMAL TORTICOLLIS OF INFANCY	0.11111099999999999	2.7777749999999997
TREMOR, NYSTAGMUS, AND DUODENAL ULCER	0.11111099999999999	2.7777749999999997
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	0.11111099999999999	2.7777749999999997
ASPLENIA WITH CARDIOVASCULAR ANOMALIES	0.11111099999999999	2.7777749999999997
BRUNNER SYNDROME; BRNRS	0.11111099999999999	2.7777749999999997
HETEROTAXY, VISCERAL, 7, AUTOSOMAL; HTX7	0.11111099999999999	2.7777749999999997
SANDIFER SYNDROME	0.11111099999999999	2.7777749999999997
TOTAL ANOMALOUS PULMONARY VENOUS RETURN 1	0.11111099999999999	2.7777749999999997
COMPLEX REGIONAL PAIN SYNDROME	0.11111099999999999	2.7777749999999997
AUTOSOMAL RECESSIVE ATAXIA DUE TO PEX10 DEFICIENCY	0.11111099999999999	2.7777749999999997
EPISODIC ATAXIA TYPE 4	0.11111099999999999	2.7777749999999997
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.109484104	2.7371026
SPINOCEREBELLAR ATAXIA 12	0.10795450000000001	2.6988625
SCHINZEL-GIEDION SYNDROME	0.10714290000000001	2.6785725000000005
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.10675886400000002	2.6689716000000008
NAGER SYNDROME	0.10549451	2.63736275
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.10525655	2.63141375
KUFOR-RAKEB SYNDROME	0.1051948	2.62987
BILATERAL POLYMICROGYRIA	0.104660764	2.6165191
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.10464479400000001	2.6161198500000005
AICARDI SYNDROME; AIC	0.10444313000000001	2.6110782500000003
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.10362397300000001	2.5905993250000003
SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE; SPG79	0.102537	2.563425
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.10187508400000002	2.5468771000000006
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.101857573	2.546439325
ADNP SYNDROME	0.101282469	2.532061725
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.10075643000000001	2.5189107500000003
POLAND SYNDROME	0.10075643000000001	2.5189107500000003
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.100541419	2.5135354750000003
CONGENITAL PULMONARY VENOUS RETURN ANOMALY	0.1	2.5
MEACHAM SYNDROME	0.1	2.5
METAPHYSEAL ANADYSPLASIA	0.1	2.5
NEUROGENIC ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.1	2.5
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT	0.1	2.5
HYDROCEPHALY-LOW INSERTION UMBILICUS SYNDROME	0.1	2.5
CONGENITAL UNILATERAL PULMONARY HYPOPLASIA	0.1	2.5
PARTIAL ATRIOVENTRICULAR CANAL	0.1	2.5
HOLT-ORAM SYNDROME	0.1	2.5
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.0992976	2.48244
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.09915028400000002	2.4787571000000006
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.09895310400000001	2.4738276000000003
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.098513364	2.4628341000000002
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.09812185000000001	2.4530462500000003
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.09812185000000001	2.4530462500000003
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.09812185000000001	2.4530462500000003
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.09812185000000001	2.4530462500000003
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.09812185000000001	2.4530462500000003
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.09744581	2.43614525
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.09708065	2.4270162500000003
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.096586434	2.4146608499999997
PELIZAEUS-MERZBACHER DISEASE	0.09618893300000002	2.4047233250000004
MARINESCO-SJÖGREN SYNDROME	0.09221108400000001	2.3052771000000005
PONTINE TEGMENTAL CAP DYSPLASIA	0.09199607300000001	2.299901825
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.09199607300000001	2.299901825
SPINOCEREBELLAR ATAXIA TYPE 36	0.09156520000000001	2.28913
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.09145465400000001	2.28636635
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.09145051900000001	2.286262975
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.091167254	2.27918135
TENDONS, EXTENSOR, OF FINGERS, ANOMALOUS INSERTION OF	0.0909091	2.2727275000000002
BAZEX-DUPRÉ-CHRISTOL SYNDROME	0.0909091	2.2727275000000002
RARE CIRCULATORY SYSTEM DISEASE	0.0909091	2.2727275000000002
SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY; SPAX8	0.0909091	2.2727275000000002
POSTAXIAL TETRAMELIC OLIGODACTYLY	0.0909091	2.2727275000000002
CORNEODERMATOOSSEOUS SYNDROME	0.0909091	2.2727275000000002
MOEBIUS SYNDROME-AXONAL NEUROPATHY-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.0909091	2.2727275000000002
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.08856235400000001	2.2140588500000002
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.08618236000000001	2.1545590000000003
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.08583135	2.14578375
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.08567275400000002	2.1418188500000004
AICARDI SYNDROME	0.08208863999999999	2.0522159999999996
TRISOMY 8P	0.08094574900000001	2.0236437250000003
DDOST-CDG	0.08090094900000001	2.0225237250000005
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.08090094900000001	2.0225237250000005
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.07822094900000001	1.9555237250000004
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.07818681	1.95467025
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.07746865400000001	1.9367163500000002
ETHYLMALONIC ENCEPHALOPATHY	0.07746451900000001	1.9366129750000003
17Q23.1Q23.2 MICRODELETION SYNDROME	0.07740602999999999	1.9351507499999996
49,XXXYY SYNDROME	0.077381	1.934525
49,XYYYY SYNDROME	0.077381	1.934525
SLC35A2-CDG	0.07703838400000002	1.9259596000000003
ISOLATED OPTIC NERVE HYPOPLASIA/APLASIA	0.07692310000000001	1.9230775000000002
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.07692310000000001	1.9230775000000002
TRICHOHEPATOENTERIC SYNDROME 1	0.07692310000000001	1.9230775000000002
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.07692310000000001	1.9230775000000002
IMMUNODEFICIENCY 36; IMD36	0.07692310000000001	1.9230775000000002
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.07692310000000001	1.9230775000000002
CONGENITAL ENTEROVIRUS INFECTION	0.07692310000000001	1.9230775000000002
BECKWITH-WIEDEMANN SYNDROME	0.07692310000000001	1.9230775000000002
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.076744873	1.9186218250000002
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.076690919	1.917272975
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.0763091	1.9077275
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.07608819	1.90220475
MOSAIC TRISOMY 15	0.0760649	1.9016225000000002
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA-DEAFNESS-NARCOLEPSY SYNDROME	0.0740259	1.8506475000000002
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.07299053	1.82476325
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.071995049	1.7998762250000002
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.07197415400000001	1.7993538500000004
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.07131023	1.78275575
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.0694982	1.737455
9P13 MICRODELETION SYNDROME	0.06946569999999999	1.7366424999999999
YOU-HOOVER-FONG SYNDROME; YHFS	0.06927438400000001	1.7318596000000002
HYPEREKPLEXIA-EPILEPSY SYNDROME	0.0686937	1.7173425
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.067964549	1.699113725
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.06742313	1.6855782499999998
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.067212254	1.68030635
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.066937103	1.6734275749999998
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.0666667	1.6666675
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.0666667	1.6666675
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.0666667	1.6666675
AUTOIMMUNE HYPOPARATHYROIDISM	0.0666667	1.6666675
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.0666667	1.6666675
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.0666667	1.6666675
FAMILIAL ISOLATED HYPOPARATHYROIDISM DUE TO AGENESIS OF PARATHYROID GLAND	0.0666667	1.6666675
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.0666667	1.6666675
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.0666667	1.6666675
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.0666667	1.6666675
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.0666667	1.6666675
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.0666667	1.6666675
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.066660814	1.6665203499999999
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 2	0.06628780000000001	1.6571950000000002
SPINOCEREBELLAR ATAXIA 27; SCA27	0.06628780000000001	1.6571950000000002
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.06590177300000001	1.6475443250000004
XQ12-Q13.3 DUPLICATION SYNDROME	0.06484029	1.62100725
INFANTILE CONVULSIONS AND CHOREOATHETOSIS	0.0648148	1.62037
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.06434340300000001	1.6085850750000001
INCONTINENTIA PIGMENTI	0.063358753	1.5839688250000001
CIRRHOSIS-DYSTONIA-POLYCYTHEMIA-HYPERMANGANESEMIA SYNDROME	0.06325643	1.58141075
X-LINKED DYSTONIA-PARKINSONISM	0.0630542	1.5763550000000002
CYANIDE-INDUCED PARKINSONISM-DYSTONIA	0.0630542	1.5763550000000002
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.063041419	1.576035475
DILATED CARDIOMYOPATHY WITH ATAXIA	0.063041419	1.576035475
UROCANIC ACIDURIA	0.0625	1.5625
HUNTINGTON DISEASE-LIKE 2	0.0625	1.5625
CARIBBEAN PARKINSONISM	0.0625	1.5625
%300703 SPINOCEREBELLAR ATAXIA, X-LINKED 5; SCAX5	0.0625	1.5625
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.0625	1.5625
LICHTENSTEIN-KNORR SYNDROME; LIKNS	0.0625	1.5625
WHITE-SUTTON SYNDROME; WHSUS	0.062352094000000004	1.5588023500000001
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.062252973999999996	1.55632435
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.06103259999999999	1.5258149999999997
RHEUMATOID ARTHRITIS	0.0607197	1.5179925
BANGSTAD SYNDROME	0.060121349	1.5030337249999999
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.059910473	1.497761825
DISTAL MONOSOMY 17Q	0.05957993	1.48949825
DISTAL MONOSOMY 12Q	0.05885138399999999	1.4712845999999997
DISLOCATION OF THE HIP-DYSMORPHISM SYNDROME	0.0588235	1.4705875
SCLEROSTEOSIS 1; SOST1	0.0588235	1.4705875
OROMANDIBULAR-LIMB HYPOGENESIS SYNDROME	0.0588235	1.4705875
VON WILLEBRAND DISEASE	0.0588235	1.4705875
RING CHROMOSOME 8 SYNDROME	0.0588235	1.4705875
ASCHER SYNDROME	0.0588235	1.4705875
ARTHROGRYPOSIS-OCULOMOTOR LIMITATION-ELECTRORETINAL ANOMALIES SYNDROME	0.0588235	1.4705875
ANOPHTHALMIA PLUS SYNDROME	0.0588235	1.4705875
RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE	0.0588235	1.4705875
CRANIO-OSTEOARTHROPATHY	0.0588235	1.4705875
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.05777791	1.4444477500000001
CORNELIA DE LANGE SYNDROME 3	0.057695713	1.442392825
PSEUDOTRISOMY 13 SYNDROME	0.05739263000000001	1.4348157500000003
LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY	0.057082400000000005	1.4270600000000002
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.056736899	1.418422475
XP22.13P22.2 DUPLICATION SYNDROME	0.056122449	1.4030612249999999
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.05596702	1.3991755
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.055555600000000004	1.3888900000000002
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.055555600000000004	1.3888900000000002
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.055555600000000004	1.3888900000000002
CONGENITAL ISOLATED ACTH DEFICIENCY	0.055555600000000004	1.3888900000000002
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.055555600000000004	1.3888900000000002
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.055555600000000004	1.3888900000000002
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.055555600000000004	1.3888900000000002
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.055555600000000004	1.3888900000000002
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.055555600000000004	1.3888900000000002
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.055555600000000004	1.3888900000000002
GITELMAN SYNDROME	0.055555600000000004	1.3888900000000002
HYPOINSULINEMIC HYPOGLYCEMIA AND BODY HEMIHYPERTROPHY	0.055555600000000004	1.3888900000000002
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.055555600000000004	1.3888900000000002
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.055555600000000004	1.3888900000000002
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.055555600000000004	1.3888900000000002
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2A2	0.0553161	1.3829025
SUPRANUCLEAR PALSY, PROGRESSIVE, 2; PSNP2	0.0553161	1.3829025
TREMOR, HEREDITARY ESSENTIAL, 1	0.0553161	1.3829025
HAMAMY SYNDROME; HMMS	0.055034759999999995	1.3758689999999998
AMISH INFANTILE EPILEPSY SYNDROME	0.055007280000000006	1.3751820000000001
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.054331419000000006	1.3582854750000002
COG2-CDG	0.05426045399999999	1.35651135
CONGENITAL ERYTHROPOIETIC PORPHYRIA	0.0527472	1.31868
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE; HMSNR	0.0527472	1.31868
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.052037643999999994	1.3009410999999997
OROFACIODIGITAL SYNDROME TYPE 6	0.051498483000000005	1.287462075
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.051181119000000004	1.2795279750000002
TRICHOTHIODYSTROPHY	0.049966884	1.2491721
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.049954319000000004	1.2488579750000002
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.049954319000000004	1.2488579750000002
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.04983053999999999	1.2457634999999998
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.04960590300000001	1.2401475750000002
X-LINKED CENTRONUCLEAR MYOPATHY	0.049444199	1.236104975
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.049404979999999994	1.2351245
PARKINSON DISEASE 7, AUTOSOMAL RECESSIVE EARLY-ONSET	0.049404699999999996	1.2351174999999999
AUTOSOMAL DOMINANT OPTIC ATROPHY AND CATARACT	0.049404699999999996	1.2351174999999999
MULTIPLE SYSTEM ATROPHY	0.049404699999999996	1.2351174999999999
MULTIPLE SYSTEM ATROPHY, CEREBELLAR TYPE	0.049404699999999996	1.2351174999999999
MULTIPLE SYSTEM ATROPHY, PARKINSONIAN TYPE	0.049404699999999996	1.2351174999999999
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.049076853999999996	1.2269213499999998
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.04893246	1.2233114999999999
DYSTONIA 23; DYT23	0.04890278	1.2225695
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.04889093	1.22227325
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.048849473000000004	1.221236825
MENTAL RETARDATION, X-LINKED 98; MRX98	0.048814132999999996	1.2203533249999998
MYOCLONUS AND ATAXIA	0.0486649	1.2166225
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.0486649	1.2166225
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.048510584	1.2127646
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.048182119	1.2045529750000001
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.0481814	1.204535
SILVER-RUSSELL SYNDROME; SRS	0.04809585399999999	1.20239635
BRAIN-LUNG-THYROID SYNDROME	0.047412684	1.1853171
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.046959530000000006	1.17398825
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.04670776	1.167694
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.04650225399999999	1.1625563499999998
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.04648261	1.16206525
OCULODENTODIGITAL DYSPLASIA	0.046325539	1.158138475
FIBULAR APLASIA, TIBIAL CAMPOMELIA, AND OLIGOSYNDACTYLY SYNDROME	0.046274	1.1568500000000002
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.046268210000000004	1.1567052500000001
HALLERMANN-STREIFF SYNDROME; HSS	0.046260180000000005	1.1565045
WHITE FORELOCK WITH MALFORMATIONS	0.046203100000000004	1.1550775000000002
FRIEDREICH ATAXIA	0.046110700000000004	1.1527675000000002
COG1-CDG	0.045956699999999996	1.1489174999999998
MICROHYDRANENCEPHALY; MHAC	0.045729990000000005	1.14324975
MAN1B1-CDG	0.045541073	1.138526825
OLIVOPONTOCEREBELLAR ATROPHY II, AUTOSOMAL RECESSIVE	0.0454545	1.1363625
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.0454545	1.1363625
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA WITH LATE-ONSET SPASTICITY	0.0454545	1.1363625
AUTOSOMAL RECESSIVE SPINOCEREBELLAR ATAXIA-BLINDNESS-DEAFNESS SYNDROME	0.0454545	1.1363625
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 46	0.0454545	1.1363625
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.045200840000000006	1.1300210000000002
CHRISTIANSON SYNDROME	0.04520084	1.130021
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.044925509999999995	1.12313775
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.04441955900000001	1.1104889750000002
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.04441955900000001	1.1104889750000002
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.044297953999999994	1.10744885
PYRIDOXINE-DEPENDENT EPILEPSY	0.044297953999999994	1.10744885
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.04423473000000001	1.10586825
HYDROXYKYNURENINURIA	0.044023854	1.10059635
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.044019719000000006	1.100492975
NEUROFIBROMATOSIS TYPE 1	0.044019719000000006	1.100492975
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.04387814000000001	1.0969535000000001
PIERPONT SYNDROME	0.043733613	1.093340325
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.043730783	1.093269575
LISSENCEPHALY, X-LINKED, 2	0.04366312900000001	1.0915782250000001
HOLT-ORAM SYNDROME	0.043526800000000004	1.08817
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.043526800000000004	1.08817
EPIDERMOLYSIS BULLOSA, LETHAL ACANTHOLYTIC; EBLA	0.043526800000000004	1.08817
GRANGE SYNDROME; GRNG	0.043526800000000004	1.08817
NEONATAL LUPUS ERYTHEMATOSUS	0.043478300000000004	1.0869575
178610 PULMONARY NODULAR LYMPHOID HYPERPLASIA, FAMILIAL	0.043478300000000004	1.0869575
HEMOSIDEROSIS, PULMONARY, WITH DEFICIENCY OF GAMMA-A GLOBULIN	0.043478300000000004	1.0869575
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.043478300000000004	1.0869575
LICHTENSTEIN SYNDROME	0.043478300000000004	1.0869575
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.043478300000000004	1.0869575
CHONDROITIN-6-SULFATURIA, DEFECTIVE CELLULAR IMMUNITY, NEPHROTIC SYNDROME	0.043478300000000004	1.0869575
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.043478300000000004	1.0869575
AUTOSOMAL DOMINANT HYPOPHOSPHATEMIC RICKETS	0.043478300000000004	1.0869575
250230 METAPHYSEAL CHONDRODYSPLASIA, KAITILA TYPE	0.043478300000000004	1.0869575
FASCIAL DYSTROPHY, CONGENITAL	0.043478300000000004	1.0869575
HYPOPLASMINOGENEMIA	0.043478300000000004	1.0869575
JUVENILE XANTHOGRANULOMA	0.043478300000000004	1.0869575
OROFACIODIGITAL SYNDROME TYPE 2	0.043302104	1.0825526
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.04326676399999999	1.0816690999999998
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.04324875399999999	1.0812188499999997
MOSAIC TRISOMY 1	0.04306724000000001	1.0766810000000002
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.042964549	1.074113725
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.042964549	1.074113725
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.042964549	1.074113725
YUNIS-VARON SYNDROME	0.042840854	1.0710213499999999
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.042778383999999996	1.0694595999999998
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.042756550000000004	1.06891375
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.042756550000000004	1.06891375
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.0427032	1.06758
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.042571844000000005	1.0642961000000002
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.042423129999999996	1.0605782499999998
DISTAL 17P13.1 MICRODELETION SYNDROME	0.042423129999999996	1.0605782499999998
PGM3-CDG	0.042208118999999995	1.0552029749999998
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.042063500000000004	1.0515875000000001
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.04202758399999999	1.0506896
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X	0.04189793	1.04744825
EPISODIC ATAXIA, TYPE 1; EA1	0.04189793	1.04744825
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.041666699999999994	1.0416674999999997
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.041666699999999994	1.0416674999999997
HISTIDINEMIA	0.041666699999999994	1.0416674999999997
AUTOIMMUNE HEMOLYTIC ANEMIA-AUTOIMMUNE THROMBOCYTOPENIA-PRIMARY IMMUNODEFICIENCY SYNDROME	0.041666699999999994	1.0416674999999997
MERRF	0.041517359999999996	1.037934
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.041233839999999994	1.030846
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.041125333	1.028133325
NON-DISTAL MONOSOMY 20Q	0.040963359	1.024083975
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.040707684	1.0176921
SPORADIC ADULT-ONSET ATAXIA OF UNKNOWN ETIOLOGY	0.0401993	1.0049825000000001
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.0400706	1.001765
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.039968699999999996	0.9992174999999999
SARCOSINEMIA	0.039845903999999994	0.9961475999999999
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.039272100000000004	0.9818025000000001
VELOCARDIOFACIAL SYNDROME	0.039217930000000005	0.9804482500000001
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.039217930000000005	0.9804482500000001
ALSTROM SYNDROME; ALMS	0.039007054	0.97517635
FABRY DISEASE	0.039002919000000004	0.9750729750000001
MEIER-GORLIN SYNDROME 5; MGORS5	0.03857009	0.96425225
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.038521299999999994	0.9630324999999998
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.038472499	0.961812475
245800 LAURENCE-MOON SYNDROME	0.0384615	0.9615375
WIDOW'S PEAK SYNDROME	0.0384615	0.9615375
MYCETOMA	0.0384615	0.9615375
HYPERTRICHOSIS-ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0384615	0.9615375
3Q13 MICRODELETION SYNDROME	0.0384615	0.9615375
DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE	0.0384615	0.9615375
MUCOLIPIDOSIS III GAMMA	0.0384615	0.9615375
DERMOCHONDROCORNEAL DYSTROPHY	0.0384615	0.9615375
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH SEVERE PROXIMAL FEMORAL DYSPLASIA	0.0384615	0.9615375
WILSON DISEASE	0.0384615	0.9615375
MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY	0.0384615	0.9615375
BLACKFAN-DIAMOND ANEMIA	0.0384615	0.9615375
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.038460649	0.961516225
LISSENCEPHALY 2; LIS2	0.038338984	0.9584746
16P13.11 MICRODELETION SYNDROME	0.038338984	0.9584746
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.038294573	0.9573643249999999
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.03825648	0.956412
DOORS SYNDROME	0.038096033999999994	0.9524008499999999
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, OKINAWA TYPE; HMSNO	0.03793108	0.9482769999999999
PROGRESSIVE SUPRANUCLEAR PALSY-PARKINSONISM SYNDROME	0.03791923	0.9479807499999999
SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1	0.03791923	0.9479807499999999
SPINOCEREBELLAR ATAXIA TYPE 37	0.03791923	0.9479807499999999
CLASSIC PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.03791923	0.9479807499999999
PROGRESSIVE SUPRANUCLEAR PALSY	0.03791923	0.9479807499999999
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.037883259999999995	0.9470814999999999
15Q13.3 MICRODELETION SYNDROME	0.037840513	0.946012825
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.03779343	0.9448357500000001
KBG SYNDROME	0.037557703000000005	0.9389425750000001
PITT-HOPKINS SYNDROME	0.037557703000000005	0.9389425750000001
DISTAL MONOSOMY 15Q	0.037557703000000005	0.9389425750000001
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.037557703000000005	0.9389425750000001
SILVER-RUSSELL SYNDROME	0.0375003	0.9375075
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.037037	0.925925
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.037037	0.925925
MCLEOD SYNDROME; MCLDS	0.037037	0.925925
MOSAIC TRISOMY 9	0.037016284	0.9254071
ZELLWEGER SYNDROME	0.03701214900000001	0.9253037250000002
COG5-CDG	0.03701214900000001	0.9253037250000002
FILIPPI SYNDROME; FLPIS	0.03701214900000001	0.9253037250000002
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.03701214900000001	0.9253037250000002
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.03701214900000001	0.9253037250000002
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.03701214900000001	0.9253037250000002
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.03701214900000001	0.9253037250000002
CHROMOSOME 1P36 DELETION SYNDROME	0.036826303	0.9206575749999999
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.036801273	0.920031825
XP21 MICRODELETION SYNDROME	0.036801273	0.920031825
ATYPICAL RETT SYNDROME	0.036280749	0.907018725
20Q11.2 MICRODELETION SYNDROME	0.036259854	0.9064963500000001
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.036259854	0.9064963500000001
47,XYY SYNDROME	0.036255719000000006	0.9063929750000002
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.036255719000000006	0.9063929750000002
SLC39A8-CDG	0.036255719000000006	0.9063929750000002
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.036235948999999996	0.9058987249999999
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.03621180399999999	0.9052950999999998
ALPERS-HUTTENLOCHER SYNDROME	0.036122034	0.90305085
THUMBS, CONGENITAL CLASPED	0.0361093	0.9027324999999999
SECKEL SYNDROME 2; SCKL2	0.03573933	0.89348325
SECKEL SYNDROME	0.03573933	0.89348325
TRICHO-DENTO-OSSEOUS SYNDROME	0.035714300000000004	0.8928575000000001
FRONTORHINY	0.035714300000000004	0.8928575000000001
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.035714300000000004	0.8928575000000001
ATYPICAL WERNER SYNDROME	0.035714300000000004	0.8928575000000001
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.035714300000000004	0.8928575000000001
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.035714300000000004	0.8928575000000001
FRONTONASAL DYSPLASIA-SEVERE MICROPHTHALMIA-SEVERE FACIAL CLEFTING SYNDROME	0.035714300000000004	0.8928575000000001
EPIPHYSEAL CHONDRODYSPLASIA, MIURA TYPE; ECDM	0.035714300000000004	0.8928575000000001
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.035671103999999995	0.8917775999999998
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.03566625	0.8916562499999999
JUVENILE ABSENCE EPILEPSY	0.03566625	0.8916562499999999
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.03566625	0.8916562499999999
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.035590300000000005	0.8897575000000001
HYDRANENCEPHALY	0.035569773	0.889244325
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.035569773	0.889244325
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.035551614	0.8887903500000001
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.035528453999999994	0.8882113499999998
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.035524319	0.8881079749999999
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.035028354	0.87570885
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.035028354	0.87570885
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.035028354	0.87570885
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.035028354	0.87570885
JAWAD SYNDROME	0.035028354	0.87570885
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.035028354	0.87570885
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.035028354	0.87570885
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.035028354	0.87570885
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.035024219	0.8756054750000001
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.035024219	0.8756054750000001
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.035024219	0.8756054750000001
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.035024219	0.8756054750000001
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.035024219	0.8756054750000001
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.0349829	0.8745725
COWDEN SYNDROME 6; CWS6	0.034896619000000004	0.872415475
COWDEN SYNDROME 5; CWS5	0.034896619000000004	0.872415475
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.034820050000000005	0.8705012500000001
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.03461480399999999	0.8653700999999998
MYOPATHY, TUBULAR AGGREGATE, 2; TAM2	0.0344828	0.86207
MYOCLONUS, FAMILIAL CORTICAL; FCM	0.0344828	0.86207
HEREDITARY MYOPATHY WITH EARLY RESPIRATORY FAILURE	0.0344828	0.86207
NORMAL PRESSURE HYDROCEPHALUS	0.0344828	0.86207
DYSTONIA 7, TORSION	0.0344828	0.86207
BECKER MUSCULAR DYSTROPHY	0.0344828	0.86207
STIFF PERSON SYNDROME AND RELATED DISORDERS	0.0344828	0.86207
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 6	0.0344828	0.86207
FAMILIAL GESTATIONAL HYPERTHYROIDISM	0.0344828	0.86207
MICROCEPHALY-POLYMICROGYRIA-CORPUS CALLOSUM AGENESIS SYNDROME	0.0344828	0.86207
PROGRESSIVE SUPRANUCLEAR PALSY-PROGRESSIVE NON-FLUENT APHASIA SYNDROME	0.0344828	0.86207
PROGRESSIVE SUPRANUCLEAR PALSY-PURE AKINESIA WITH GAIT FREEZING SYNDROME	0.0344828	0.86207
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 6; CMTX6	0.0344828	0.86207
PRKAR1B-RELATED NEURODEGENERATIVE DEMENTIA WITH INTERMEDIATE FILAMENTS	0.0344828	0.86207
SPINAL MUSCULAR ATROPHY, TYPE III; SMA3	0.0344828	0.86207
SPINAL MUSCULAR ATROPHY, TYPE II	0.0344828	0.86207
PSEUDOHYPERKALEMIA, FAMILIAL, 2, DUE TO RED CELL LEAK	0.0344828	0.86207
RAMOS-ARROYO SYNDROME	0.0344828	0.86207
SPINOCEREBELLAR ATAXIA TYPE 27	0.0344828	0.86207
CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY	0.0344828	0.86207
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2O; CMT2O	0.0344828	0.86207
SPINAL MUSCULAR ATROPHY, TYPE IV	0.0344828	0.86207
MITOCHONDRIAL MEMBRANE PROTEIN-ASSOCIATED NEURODEGENERATION	0.0344828	0.86207
RICHIERI COSTA-DA SILVA SYNDROME	0.0344828	0.86207
GIANT AXONAL NEUROPATHY	0.0344828	0.86207
MICROCEPHALY-GLOMERULONEPHRITIS-MARFANOID HABITUS SYNDROME	0.0344828	0.86207
SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	0.0344828	0.86207
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.034101503	0.8525375749999999
WOLF-HIRSCHHORN SYNDROME	0.034101503	0.8525375749999999
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.034069249999999995	0.8517312499999998
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.034069249999999995	0.8517312499999998
PEHO SYNDROME	0.033560084	0.8390021
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.033560084	0.8390021
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.033555949	0.8388987250000001
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.033555949	0.8388987250000001
ISOLATED CEREBELLAR AGENESIS	0.033555949	0.8388987250000001
GRISCELLI SYNDROME TYPE 1	0.033345072999999996	0.8336268249999998
DERMOCHONDROCORNEAL DYSTROPHY	0.0331536	0.8288399999999999
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.032803653999999995	0.8200913499999999
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.032803653999999995	0.8200913499999999
OXOGLUTARIC ACIDURIA	0.032803653999999995	0.8200913499999999
LEIGH SYNDROME	0.032799519	0.819987975
TUBEROUS SCLEROSIS 2; TSC2	0.032799519	0.819987975
SANDHOFF DISEASE	0.032799519	0.819987975
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.032799519	0.819987975
TUBEROUS SCLEROSIS-1	0.032799519	0.819987975
FLYNN-AIRD SYNDROME	0.032799519	0.819987975
DEND SYNDROME	0.032799519	0.819987975
NEURONAL CEROID LIPOFUSCINOSIS	0.032799519	0.819987975
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.032799519	0.819987975
ALG13-CDG	0.0322581	0.8064524999999999
TREMOR-NYSTAGMUS-DUODENAL ULCER SYNDROME	0.0322581	0.8064524999999999
DYSTONIA, JUVENILE-ONSET	0.0322581	0.8064524999999999
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN BRANCHING ENZYME DEFICIENCY	0.0322581	0.8064524999999999
3-METHYLCROTONYL-COA CARBOXYLASE DEFICIENCY	0.0322581	0.8064524999999999
ANIRIDIA-RENAL AGENESIS-PSYCHOMOTOR RETARDATION SYNDROME	0.0322581	0.8064524999999999
MILD CANAVAN DISEASE	0.0322581	0.8064524999999999
FAMILIAL OR SPORADIC HEMIPLEGIC MIGRAINE	0.0322581	0.8064524999999999
HUNTINGTON DISEASE	0.0322581	0.8064524999999999
ATTENUATED CHÉDIAK-HIGASHI SYNDROME	0.0322581	0.8064524999999999
9Q31.1Q31.3 MICRODELETION SYNDROME	0.0322581	0.8064524999999999
WEST SYNDROME	0.0322581	0.8064524999999999
CONGENITAL ANALBUMINEMIA	0.0322581	0.8064524999999999
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.0322581	0.8064524999999999
DENT DISEASE	0.0322581	0.8064524999999999
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.0322581	0.8064524999999999
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.0322581	0.8064524999999999
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.0322581	0.8064524999999999
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.0322581	0.8064524999999999
HSD10 DISEASE, ATYPICAL TYPE	0.0322581	0.8064524999999999
DIENCEPHALIC SYNDROME	0.0322581	0.8064524999999999
LESCH-NYHAN SYNDROME	0.0322581	0.8064524999999999
PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22	0.03201968	0.8004920000000001
PARKINSON DISEASE, LATE-ONSET; PD	0.03200783	0.80019575
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.03132383	0.78309575
3P25.3 MICRODELETION SYNDROME	0.031226909999999997	0.7806727499999999
EPILEPSY, IDIOPATHIC GENERALIZED	0.031226909999999997	0.7806727499999999
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.030467402999999997	0.7616850749999999
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0303993	0.7599825
ACRORENAL-MANDIBULAR SYNDROME	0.030080239999999998	0.752006
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.029873384	0.7468346
HAREL-YOON SYNDROME; HAYOS	0.029756653999999997	0.7439163499999999
WAISMAN SYNDROME; WSMN	0.029658373000000002	0.741459325
X-LINKED PARKINSONISM-SPASTICITY SYNDROME	0.029112819	0.727820475
ATYPICAL JUVENILE PARKINSONISM	0.029112819	0.727820475
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.029112819	0.727820475
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.029112819	0.727820475
RAPID-ONSET DYSTONIA-PARKINSONISM	0.029112819	0.727820475
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.029079784	0.7269946
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.029079784	0.7269946
MENKES DISEASE	0.029075649000000002	0.726891225
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.029071272999999998	0.726781825
FEBRILE CONVULSIONS, FAMILIAL, 9	0.028623999999999997	0.7155999999999999
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.028623999999999997	0.7155999999999999
PARKINSON DISEASE 23, AUTOSOMAL RECESSIVE EARLY-ONSET	0.0285714	0.7142850000000001
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.0285714	0.7142850000000001
FAMILIAL DYSKINESIA AND FACIAL MYOKYMIA	0.0285714	0.7142850000000001
PARKINSON DISEASE 8, AUTOSOMAL DOMINANT; PARK8	0.0285714	0.7142850000000001
PARKINSON DISEASE 6, AUTOSOMAL RECESSIVE EARLY-ONSET	0.0285714	0.7142850000000001
HEREDITARY LATE-ONSET PARKINSON DISEASE	0.0285714	0.7142850000000001
PARKINSON DISEASE 1, AUTOSOMAL DOMINANT; PARK1	0.0285714	0.7142850000000001
PARKINSONISM WITH SPASTICITY, X-LINKED	0.0285714	0.7142850000000001
15Q24 RECURRENT MICRODELETION SYNDROME	0.02853423	0.7133557500000001
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.02853423	0.7133557500000001
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.02853423	0.7133557500000001
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.02853423	0.7133557500000001
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.028529854	0.71324635
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.028529853999999997	0.7132463499999999
EPILEPSY, PYRIDOXINE-DEPENDENT	0.028341364	0.7085341000000001
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.028341364	0.7085341000000001
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.028323354000000002	0.7080838500000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.028178494	0.70446235
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.028051299999999998	0.7012824999999999
DWARFISM, LEVI TYPE	0.027777800000000002	0.6944450000000001
CLEFT CHIN	0.027777800000000002	0.6944450000000001
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.027777800000000002	0.6944450000000001
22Q11.2 DISTAL DELETION SYNDROME	0.027777800000000002	0.6944450000000001
SPEECH-LANGUAGE DISORDER 1	0.027777800000000002	0.6944450000000001
DIMPLES, FACIAL	0.027777800000000002	0.6944450000000001
EDINBURGH MALFORMATION SYNDROME	0.027777800000000002	0.6944450000000001
OSTEOPENIA AND SPARSE HAIR	0.027777800000000002	0.6944450000000001
PERIVENTRICULAR NODULAR HETEROTOPIA	0.027777800000000002	0.6944450000000001
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.027777800000000002	0.6944450000000001
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.027777800000000002	0.6944450000000001
NASAL BONES, ABSENCE OF	0.027777800000000002	0.6944450000000001
WAARDENBURG SYNDROME, TYPE IIB	0.027777800000000002	0.6944450000000001
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.027777800000000002	0.6944450000000001
GANGLIOCYTOMA	0.027777800000000002	0.6944450000000001
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.027777800000000002	0.6944450000000001
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.027777800000000002	0.6944450000000001
TESTICULAR REGRESSION SYNDROME	0.027777800000000002	0.6944450000000001
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.027777800000000002	0.6944450000000001
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.027777800000000002	0.6944450000000001
CYANIDE, INABILITY TO SMELL	0.027777800000000002	0.6944450000000001
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.027777800000000002	0.6944450000000001
NASAL GROOVE, FAMILIAL TRANSVERSE	0.027777800000000002	0.6944450000000001
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.027777800000000002	0.6944450000000001
OROFACIAL CLEFT 3	0.027777800000000002	0.6944450000000001
FIBULAR DIMELIA-DIPLOPODIA SYNDROME	0.027777800000000002	0.6944450000000001
NASAL ALAR COLLAPSE, BILATERAL	0.027777800000000002	0.6944450000000001
MENINGIOMA	0.027777800000000002	0.6944450000000001
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.027572554	0.68931385
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.027568419	0.689210475
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.027519154	0.68797885
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.027418719	0.685467975
MEIER-GORLIN SYNDROME 7	0.027402054	0.68505135
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.027202989	0.680074725
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.027027	0.675675
CHROMOSOME 17Q12 DELETION SYNDROME	0.027027	0.675675
BENIGN OCCIPITAL EPILEPSY	0.027027	0.675675
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.027027	0.675675
APNEA, OBSTRUCTIVE SLEEP	0.027027	0.675675
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.026879454000000004	0.6719863500000001
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.026879454000000004	0.6719863500000001
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.0268565	0.6714125
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.026833773000000002	0.670844325
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.02649786	0.6624465
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.026494884	0.6623721
MILLER-DIEKER SYNDROME	0.025993519	0.649837975
AUTOSOMAL RECESSIVE SPASTIC ATAXIA OF CHARLEVOIX-SAGUENAY	0.025913600000000002	0.6478400000000001
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.025852139	0.646303475
PEHO-LIKE SYNDROME; PEHOL	0.025738453999999997	0.6434613499999999
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.025738453999999997	0.6434613499999999
WRINKLY SKIN SYNDROME	0.025738453999999997	0.6434613499999999
CONGENITAL CEREBELLAR ATAXIA DUE TO RNU12 MUTATION	0.0253265	0.6331625
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.024570703	0.614267575
POTOCKI-LUPSKI SYNDROME	0.024570703	0.614267575
BEEMER LETHAL MALFORMATION SYNDROME	0.02436241	0.60906025
MANGANESE POISONING	0.02428158	0.6070395000000001
ATP13A2-RELATED JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.02428158	0.6070395000000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.024088054	0.6022013500000001
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.024088054	0.6022013500000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.024088054	0.6022013500000001
FETAL HYDANTOIN SYNDROME	0.024029283999999998	0.6007321
KAGAMI-OGATA SYNDROME	0.023814273	0.595356825
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.0235425	0.5885625
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.0235425	0.5885625
X SMALL RINGS	0.023470504	0.5867626
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.023433459	0.585836475
SALT-AND-PEPPER SYNDROME	0.023274964	0.5818741
HYPOADRENOCORTICISM, FAMILIAL	0.023268719	0.581717975
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.02323564	0.5808909999999999
OHDO SYNDROME	0.023046429	0.576160725
CHROMOSOME XP11.23-P11.22 DUPLICATION SYNDROME	0.0227379	0.5684475
SIRENOMELIA	0.0227273	0.5681824999999999
WATSON SYNDROME	0.0227273	0.5681824999999999
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.0227273	0.5681824999999999
COCAINE EMBRYOFETOPATHY	0.0227273	0.5681824999999999
FATCO SYNDROME	0.0227273	0.5681824999999999
CONGENITAL ATRANSFERRINEMIA	0.0227273	0.5681824999999999
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.0227273	0.5681824999999999
CRANIOFACIOFRONTODIGITAL SYNDROME	0.0227273	0.5681824999999999
ATROPHODERMA VERMICULATA; AVA	0.0227273	0.5681824999999999
GLYCOGEN STORAGE DISEASE DUE TO MUSCLE GLYCOGEN PHOSPHORYLASE DEFICIENCY	0.0227273	0.5681824999999999
MITOCHONDRIAL MYOPATHY WITH REVERSIBLE CYTOCHROME C OXIDASE DEFICIENCY	0.0227273	0.5681824999999999
LARSEN SYNDROME	0.0227273	0.5681824999999999
THUMB DEFORMITY	0.0227273	0.5681824999999999
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.0227273	0.5681824999999999
PREPAPILLARY VASCULAR LOOPS	0.0227273	0.5681824999999999
ARTERIES, ANOMALIES OF	0.0227273	0.5681824999999999
HEMANGIOPERICYTOMA, MALIGNANT	0.0227273	0.5681824999999999
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.0227273	0.5681824999999999
BETHLEM MYOPATHY 1	0.0227273	0.5681824999999999
ACUTE RESPIRATORY CORONAVIRUS INFECTION	0.0227273	0.5681824999999999
VENULAR INSUFFICIENCY, SYSTEMIC	0.0227273	0.5681824999999999
MUSCULAR HYPERTONIA, LETHAL	0.0227273	0.5681824999999999
RHOMBENCEPHALOSYNAPSIS	0.0227273	0.5681824999999999
%113950 BUNDLE BRANCH BLOCK, FAMILIAL ISOLATED COMPLETE RIGHT	0.0227273	0.5681824999999999
150590 LEG ULCERS, FAMILIAL, OF JUVENILE ONSET	0.0227273	0.5681824999999999
PARIS-TROUSSEAU THROMBOCYTOPENIA	0.0227273	0.5681824999999999
SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS	0.0227273	0.5681824999999999
AMYLOIDOSIS	0.0227273	0.5681824999999999
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.022513204	0.5628301
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.022513204	0.5628301
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.022513204	0.5628301
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.022403858999999998	0.5600964749999999
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.02231618	0.5579045
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.022135283999999998	0.5533821
AARSKOG-SCOTT SYNDROME	0.022132924000000002	0.5533231000000001
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.022055544	0.5513886
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.02197298	0.5493245
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.02196765	0.5491912499999999
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.021715964	0.5428991
CHOREOACANTHOCYTOSIS	0.021711829000000002	0.5427957250000001
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.021711829000000002	0.5427957250000001
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.021647429	0.541185725
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.021647429	0.541185725
COG8-CDG	0.021647429	0.541185725
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.02132174	0.5330435
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.021286404	0.5321600999999999
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.021106009999999998	0.52765025
SMITH-MAGENIS SYNDROME	0.020863932999999998	0.5215983249999999
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.0208333	0.5208325
LEBER HEREDITARY OPTIC NEUROPATHY	0.0208333	0.5208325
SPINOCEREBELLAR ATAXIA 20	0.0208333	0.5208325
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.0208333	0.5208325
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 4	0.0208333	0.5208325
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 17	0.0208333	0.5208325
GILLESPIE SYNDROME; GLSP	0.0208333	0.5208325
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9B	0.0208333	0.5208325
SPINOCEREBELLAR ATAXIA 15	0.0208333	0.5208325
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 72	0.0208333	0.5208325
DYSTONIA, DOPA-RESPONSIVE; DRD	0.0208333	0.5208325
SPINOCEREBELLAR ATAXIA 2; SCA2	0.0208333	0.5208325
CHILDHOOD-ONSET AUTOSOMAL RECESSIVE SLOWLY PROGRESSIVE SPINOCEREBELLAR ATAXIA	0.0208333	0.5208325
DYSTONIA 27; DYT27	0.0208333	0.5208325
DYSTONIA 16	0.0208333	0.5208325
PRIMARY PROGRESSIVE FREEZING GAIT	0.0208333	0.5208325
SPINOCEREBELLAR ATAXIA TYPE 1	0.0208333	0.5208325
AUTOSOMAL DOMINANT DOPA-RESPONSIVE DYSTONIA	0.0208333	0.5208325
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.020740849999999998	0.5185212499999999
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.020740849999999998	0.5185212499999999
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.020740849999999998	0.5185212499999999
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.020711303	0.517782575
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.02056531	0.51413275
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.020556863	0.513921575
MYHRE SYNDROME	0.020556863	0.513921575
19P13.3 MICRODUPLICATION SYNDROME	0.020556144	0.5139035999999999
WEBB-DATTANI SYNDROME; WEDAS	0.020542583000000003	0.5135645750000001
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.020542583	0.513564575
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.020392434000000004	0.5098108500000001
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.020341133	0.508528325
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.020341132999999997	0.5085283249999999
WITTEVEEN-KOLK SYNDROME	0.020246412999999998	0.506160325
WARSAW BREAKAGE SYNDROME; WABS	0.020015444	0.5003861000000001
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.020011309	0.500282725
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.019997029	0.499925725
BAND HETEROTOPIA; BH	0.019954873	0.49887182500000005
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.019954394	0.49885985
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.019838533999999998	0.49596334999999997
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.019737940000000002	0.49344850000000007
GAUCHER DISEASE	0.01973794	0.49344849999999996
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.019619	0.49047500000000005
HYPERMANGANESEMIA WITH DYSTONIA 2	0.019478464	0.4869616
WARBURG MICRO SYNDROME 2; WARBM2	0.01945561	0.48639025
COPPER DEFICIENCY, FAMILIAL BENIGN	0.019409319	0.485232975
HHHH SYNDROME	0.019409319	0.485232975
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.019409319	0.485232975
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.019082104	0.4770526
COCKAYNE SYNDROME	0.019019979	0.475499475
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0188679	0.4716975
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0188679	0.4716975
TOE, MISSHAPEN	0.0188679	0.4716975
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0188679	0.4716975
THALIDOMIDE SUSCEPTIBILITY	0.0188679	0.4716975
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.0188679	0.4716975
CIRCUMVALLATE PLACENTA SYNDROME	0.0188679	0.4716975
MONOPHALANGY OF GREAT TOE	0.0188679	0.4716975
THROMBOCYTHEMIA, ESSENTIAL	0.0188679	0.4716975
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.0188679	0.4716975
VAN DEN BOSCH SYNDROME	0.0188679	0.4716975
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0188679	0.4716975
SPINAL ARACHNOIDITIS	0.0188679	0.4716975
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0188679	0.4716975
NEPHROSIALIDOSIS	0.0188679	0.4716975
TRACHEOBRONCHOMEGALY	0.0188679	0.4716975
248100 MACROSOMIA ADIPOSA CONGENITA	0.0188679	0.4716975
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0188679	0.4716975
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.0188679	0.4716975
PRIMARY HYPEROXALURIA TYPE 1	0.0188679	0.4716975
LETTERER-SIWE DISEASE	0.0188679	0.4716975
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.0188679	0.4716975
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0188679	0.4716975
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0188679	0.4716975
MEGAEPIPHYSEAL DWARFISM	0.0188679	0.4716975
VESICOURETERAL REFLUX 1	0.0188679	0.4716975
MICROPHTHALMIA, SYNDROMIC 4	0.0188679	0.4716975
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0188679	0.4716975
DOUBLE NAIL FOR FIFTH TOE	0.0188679	0.4716975
CARPAL DISPLACEMENT	0.0188679	0.4716975
KNUCKLE PADS	0.0188679	0.4716975
PACHYDERMODACTYLY, FAMILIAL	0.0188679	0.4716975
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0188679	0.4716975
THROMBOCYTOPENIA 3	0.0188679	0.4716975
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.0188679	0.4716975
TRACHEOPATHIA OSTEOPLASTICA	0.0188679	0.4716975
PUBIC BONE DYSPLASIA	0.0188679	0.4716975
RAYNAUD DISEASE	0.0188679	0.4716975
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0188679	0.4716975
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.0188679	0.4716975
SPLIT-HAND/FOOT MALFORMATION 1; SHFM1	0.018862570000000002	0.4715642500000001
4Q21 MICRODELETION SYNDROME	0.018738199	0.468454975
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.01871346	0.46783650000000004
CRANIOSYNOSTOSIS AND DENTAL ANOMALIES; CRSDA	0.01871346	0.46783650000000004
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.01853655	0.46341374999999996
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.018490410000000002	0.46226025000000004
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.018437013999999998	0.46092534999999996
MYOCLONIC-ATONIC EPILEPSY	0.01836183	0.45904575
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.018222002999999997	0.45555007499999994
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.018149314000000003	0.4537328500000001
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.018097473000000003	0.45243682500000004
BARAITSER-WINTER SYNDROME 2; BRWS2	0.018084129000000004	0.4521032250000001
DIAPHRAGMATIC DEFECTS, LIMB DEFICIENCIES, AND OSSIFICATION DEFECTS OF SKULL	0.01789024	0.44725600000000004
PHELAN-MCDERMID SYNDROME	0.017726103000000003	0.4431525750000001
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.017726103000000003	0.4431525750000001
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.017725383999999997	0.44313459999999993
PERIPHERAL NEUROPATHY, MYOPATHY, HOARSENESS, AND HEARING LOSS; PNMHH	0.01772213	0.44305324999999995
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.017680584	0.4420146
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.017667964	0.4416991
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	0.431035
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.431035
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.431035
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	0.431035
ALCOHOL DEPENDENCE	0.0172414	0.431035
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.431035
MYOPATHY, CONGENITAL	0.0172414	0.431035
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.431035
CARDIAC ARRHYTHMIA	0.0172414	0.431035
CERVICAL RIB	0.0172414	0.431035
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.431035
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	0.431035
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	0.431035
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.431035
ERYTHERMALGIA, PRIMARY	0.0172414	0.431035
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.431035
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.431035
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	0.431035
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.431035
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	0.431035
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.431035
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.431035
JUMPING FRENCHMAN OF MAINE	0.0172414	0.431035
MOTION SICKNESS	0.0172414	0.431035
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0172414	0.431035
TRANSSEXUALITY	0.0172414	0.431035
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.431035
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	0.431035
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.431035
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.431035
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.431035
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.431035
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	0.431035
SICKLE CELL ANEMIA	0.0172414	0.431035
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.431035
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.431035
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	0.431035
CONGENITAL TRACHEAL STENOSIS	0.0172414	0.431035
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	0.431035
269800 SENILE PLAQUE FORMATION	0.0172414	0.431035
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.431035
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.431035
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	0.431035
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.431035
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.431035
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.431035
PALMOMENTAL REFLEX	0.0172414	0.431035
DIASTEMATOMYELIA	0.0172414	0.431035
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.431035
DUPLICATION/INVERSION 15Q11	0.017180549000000003	0.42951372500000007
CORNELIA DE LANGE SYNDROME 1	0.017180549	0.429513725
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.01705794	0.4264485
AYMÉ-GRIPP SYNDROME	0.016968953999999998	0.42422384999999996
BOWEN-CONRADI SYNDROME	0.016924569	0.423114225
C SYNDROME	0.016870099	0.421752475
DUBOWITZ SYNDROME	0.016870099	0.421752475
PERMANENT NEONATAL DIABETES MELLITUS	0.016847064	0.42117659999999996
TRANSIENT NEONATAL DIABETES MELLITUS	0.016847064	0.42117659999999996
MOEBIUS SYNDROME; MBS	0.01681634	0.42040849999999996
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.016639130000000002	0.41597825000000005
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.016639130000000002	0.41597825000000005
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.016638414	0.41596035000000003
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.016583453	0.41458632500000003
OCULOFACIOCARDIODENTAL SYNDROME	0.016428254	0.41070635
DISTAL MONOSOMY 10P	0.01638315	0.40957875
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.016301509999999998	0.40753775
EARLY-ONSET SPASTIC ATAXIA-MYOCLONIC EPILEPSY-NEUROPATHY SYNDROME	0.016301509999999998	0.40753775
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.016301509999999998	0.40753775
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.016232714	0.40581785
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.016151303	0.403782575
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.016129103000000002	0.40322757500000006
ACROCALLOSAL SYNDROME; ACLS	0.016113669	0.40284172500000004
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.016026049	0.400651225
BRACHYDACTYLY, TYPE A2; BDA2	0.0158827	0.3970675
MESOAXIAL SYNOSTOTIC SYNDACTYLY WITH PHALANGEAL REDUCTION	0.0158827	0.3970675
HUNTER-MACDONALD SYNDROME	0.0158827	0.3970675
MULTINUCLEATED NEURONS, ANHYDRAMNIOS, RENAL DYSPLASIA, CEREBELLAR HYPOPLASIA, AND HYDRANENCEPHALY; MARCH	0.0158827	0.3970675
BRACHYDACTYLY TYPE A7	0.0158827	0.3970675
SYNDACTYLY TYPE 2	0.0158827	0.3970675
SYNDACTYLY TYPE 5	0.0158827	0.3970675
RECOMBINANT CHROMOSOME 8 SYNDROME	0.015859973000000003	0.39649932500000007
8Q24.3 MICRODELETION SYNDROME	0.015859973000000003	0.39649932500000007
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.015583549	0.389588725
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.015542002999999997	0.38855007499999994
YUNIS-VARON SYNDROME	0.01551678	0.38791950000000003
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.015470953999999999	0.38677385
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.015470953999999999	0.38677385
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.015470953999999999	0.38677385
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.015470953999999999	0.38677385
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.015470953999999999	0.38677385
MENTAL RETARDATION, X-LINKED 41	0.015470953999999999	0.38677385
INFANTILE SIALIC ACID STORAGE DISEASE	0.015372673	0.384316825
PALLISTER-KILLIAN SYNDROME	0.015314419000000003	0.3828604750000001
WARBURG MICRO SYNDROME 3; WARBM3	0.015314419000000003	0.3828604750000001
2Q24 MICRODELETION SYNDROME	0.015301769	0.382544225
KBG SYNDROME	0.015211463000000001	0.380286575
AMISH LETHAL MICROCEPHALY	0.015206089999999998	0.38015224999999997
RING CHROMOSOME 22 SYNDROME	0.015001303	0.37503257500000003
SMITH-LEMLI-OPITZ SYNDROME	0.015001303	0.37503257500000003
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.015000583999999999	0.3750146
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.015000583999999999	0.3750146
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.01493073	0.37326824999999997
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.01493073	0.37326824999999997
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.014925399999999998	0.37313499999999994
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.014925399999999998	0.37313499999999994
NIEMANN-PICK DISEASE TYPE B	0.014925399999999998	0.37313499999999994
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.014894118999999999	0.372352975
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.014831254	0.37078135
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.014831254	0.37078135
BAKER-GORDON SYNDROME; BAGOS	0.014831254	0.37078135
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.014831254	0.37078135
DEXTROCARDIA	0.014831254	0.37078135
JOUBERT SYNDROME 2	0.014831254	0.37078135
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.014831254	0.37078135
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.014831254	0.37078135
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.014831254	0.37078135
JOUBERT SYNDROME 1	0.014831254	0.37078135
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.014831254	0.37078135
FOUNTAIN SYNDROME	0.014827119	0.370677975
HENNEKAM SYNDROME	0.014827119	0.370677975
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.014812019	0.37030047499999996
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.014785572999999998	0.36963932499999996
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.014785572999999998	0.36963932499999996
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.014785572999999998	0.36963932499999996
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.014785572999999998	0.36963932499999996
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.014785572999999998	0.36963932499999996
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.014785572999999998	0.36963932499999996
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.014785572999999998	0.36963932499999996
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.014785572999999998	0.36963932499999996
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.014785572999999998	0.36963932499999996
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.014785572999999998	0.36963932499999996
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.014785572999999998	0.36963932499999996
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.014785572999999998	0.36963932499999996
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.014785572999999998	0.36963932499999996
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.014785572999999998	0.36963932499999996
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.014785572999999998	0.36963932499999996
PEHO SYNDROME; PEHO	0.014785572999999998	0.36963932499999996
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.014785572999999998	0.36963932499999996
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.014785572999999998	0.36963932499999996
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.014785572999999998	0.36963932499999996
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.014785572999999998	0.36963932499999996
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.014785572999999998	0.36963932499999996
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.014785572999999998	0.36963932499999996
14Q11.2 MICRODELETION SYNDROME	0.014760349999999998	0.36900874999999994
C SYNDROME	0.014751903	0.368797575
CHROMOSOME 10Q26 DELETION SYNDROME	0.014751903	0.368797575
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.014683390000000001	0.36708475
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.014670044	0.3667511
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.014670044	0.3667511
MICROPHTHALMIA, SYNDROMIC 1	0.014665909000000001	0.36664772500000004
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.014459884000000001	0.3614971
TOWNES-BROCKS SYNDROME 1; TBS1	0.014459884000000001	0.3614971
ADAMS-OLIVER SYNDROME 3; AOS3	0.014459884000000001	0.3614971
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.014459884000000001	0.3614971
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.014455749	0.361393725
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.014455749	0.361393725
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.014455749	0.361393725
PRADER-WILLI SYNDROME; PWS	0.014455032999999999	0.361375825
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.014455029999999999	0.36137575
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.01444966	0.3612415
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.01444966	0.3612415
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.01444966	0.3612415
MYASTHENIC SYNDROME, CONGENITAL, 23, PRESYNAPTIC; CMS23	0.0142857	0.35714250000000003
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE C; CMTDIC	0.0142857	0.35714250000000003
SPASTIC PARAPLEGIA 73, AUTOSOMAL DOMINANT; SPG73	0.0142857	0.35714250000000003
GORLIN-CHAUDHRY-MOSS SYNDROME	0.0142857	0.35714250000000003
NEUROPATHY, CONGENITAL HYPOMYELINATING, 2; CHN2	0.0142857	0.35714250000000003
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.0142857	0.35714250000000003
%609166 BRANCHIOGENIC-DEAFNESS SYNDROME	0.0142857	0.35714250000000003
236640 HYDROCEPHALUS WITH ASSOCIATED MALFORMATIONS	0.0142857	0.35714250000000003
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.0142857	0.35714250000000003
139750 HAND AND FOOT DEFORMITY WITH FLAT FACIES	0.0142857	0.35714250000000003
MYOPATHY, DISTAL 3	0.0142857	0.35714250000000003
NEUROPATHY, HEREDITARY SENSORY, WITH SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE	0.0142857	0.35714250000000003
ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD	0.0142857	0.35714250000000003
HYPOPHOSPHATASIA, ADULT	0.0142857	0.35714250000000003
CRANIOMETADIAPHYSEAL DYSPLASIA, WORMIAN BONE TYPE	0.0142857	0.35714250000000003
EXOSTOSES, MULTIPLE, TYPE I	0.0142857	0.35714250000000003
HEART-HAND SYNDROME, SLOVENIAN TYPE	0.0142857	0.35714250000000003
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IC; HSAN1C	0.0142857	0.35714250000000003
259610 OSTEOLYSIS SYNDROME, RECESSIVE;;OSTEOLYSIS, DISTAL, WITH SHORT STATURE, MENTAL RETARDATION, AND CHARACTERISTICFACIAL APPEARANCE	0.0142857	0.35714250000000003
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 19	0.0142857	0.35714250000000003
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.0142857	0.35714250000000003
NEUROMYOTONIA AND AXONAL NEUROPATHY, AUTOSOMAL RECESSIVE	0.0142857	0.35714250000000003
21Q22.11Q22.12 MICRODELETION SYNDROME	0.014260819000000001	0.356520475
SECKEL SYNDROME 7; SCKL7	0.014260819	0.356520475
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.014244873	0.356121825
MEND SYNDROME	0.014244873	0.356121825
SIALURIA	0.014244873	0.356121825
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.014244873	0.356121825
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.014244873	0.356121825
MEND SYNDROME; MEND	0.014244873	0.356121825
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.014244153999999998	0.35610384999999994
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.014244153999999998	0.35610384999999994
DE BARSY SYNDROME	0.014244153999999998	0.35610384999999994
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.014244153999999998	0.35610384999999994
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.014244153999999998	0.35610384999999994
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.014244153999999998	0.35610384999999994
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.014240018999999998	0.3560004749999999
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.014240018999999998	0.3560004749999999
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.014240018999999998	0.3560004749999999
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.014240018999999998	0.3560004749999999
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.014240018999999998	0.3560004749999999
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.014240018999999998	0.3560004749999999
RETT SYNDROME, CONGENITAL VARIANT	0.014240018999999998	0.3560004749999999
ROBERTS SYNDROME; RBS	0.01412449	0.35311225
MECKEL SYNDROME, TYPE 1; MKS1	0.01412449	0.35311225
CRI-DU-CHAT SYNDROME	0.01406344	0.351586
X-LINKED INTELLECTUAL DISABILITY-CRANIOFACIOSKELETAL SYNDROME	0.01391433	0.34785825000000004
FEINGOLD SYNDROME 1; FGLDS1	0.01391433	0.34785825000000004
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.013913614000000001	0.34784035
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.013913614000000001	0.34784035
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.013913614000000001	0.34784035
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.013913614000000001	0.34784035
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.013891603000000002	0.3472900750000001
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.013703454	0.34258635
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.013699319	0.34248297499999997
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.013698599999999998	0.34246499999999996
TRICHOTHIODYSTROPHY 5, NONPHOTOSENSITIVE	0.013698599999999998	0.34246499999999996
MENTAL RETARDATION, X-LINKED 77	0.013698599999999998	0.34246499999999996
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.013698599999999998	0.34246499999999996
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.013698599999999998	0.34246499999999996
EPILEPSY, HOT WATER, 1	0.013698599999999998	0.34246499999999996
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.013698599999999998	0.34246499999999996
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.013698599999999998	0.34246499999999996
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.013664929999999999	0.34162325
MONOSOMY 5P	0.01365835	0.34145875
FRASER SYNDROME	0.013603879999999999	0.340097
BARTSOCAS-PAPAS SYNDROME	0.013603879999999999	0.340097
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.013504388999999999	0.33760972499999997
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.013471303	0.33678257500000003
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.013471303	0.33678257500000003
JOUBERT SYNDROME WITH RENAL DEFECT	0.013466193	0.336654825
OROFACIODIGITAL SYNDROME VI	0.013454054	0.33635135
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.013368060000000001	0.33420150000000004
WAHAB SYNDROME	0.013368060000000001	0.33420150000000004
201020 ACROCEPHALOPOLYSYNDACTYLY TYPE IV;;ACPS IV;;GOODMAN SYNDROME	0.013368060000000001	0.33420150000000004
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.013337703	0.33344257499999996
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.013286044	0.33215110000000003
KRABBE DISEASE	0.013253094	0.33132735
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.013241244	0.33103109999999997
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.013241244	0.33103109999999997
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.0131579	0.3289475
16P12.1P12.3 TRIPLICATION SYNDROME	0.0131579	0.3289475
SPLIT HAND/FOOT MALFORMATION 1 (SHFM1)	0.0131579	0.3289475
227210 EYEBROWS, DUPLICATION OF, WITH STRETCHABLE SKIN AND SYNDACTYLY	0.0131579	0.3289475
CHROMOSOME 2Q35 DUPLICATION SYNDROME	0.0131579	0.3289475
%608572 BURN-MCKEOWN SYNDROME	0.0131579	0.3289475
SYNDACTYLY, TYPE IV; SDTY4	0.0131579	0.3289475
SCALP-EAR-NIPPLE SYNDROME; SENS	0.0131579	0.3289475
JACKSON-WEISS SYNDROME	0.0131579	0.3289475
W SYNDROME	0.013143364000000001	0.32858410000000005
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.013135173000000002	0.32837932500000006
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.013135173000000002	0.32837932500000006
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.013135173000000002	0.32837932500000006
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.013135173000000002	0.32837932500000006
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.013135173000000002	0.32837932500000006
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.013135173000000002	0.32837932500000006
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.013135173000000002	0.32837932500000006
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.013135173000000002	0.32837932500000006
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.013135173000000002	0.32837932500000006
LISSENCEPHALY 1; LIS1	0.013135173000000002	0.32837932500000006
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.013135173000000002	0.32837932500000006
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.013135173000000002	0.32837932500000006
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.013135173000000002	0.32837932500000006
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.013135173000000002	0.32837932500000006
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.013135173000000002	0.32837932500000006
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.013135173000000002	0.32837932500000006
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.013135173000000002	0.32837932500000006
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.013135173000000002	0.32837932500000006
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.012929884	0.3232471
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.012925749	0.323143725
KALLMANN SYNDROME	0.012920639000000001	0.323015975
FIBULAR APLASIA OR HYPOPLASIA, FEMORAL BOWING AND POLY-, SYN-, AND OLIGODACTYLY	0.0129085	0.3227125
SYMPHALANGISM WITH MULTIPLE ANOMALIES OF HANDS AND FEET	0.0129085	0.3227125
OROFACIODIGITAL SYNDROME IV; OFD4	0.0129085	0.3227125
FACIOCARDIORENAL SYNDROME	0.0129085	0.3227125
APERT SYNDROME	0.01284745	0.32118625
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.012796284	0.3199071
FUMARASE DEFICIENCY; FMRD	0.012796284	0.3199071
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.012796284	0.3199071
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.012796284	0.3199071
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.012796284	0.3199071
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.012796284	0.3199071
BETA-UREIDOPROPIONASE DEFICIENCY	0.012796284	0.3199071
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.012796284	0.3199071
RING CHROMOSOME 14 SYNDROME	0.012796284	0.3199071
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.012796284	0.3199071
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.012796284	0.3199071
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.012796284	0.3199071
48,XXXY SYNDROME	0.012742713000000001	0.318567825
49,XXXXY SYNDROME	0.012742713000000001	0.318567825
48,XXYY SYNDROME	0.012742713000000001	0.318567825
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.012714873	0.317871825
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.012714873	0.317871825
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.012714873	0.317871825
GAUCHER DISEASE TYPE 3	0.01270754	0.3176885
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.01270754	0.3176885
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.012695689999999999	0.31739225
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.012593754000000002	0.31484385000000004
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.012593754000000002	0.31484385000000004
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.012593754000000002	0.31484385000000004
MENTAL RETARDATION, X-LINKED 1	0.012589619000000002	0.314740475
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.012589619000000002	0.314740475
RETT SYNDROME; RTT	0.012589619000000002	0.314740475
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.012589619000000002	0.314740475
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.012589619000000002	0.314740475
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.012589619000000002	0.314740475
HYPERPROLINEMIA, TYPE I	0.012581272999999999	0.314531825
VERVERI-BRADY SYNDROME; VERBRAS	0.01238433	0.30960825000000003
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.012380703	0.309517575
PETERS-PLUS SYNDROME; PTRPLS	0.012380703	0.309517575
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.01225073	0.30626824999999996
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.012173454	0.30433635000000003
CEREBELLAR ATAXIA, CAYMAN TYPE	0.012173454	0.30433635000000003
SPINOCEREBELLAR ATAXIA 5; SCA5	0.012173454	0.30433635000000003
SPINOCEREBELLAR ATAXIA TYPE 29	0.012173454	0.30433635000000003
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.012173454	0.30433635000000003
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.012173454	0.30433635000000003
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.012173454	0.30433635000000003
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.012173454	0.30433635000000003
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.012173454	0.30433635000000003
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.012173454	0.30433635000000003
PEROXISOME BIOGENESIS DISORDER 6B	0.012173454	0.30433635000000003
MEDULLOBLASTOMA	0.012173454	0.30433635000000003
GLUTATHIONE SYNTHETASE DEFICIENCY	0.012169319	0.304232975
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.012169319	0.304232975
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.012169319	0.304232975
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.012169319	0.304232975
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.012169319	0.304232975
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.012169319	0.304232975
COFFIN-LOWRY SYNDROME	0.012153539	0.303838475
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.012153539	0.303838475
CHROMOSOME 18Q DELETION SYNDROME	0.012087219	0.302180475
SCHIMKE X-LINKED MENTAL RETARDATION SYNDROME	0.012048200000000002	0.30120500000000006
HYPOHIDROSIS-ENAMEL HYPOPLASIA-PALMOPLANTAR KERATODERMA-INTELLECTUAL DISABILITY SYNDROME	0.012048200000000002	0.30120500000000006
INFANTILE CATARACT, SKIN ABNORMALITIES, GLUTAMATE EXCESS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; CASGID	0.012048200000000002	0.30120500000000006
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.012039854	0.30099634999999997
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.012039854	0.30099634999999997
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.012039854	0.30099634999999997
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.012039854	0.30099634999999997
PERLMAN SYNDROME	0.012039854	0.30099634999999997
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.012039854	0.30099634999999997
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.01201721	0.30043025
2Q31.1 MICRODELETION SYNDROME	0.011921142999999999	0.29802857499999996
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.011921142999999999	0.29802857499999996
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.011921142999999999	0.29802857499999996
1Q21.1 MICRODELETION SYNDROME	0.011921142999999999	0.29802857499999996
2Q37 MICRODELETION SYNDROME	0.011921142999999999	0.29802857499999996
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.011835149	0.295878725
233270 GOMBO SYNDROME;;GROWTH RETARDATION, OCULAR ABNORMALITIES, MICROCEPHALY, BRACHYDACTYLY,AND OLIGOPHRENIA	0.011806500000000001	0.29516250000000005
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.011667590000000002	0.29168975
DOWN SYNDROME	0.01166759	0.29168975
ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA	0.0116279	0.2906975
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 22	0.0116279	0.2906975
SPINOCEREBELLAR ATAXIA 34; SCA34	0.0116279	0.2906975
EARLY-ONSET X-LINKED OPTIC ATROPHY	0.0116279	0.2906975
UNVERRICHT-LUNDBORG DISEASE	0.0116279	0.2906975
SPINOCEREBELLAR ATAXIA TYPE 40	0.0116279	0.2906975
PARKINSONIAN-PYRAMIDAL SYNDROME	0.0116279	0.2906975
ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD	0.0116279	0.2906975
X-LINKED NON PROGRESSIVE CEREBELLAR ATAXIA	0.0116279	0.2906975
SPINOCEREBELLAR ATAXIA 40; SCA40	0.0116279	0.2906975
TREMOR OF INTENTION, ATAXIA, AND LIPOFUSCINOSIS	0.0116279	0.2906975
LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	0.0116279	0.2906975
X-LINKED PROGRESSIVE CEREBELLAR ATAXIA	0.0116279	0.2906975
FRAGILE X-ASSOCIATED TREMOR/ATAXIA SYNDROME	0.0116279	0.2906975
DEMENTIA, FAMILIAL DANISH	0.0116279	0.2906975
SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	0.0116279	0.2906975
EPISODIC ATAXIA, TYPE 8	0.0116279	0.2906975
BOUCHER-NEUHAUSER SYNDROME	0.0116279	0.2906975
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.0116279	0.2906975
SPINOCEREBELLAR ATAXIA TYPE 35	0.0116279	0.2906975
CEREBELLAR ATAXIA WITH NEUROPATHY AND BILATERAL VESTIBULAR AREFLEXIA SYNDROME	0.0116279	0.2906975
MYOCLONUS-CEREBELLAR ATAXIA-DEAFNESS SYNDROME	0.0116279	0.2906975
SPINOCEREBELLAR ATAXIA TYPE 6	0.0116279	0.2906975
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.0116279	0.2906975
TARP SYNDROME; TARPS	0.011595624	0.2898906
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.011494299999999999	0.2873575
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.011494299999999999	0.2873575
X-LINKED SPASTICITY-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.011494299999999999	0.2873575
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.011494299999999999	0.2873575
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.011494299999999999	0.2873575
HENNEKAM-BEEMER SYNDROME	0.011430059	0.285751475
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.011385258999999998	0.28463147499999997
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.011379724	0.2844931
17Q21.31 MICRODUPLICATION SYNDROME	0.011379724	0.2844931
FANCONI ANEMIA	0.011379724	0.2844931
CORNELIA DE LANGE SYNDROME	0.011375589	0.284389725
BLOOM SYNDROME	0.01129373	0.28234325
DUBOWITZ SYNDROME	0.01129373	0.28234325
MELAS	0.01123511	0.28087775
SIMPSON-GOLABI-BEHMEL SYNDROME	0.011164713	0.279117825
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.011102663	0.27756657500000004
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA	0.01105007	0.27625175
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.011024234	0.27560585000000004
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.011020098999999998	0.27550247499999997
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.01088864	0.272216
RING CHROMOSOME 7 SYNDROME	0.01088864	0.272216
TRISOMY XQ28	0.01085569	0.27139225
GABRIELE-DE VRIES SYNDROME	0.01084384	0.271096
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.01083417	0.27085425
19Q13.11 MICRODELETION SYNDROME	0.01083417	0.27085425
ERMINE PHENOTYPE	0.01083417	0.27085425
FEINGOLD SYNDROME	0.01083417	0.27085425
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.010786193000000001	0.26965482500000004
FRYNS SYNDROME	0.010673628999999999	0.26684072499999995
8P INVERTED DUPLICATION/DELETION SYNDROME	0.010673628999999999	0.26684072499999995
INTELLECTUAL DISABILITY, WOLFF TYPE	0.010673628999999999	0.26684072499999995
14Q22Q23 MICRODELETION SYNDROME	0.010623294	0.26558235
CRANIOFRONTONASAL SYNDROME; CFNS	0.010623294	0.26558235
CHAR SYNDROME	0.010623294	0.26558235
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.010619159	0.265478975
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.010561244000000001	0.2640311
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.010561244000000001	0.2640311
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.0105373	0.26343249999999996
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.0105373	0.26343249999999996
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.0105373	0.26343249999999996
OLIVER SYNDROME	0.01052348	0.263087
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.01049053	0.26226325
CRANIOFACIAL DYSSYNOSTOSIS	0.01013221	0.25330525
MICROPHTHALMIA WITH LIMB ANOMALIES	0.01007774	0.2519435
URBAN-ROGERS-MEYER SYNDROME	0.01007774	0.2519435
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.01007774	0.2519435
INTELLECTUAL DISABILITY-POLYDACTYLY-UNCOMBABLE HAIR SYNDROME	0.01007774	0.2519435
LIMB-MAMMARY SYNDROME	0.01007774	0.2519435
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.01007774	0.2519435
TOWNES-BROCKS SYNDROME	0.01007774	0.2519435
6Q25 MICRODELETION SYNDROME	0.010062713	0.25156782499999997
RUBINSTEIN-TAYBI SYNDROME	0.010062713	0.25156782499999997
PAINE SYNDROME	0.01001569	0.25039225000000004
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.01001569	0.25039225000000004
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.01001569	0.25039225000000004
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.009804814	0.24512035000000001
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.009804814	0.24512035000000001
ROIFMAN-CHITAYAT SYNDROME	0.009804814	0.24512035000000001
BIOTINIDASE DEFICIENCY	0.009804814	0.24512035000000001
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.009804814	0.24512035000000001
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.009804814	0.24512035000000001
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.009804814	0.24512035000000001
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.009804814	0.24512035000000001
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.009800679	0.245016975
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.009800679	0.245016975
BOHRING-OPITZ SYNDROME	0.009655902999999999	0.24139757499999998
ROBERTS SYNDROME	0.009521294	0.23803235
6Q16 MICRODELETION SYNDROME	0.009521294	0.23803235
MICROPHTHALMIA, LENZ TYPE	0.009517158999999999	0.237928975
15Q11Q13 MICRODUPLICATION SYNDROME	0.009306283	0.23265707500000002
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.00925926	0.2314815
CARNOSINASE DEFICIENCY	0.00925926	0.2314815
CARNOSINEMIA	0.00925926	0.2314815
GAUCHER DISEASE TYPE 2	0.00925926	0.2314815
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.00925926	0.2314815
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.00925926	0.2314815
HYDROXYLYSINURIA	0.00925926	0.2314815
GLYCINE ENCEPHALOPATHY	0.00925926	0.2314815
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.00925926	0.2314815
SEIZURES-INTELLECTUAL DISABILITY DUE TO HYDROXYLYSINURIA SYNDROME	0.00925926	0.2314815
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.00925926	0.2314815
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.00925926	0.2314815
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.00925926	0.2314815
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.009250813	0.231270325
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.009250813	0.231270325
ADENYLOSUCCINASE DEFICIENCY	0.009250813	0.231270325
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.009250813	0.231270325
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.009250813	0.231270325
LATHOSTEROLOSIS	0.009196343	0.22990857499999998
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.009196343	0.22990857499999998
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.009196343	0.22990857499999998
15Q24 MICRODELETION SYNDROME	0.009196343	0.22990857499999998
3Q29 MICRODUPLICATION SYNDROME	0.009196343	0.22990857499999998
ADAMS-OLIVER SYNDROME 1; AOS1	0.009196343	0.22990857499999998
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.009196343	0.22990857499999998
CEREBROFACIOARTICULAR SYNDROME	0.009114484	0.2278621
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.009114484	0.2278621
HARTSFIELD SYNDROME; HRTFDS	0.009114484	0.2278621
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.009114483999999999	0.22786209999999998
INTELLECTUAL DISABILITY-MYOPATHY-SHORT STATURE-ENDOCRINE DEFECT SYNDROME	0.00897574	0.2243935
MONOSOMY 13Q14	0.00897574	0.2243935
HALLERMANN-STREIFF SYNDROME	0.00897574	0.2243935
TRISOMY 20P	0.00894279	0.22356975
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.008899473	0.222486825
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.008899473	0.222486825
TIMOTHY SYNDROME; TS	0.008899473	0.222486825
TRISOMY 12P	0.008764864	0.21912160000000003
DISTAL TRISOMY 18Q	0.008764864	0.21912160000000003
TETRASOMY X	0.008764864	0.21912160000000003
FLOATING-HARBOR SYNDROME	0.008764864	0.21912160000000003
SAETHRE-CHOTZEN SYNDROME	0.008760729	0.219018225
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.008760729	0.219018225
15Q OVERGROWTH SYNDROME	0.008760729	0.219018225
HSD10 DISEASE	0.008728113	0.218202825
PYRUVATE DEHYDROGENASE DEFICIENCY	0.008728113	0.218202825
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.008705259	0.217631475
COFS SYNDROME	0.008705259	0.217631475
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.008705259	0.217631475
DPM1-CDG	0.008705259	0.217631475
KEPPEN-LUBINSKY SYNDROME	0.008705259	0.217631475
LOWRY-MACLEAN SYNDROME	0.008705259	0.217631475
HEREDITARY METHEMOGLOBINEMIA	0.008705259	0.217631475
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.008705259	0.217631475
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.008705259	0.217631475
ADENYLOSUCCINATE LYASE DEFICIENCY	0.008705259	0.217631475
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.008705259	0.217631475
CROME SYNDROME	0.008705259	0.217631475
TEMPLE-BARAITSER SYNDROME	0.008705259	0.217631475
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.008705259	0.217631475
HALL-RIGGS SYNDROME	0.008705259	0.217631475
MEHMO SYNDROME	0.008705259	0.217631475
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.008705259	0.217631475
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.008705259	0.217631475
OROFACIODIGITAL SYNDROME IX; OFD9	0.008654924	0.21637309999999998
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.008654924	0.21637309999999998
NEVUS COMEDONICUS SYNDROME	0.008650788999999999	0.21626972499999997
LATHOSTEROLOSIS	0.008650788999999999	0.21626972499999997
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.008650788999999999	0.21626972499999997
%600384 APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSALIV	0.00856893	0.21422325
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00856893	0.21422325
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.00856893	0.21422325
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.00856893	0.21422325
SPINAL MUSCULAR ATROPHY WITH MENTAL RETARDATION	0.00856893	0.21422325
FONTAINE PROGEROID SYNDROME; FPS	0.00856893	0.21422325
TEEBI-SHALTOUT SYNDROME; TBSH	0.00856893	0.21422325
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.008494383	0.212359575
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.008494383	0.212359575
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.008494383	0.212359575
PFEIFFER SYNDROME TYPE 2	0.008439913	0.210997825
PALLISTER-HALL SYNDROME	0.008439913	0.210997825
JACOBSEN SYNDROME	0.008439913	0.210997825
OROFACIODIGITAL SYNDROME VIII; OFD8	0.008358054	0.20895135
BARDET-BIEDL SYNDROME 1; BBS1	0.008358054	0.20895135
JOUBERT SYNDROME 17; JBTS17	0.008358054	0.20895135
CURRY-JONES SYNDROME	0.008358054	0.20895135
RITSCHER-SCHINZEL SYNDROME 1	0.008358054	0.20895135
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.008353919	0.208847975
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.008353919	0.208847975
ADAMS-OLIVER SYNDROME 5; AOS5	0.008353919	0.208847975
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.008344233999999999	0.20860584999999998
1Q44 MICRODELETION SYNDROME	0.008344233999999999	0.20860584999999998
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.008344233999999999	0.20860584999999998
EYE DEFECTS-ARACHNODACTYLY-CARDIOPATHY SYNDROME	0.00821931	0.20548275000000002
MOSAIC TRISOMY 8	0.00821931	0.20548275000000002
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00821931	0.20548275000000002
POSTAXIAL POLYDACTYLY-DENTAL AND VERTEBRAL ANOMALIES SYNDROME	0.00821931	0.20548275000000002
MESOMELIA-SYNOSTOSES SYNDROME	0.00821931	0.20548275000000002
FRONTONASAL DYSPLASIA	0.00821931	0.20548275000000002
KEIPERT SYNDROME	0.00821931	0.20548275000000002
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.008186694000000001	0.20466735000000003
COCKAYNE SYNDROME A; CSA	0.008182558999999999	0.20456397499999998
ALLAN-HERNDON-DUDLEY SYNDROME	0.00816384	0.204096
SPORADIC FETAL BRAIN DISRUPTION SEQUENCE	0.00816384	0.204096
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.00816384	0.204096
APHALANGY-SYNDACTYLY-MICROCEPHALY SYNDROME	0.00810937	0.20273424999999998
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.00810937	0.20273424999999998
FOCAL DERMAL HYPOPLASIA; FDH	0.00810937	0.20273424999999998
JUBERG-HAYWARD SYNDROME	0.00810937	0.20273424999999998
1P36 DELETION SYNDROME	0.008016483	0.200412075
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.008004633	0.20011582500000002
JOUBERT SYNDROME	0.007971683	0.199292075
JOUBERT SYNDROME WITH OCULAR DEFECT	0.007971683	0.199292075
NIEMANN-PICK DISEASE TYPE C	0.007971683	0.199292075
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.007971683	0.199292075
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.007952964	0.1988241
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.007952964	0.1988241
300270 ADRENOMYODYSTROPHY	0.007952964	0.1988241
TRISOMY 13	0.007948829	0.198720725
PITT-HOPKINS-LIKE SYNDROME	0.007948829	0.198720725
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.007948829	0.198720725
QAZI-MARKOUIZOS SYNDROME	0.007948829	0.198720725
ADRENOMYODYSTROPHY	0.007948829	0.198720725
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.007948829	0.198720725
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.007948829	0.198720725
LISSENCEPHALY 5; LIS5	0.007948829	0.198720725
NEONATAL ADRENOLEUKODYSTROPHY	0.007948829	0.198720725
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.007948829	0.198720725
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.007948829	0.198720725
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.007948829	0.198720725
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.007948829	0.198720725
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.007948829	0.198720725
SMITH-FINEMAN-MYERS SYNDROME	0.007948829	0.198720725
GLUTAMINE DEFICIENCY, CONGENITAL	0.007948829	0.198720725
1Q41Q42 MICRODELETION SYNDROME	0.007948829	0.198720725
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.007948829	0.198720725
CONO-SPONDYLAR DYSPLASIA	0.007948829	0.198720725
ABLEPHARON MACROSTOMIA SYNDROME	0.007898493999999999	0.19746234999999998
8P23.1 DUPLICATION SYNDROME	0.007898493999999999	0.19746234999999998
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.007898493999999999	0.19746234999999998
16P11.2P12.2 MICRODELETION SYNDROME	0.007898493999999999	0.19746234999999998
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.007894359	0.197358975
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.007894359	0.197358975
ZLOTOGORA-OGUR SYNDROME	0.007894359	0.197358975
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.007894359	0.197358975
5Q14.3 MICRODELETION SYNDROME	0.007894359	0.197358975
17Q12 MICRODUPLICATION SYNDROME	0.007894359	0.197358975
LINEAR VERRUCOUS NEVUS SYNDROME	0.007894359	0.197358975
PFEIFFER SYNDROME TYPE 3	0.007894359	0.197358975
ACROCARDIOFACIAL SYNDROME	0.007894359	0.197358975
SCHIZOPHRENIA 1; SCZD1	0.0078125	0.1953125
SPLIT-HAND/FOOT MALFORMATION 4; SHFM4	0.0078125	0.1953125
ADAMS-OLIVER SYNDROME 6; AOS6	0.0078125	0.1953125
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.0078125	0.1953125
SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18	0.0078125	0.1953125
BARDET-BIEDL SYNDROME 4; BBS4	0.0078125	0.1953125
CLEFT-LIMB-HEART MALFORMATION SYNDROME	0.0078125	0.1953125
DUANE-RADIAL RAY SYNDROME; DRRS	0.0078125	0.1953125
MENTAL RETARDATION, AUTOSOMAL DOMINANT 4; MRD4	0.0078125	0.1953125
BRACHYDACTYLY, TYPE B1	0.0078125	0.1953125
%613576 ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 2; EDSS2	0.0078125	0.1953125
CRANIOECTODERMAL DYSPLASIA 3	0.0078125	0.1953125
BARDET-BIEDL SYNDROME 5; BBS5	0.0078125	0.1953125
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 33	0.0078125	0.1953125
CAMPTOBRACHYDACTYLY	0.0078125	0.1953125
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.0078125	0.1953125
ECTODERMAL DYSPLASIA, ECTRODACTYLY, AND MACULAR DYSTROPHY SYNDROME	0.0078125	0.1953125
%217100 CONSTRICTING BANDS, CONGENITAL;;AMNIOTIC BAND SEQUENCE; ABS;;STREETER ANOMALYADAM COMPLEX, INCLUDED;;TERMINAL TRANSVERSE DEFECTS OF ARM, INCLUDED;;AMPUTATION, CONGENITAL, INCLUDED	0.0078125	0.1953125
HALLUX VARUS AND PREAXIAL POLYSYNDACTYLY	0.0078125	0.1953125
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.0078125	0.1953125
228940 FIBULOULNAR APLASIA OR HYPOPLASIA WITH RENAL ABNORMALITIES	0.0078125	0.1953125
POLYDACTYLY, POSTAXIAL, TYPE A1; PAPA1	0.0078125	0.1953125
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.0078125	0.1953125
BARDET-BIEDL SYNDROME 6; BBS6	0.0078125	0.1953125
ACROCEPHALOPOLYSYNDACTYLY TYPE III	0.0078125	0.1953125
%263630 POLYSYNDACTYLY WITH CARDIAC MALFORMATION;;BONNEAU SYNDROME	0.0078125	0.1953125
TUKEL SYNDROME	0.0078125	0.1953125
BARTSOCAS-PAPAS SYNDROME; BPS	0.0078125	0.1953125
SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY; SRTD19	0.0078125	0.1953125
613005 SANTOS SYNDROME;;FIBULAR AGENESIS/HYPOPLASIA, OLIGODACTYLOUS CLUBFEET, AND ANONYCHIA/NAILHYPOPLASIA SYNDROME	0.0078125	0.1953125
%263450 POLYDACTYLY, POSTAXIAL, TYPE A5; PAPA5	0.0078125	0.1953125
GRANGE SYNDROME	0.0078125	0.1953125
TERMINAL OSSEOUS DYSPLASIA; TOD	0.0078125	0.1953125
SUMMITT SYNDROME	0.0078125	0.1953125
%173800 POLAND SYNDROME;;POLAND SYNDACTYLY;;POLAND ANOMALY;;POLAND SEQUENCEPECTORALIS MUSCLE, ABSENCE OF, INCLUDED	0.0078125	0.1953125
CRANIOFRONTONASAL DYSPLASIA-POLAND ANOMALY SYNDROME	0.0078125	0.1953125
ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	0.0078125	0.1953125
ULNAR HYPOPLASIA WITH LOBSTER-CLAW DEFORMITY OF FEET	0.0078125	0.1953125
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.00779868	0.194967
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.00779868	0.194967
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00779868	0.194967
MENTAL RETARDATION, X-LINKED 12; MRX12	0.00764114	0.19102850000000002
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.007587804	0.1896951
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.007587804	0.1896951
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.007587804	0.1896951
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.007587804	0.1896951
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.007587804	0.1896951
PELGER-HUET ANOMALY; PHA	0.007587804	0.1896951
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.0075836689999999995	0.189591725
3Q29 MICRODELETION SYNDROME	0.007475064	0.1868766
12Q14 MICRODELETION SYNDROME	0.007463214	0.18658035
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.007430264000000001	0.18575660000000002
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.007430264000000001	0.18575660000000002
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.007426129	0.185653225
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.007426129	0.185653225
SIALIDOSIS TYPE 1	0.007426129	0.185653225
ATAXIA-TELANGIECTASIA	0.007426129	0.185653225
ALEXANDER DISEASE	0.007426129	0.185653225
KUFOR-RAKEB SYNDROME	0.007426129	0.185653225
SPONTANEOUS PERIODIC HYPOTHERMIA	0.007426129	0.185653225
MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS	0.00740741	0.18518525
KID SYNDROME	0.00740741	0.18518525
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	0.00740741	0.18518525
ALLAN-HERNDON-DUDLEY SYNDROME	0.00740741	0.18518525
INTELLECTUAL DISABILITY-OBESITY-PROGNATHISM-EYE AND SKIN ANOMALIES SYNDROME	0.00740741	0.18518525
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.00740741	0.18518525
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.007398963000000001	0.18497407500000002
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.007398963000000001	0.18497407500000002
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.007398963000000001	0.18497407500000002
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.007398963000000001	0.18497407500000002
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.007398963000000001	0.18497407500000002
MATERNAL PHENYLKETONURIA	0.007398963000000001	0.18497407500000002
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.007398963000000001	0.18497407500000002
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.007398963	0.184974075
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.007398963	0.184974075
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.007398963	0.184974075
DEAFNESS-GENITAL ANOMALIES-METACARPAL AND METATARSAL SYNOSTOSIS SYNDROME	0.00735294	0.1838235
CENANI-LENZ SYNDROME	0.00735294	0.1838235
ACRO-RENAL-OCULAR SYNDROME	0.00735294	0.1838235
ACROPECTOROVERTEBRAL DYSPLASIA, F-FORM OF	0.00735294	0.1838235
FAMILIAL SCAPHOCEPHALY SYNDROME, MCGILLIVRAY TYPE	0.00735294	0.1838235
ABLEPHARON-MACROSTOMIA SYNDROME	0.00735294	0.1838235
SYNPOLYDACTYLY 2	0.00735294	0.1838235
KENNERKNECHT SYNDROME	0.00735294	0.1838235
DEAFNESS, CONGENITAL, AND ONYCHODYSTROPHY, AUTOSOMAL DOMINANT	0.00735294	0.1838235
CAMPTOBRACHYDACTYLY	0.00735294	0.1838235
SYNDACTYLY TYPE 1	0.00735294	0.1838235
DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.00735294	0.1838235
AUTOSOMAL DOMINANT POPLITEAL PTERYGIUM SYNDROME	0.00735294	0.1838235
CARPENTER SYNDROME	0.00735294	0.1838235
TRISOMY 1Q	0.00735294	0.1838235
JEUNE SYNDROME	0.00735294	0.1838235
CRANE-HEISE SYNDROME	0.00735294	0.1838235
FIBULAR HEMIMELIA	0.00735294	0.1838235
EEC SYNDROME	0.00735294	0.1838235
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3	0.00735294	0.1838235
185750 SYMPHALANGISM WITH MULTIPLE ANOMALIES OF HANDS AND FEET	0.00735294	0.1838235
APLASIA CUTIS CONGENITA	0.00735294	0.1838235
APHALANGY-HEMIVERTEBRAE-UROGENITAL-INTESTINAL DYSGENESIS SYNDROME	0.00735294	0.1838235
SYNDACTYLY TYPE 4	0.00735294	0.1838235
ADULT SYNDROME	0.00735294	0.1838235
SPLIT-HAND/FOOT MALFORMATION 6	0.00735294	0.1838235
PFEIFFER SYNDROME TYPE 1	0.00735294	0.1838235
ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY	0.00735294	0.1838235
DYSOSTOSIS WITH BRACHYDACTYLY	0.00735294	0.1838235
ABRUZZO-ERICKSON SYNDROME	0.00735294	0.1838235
SPLIT-FOOT DEFORMITY WITH MANDIBULOFACIAL DYSOSTOSIS	0.00735294	0.1838235
LAURIN-SANDROW SYNDROME	0.00735294	0.1838235
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.00735294	0.1838235
BRACHYDACTYLY-SYNDACTYLY, ZHAO TYPE	0.00735294	0.1838235
CURRY-JONES SYNDROME	0.00735294	0.1838235
COFFIN-SIRIS SYNDROME	0.007337913	0.18344782499999998
KOOLEN-DE VRIES SYNDROME; KDVS	0.007337913	0.18344782499999998
DUANE RETRACTION SYNDROME	0.007337913	0.18344782499999998
MONOSOMY 9P	0.007337913	0.18344782499999998
COFFIN-SIRIS SYNDROME 3; CSS3	0.007337913	0.18344782499999998
BOHRING-OPITZ SYNDROME	0.007337913	0.18344782499999998
COFFIN-SIRIS SYNDROME 4; CSS4	0.007337913	0.18344782499999998
TRISOMY X	0.007248203	0.181205075
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.00704225	0.17605625
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.00704225	0.17605625
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.00704225	0.17605625
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.00704225	0.17605625
TUBULAR RENAL DISEASE-CARDIOMYOPATHY SYNDROME	0.00704225	0.17605625
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.00704225	0.17605625
MYOCLONIC EPILEPSY, JUVENILE, 2	0.00704225	0.17605625
EPILEPSY, BENIGN NEONATAL, 3	0.00704225	0.17605625
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.00704225	0.17605625
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.00704225	0.17605625
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.00704225	0.17605625
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.00704225	0.17605625
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.00704225	0.17605625
WILLIAMS SYNDROME	0.00691766	0.1729415
ATAXIA WITH VITAMIN E DEFICIENCY	0.0068847100000000005	0.17211775
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.0068847100000000005	0.17211775
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 5	0.0068847100000000005	0.17211775
ATYPICAL PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.0068847100000000005	0.17211775
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.0068847100000000005	0.17211775
CLASSIC GALACTOSEMIA	0.0068847100000000005	0.17211775
BEHR SYNDROME	0.0068847100000000005	0.17211775
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	0.0068847100000000005	0.17211775
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 4	0.0068847100000000005	0.17211775
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 3	0.0068847100000000005	0.17211775
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 1	0.0068847100000000005	0.17211775
CORTICOBASAL SYNDROME	0.0068847100000000005	0.17211775
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.006857544	0.1714386
TURNPENNY-FRY SYNDROME; TPFS	0.006857544	0.1714386
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.006857544	0.1714386
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.006857544	0.1714386
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.006857544	0.1714386
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.006857544	0.1714386
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.006857544	0.1714386
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.006857544	0.1714386
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.006857544	0.1714386
GOLDBERG-SHPRINTZEN SYNDROME	0.006857544	0.1714386
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.006857544	0.1714386
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.006857544	0.1714386
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.006853409	0.171335225
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.006853409	0.171335225
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.006853409	0.171335225
OCULODENTODIGITAL DYSPLASIA; ODDD	0.006853409	0.171335225
20P13 MICRODELETION SYNDROME	0.006853409	0.171335225
PITT-HOPKINS SYNDROME	0.006853409	0.171335225
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.006853409	0.171335225
MONOSOMY 18P	0.006796494	0.16991235
17P11.2 MICRODUPLICATION SYNDROME	0.006796494	0.16991235
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.006796494	0.16991235
OROFACIODIGITAL SYNDROME TYPE 4	0.006796494	0.16991235
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.006796494	0.16991235
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.006796494	0.16991235
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.006796494	0.16991235
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.0067923589999999995	0.169808975
DISTAL TRISOMY 15Q	0.0067923589999999995	0.169808975
OROFACIODIGITAL SYNDROME TYPE 1	0.006702649	0.16756622499999999
6Q TERMINAL DELETION SYNDROME	0.006642533000000001	0.166063325
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.006642533000000001	0.166063325
TARP SYNDROME	0.006642533000000001	0.166063325
MENTAL RETARDATION, X-LINKED 91; MRX91	0.006642533000000001	0.166063325
MUENKE SYNDROME	0.006642533000000001	0.166063325
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.006642533000000001	0.166063325
WEAVER SYNDROME	0.006642533000000001	0.166063325
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.006642533000000001	0.166063325
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.006642533000000001	0.166063325
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.006642533	0.166063325
SCHAAF-YANG SYNDROME; SHFYNG	0.006642533	0.166063325
19P13.13 MICRODELETION SYNDROME	0.006642533	0.166063325
COFFIN-SIRIS SYNDROME 2; CSS2	0.006581483000000001	0.16453707500000003
SRD5A3-CDG	0.006581483000000001	0.16453707500000003
MOSAIC TRISOMY 14	0.006581483000000001	0.16453707500000003
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.006581483000000001	0.16453707500000003
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.006581483000000001	0.16453707500000003
ZTTK SYNDROME; ZTTKS	0.006581483000000001	0.16453707500000003
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.006581483000000001	0.16453707500000003
SMITH-MAGENIS SYNDROME; SMS	0.006581483000000001	0.16453707500000003
XYLT1-CDG	0.00631199	0.15779975
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00631199	0.15779975
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.00631199	0.15779975
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00631199	0.15779975
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.00631199	0.15779975
COFFIN-SIRIS SYNDROME 10; CSS10	0.00631199	0.15779975
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR I RESISTANCE	0.00631199	0.15779975
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00631199	0.15779975
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.00625094	0.1562735
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.00625094	0.1562735
FAMILIAL VISCERAL MYOPATHY	0.00625094	0.1562735
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.00625094	0.1562735
ACROCRANIOFACIAL DYSOSTOSIS	0.00625094	0.1562735
ERYTHROKERATODERMIA VARIABILIS	0.00625094	0.1562735
NEU-LAXOVA SYNDROME	0.00625094	0.1562735
AUTOSOMAL DOMINANT SPONDYLOCOSTAL DYSOSTOSIS	0.00625094	0.1562735
FANCONI ANEMIA	0.00625094	0.1562735
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.00625094	0.1562735
NON-DISTAL TRISOMY 10Q	0.00625094	0.1562735
TRISOMY 4P	0.00625094	0.1562735
SCHISIS ASSOCIATION	0.00625094	0.1562735
SPASTIC PARAPLEGIA-NEPHRITIS-DEAFNESS SYNDROME	0.006173080000000001	0.15432700000000002
MASA SYNDROME	0.006173080000000001	0.15432700000000002
NON-DISTAL MONOSOMY 10Q	0.006173080000000001	0.15432700000000002
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.006101114	0.15252785000000002
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.006101114	0.15252785000000002
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.006101114	0.15252785000000002
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.006101114	0.15252785000000002
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.006101114	0.15252785000000002
COFFIN-SIRIS SYNDROME 7; CSS7	0.006101114	0.15252785000000002
CHROMOSOME 18P DELETION SYNDROME	0.006101114	0.15252785000000002
COFFIN-SIRIS SYNDROME 6; CSS6	0.006101114	0.15252785000000002
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.006101114	0.15252785000000002
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.006101114	0.15252785000000002
LAMB-SHAFFER SYNDROME	0.006101114	0.15252785000000002
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.006101114	0.15252785000000002
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.006101114	0.15252785000000002
311450 PALLISTER W SYNDROME;;W SYNDROME	0.006096979000000001	0.152424475
SPINOCEREBELLAR ATAXIA 47; SCA47	0.006096979000000001	0.152424475
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.006096979000000001	0.152424475
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.006040064	0.1510016
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.006040064	0.1510016
DISTAL MONOSOMY 9P	0.006040064	0.1510016
TRISOMY 8Q	0.006040064	0.1510016
DISTAL TRISOMY 6P	0.006040064	0.1510016
WEAVER SYNDROME	0.006040064	0.1510016
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.006035929000000001	0.15089822500000002
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.006035929000000001	0.15089822500000002
ISOLATED SPINA BIFIDA	0.006035929000000001	0.15089822500000002
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.006035929000000001	0.15089822500000002
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.006035929000000001	0.15089822500000002
ZIMMERMANN-LABAND SYNDROME	0.006035929000000001	0.15089822500000002
OTOFACIOCERVICAL SYNDROME 2	0.00555556	0.138889
ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ	0.00555556	0.138889
MCDONOUGH SYNDROME	0.00555556	0.138889
OROFACIODIGITAL SYNDROME XVII	0.00555556	0.138889
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00555556	0.138889
%165660 OSLAM SYNDROME;;OSTEOSARCOMA, LIMB ANOMALIES, AND MACROCYTOSIS;;OSTEOSARCOMA, LIMB ANOMALIES, AND ERYTHROID MACROCYTOSIS WITH MEGALOBLASTICMARROW	0.00555556	0.138889
DISPROPORTIONATE SHORT STATURE WITH PTOSIS AND VALVULAR HEART LESIONS	0.00555556	0.138889
AL-GAZALI-BAKALINOVA SYNDROME; AGBK	0.00555556	0.138889
KEIPERT SYNDROME; KPTS	0.00555556	0.138889
3MC SYNDROME 3	0.00555556	0.138889
ESOPHAGEAL ATRESIA	0.00555556	0.138889
201310 ACRORENAL SYNDROME, AUTOSOMAL RECESSIVE	0.00555556	0.138889
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2; PRAAS2	0.00555556	0.138889
ANTENATAL MULTIMINICORE DISEASE WITH ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.00555556	0.138889
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.00555556	0.138889
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.00555556	0.138889
VAN MALDERGEM SYNDROME 1; VMLDS1	0.00555556	0.138889
BLEPHAROCHEILODONTIC SYNDROME 1; BCDS1	0.00555556	0.138889
CONGENITAL ADRENAL HYPERPLASIA DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY	0.00555556	0.138889
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.00555556	0.138889
ARTHROGRYPOSIS, DISTAL, TYPE 2B2; DA2B2	0.00555556	0.138889
%607004 BRACHYDACTYLY, TYPE A1, B; BDA1B	0.00555556	0.138889
FRONTONASAL DYSPLASIA 1; FND1	0.00555556	0.138889
SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY; SPSMA	0.00555556	0.138889
VAN MALDERGEM SYNDROME 2; VMLDS2	0.00555556	0.138889
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.00555556	0.138889
HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES	0.00555556	0.138889
184000 SPONDYLOEPIPHYSEAL DYSPLASIA, MYOPIA, AND SENSORINEURAL DEAFNESS	0.00555556	0.138889
SHORT SYNDROME	0.00555556	0.138889
MULTIPLE EPIPHYSEAL DYSPLASIA, AL-GAZALI TYPE	0.00555556	0.138889
HYPOGONADOTROPIC HYPOGONADISM 9 WITH OR WITHOUT ANOSMIA; HH9	0.00555556	0.138889
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.00555556	0.138889
TEMPLE SYNDROME	0.00555556	0.138889
109300 BANKI SYNDROME	0.00555556	0.138889
CRANIOECTODERMAL DYSPLASIA 1	0.00555556	0.138889
RUIJS-AALFS SYNDROME; RJALS	0.00555556	0.138889
ISOLATED HEMIHYPERPLASIA	0.00549451	0.13736275
LAURENCE-MOON SYNDROME	0.00549451	0.13736275
601165 CLEFT LIP/PALATE WITH CHARACTERISTIC FACIES, INTESTINAL MALROTATION,AND LETHAL CONGENITAL HEART DISEASE	0.00549451	0.13736275
LOWER LIMB MALFORMATION-HYPOSPADIAS SYNDROME	0.00549451	0.13736275
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC TYPE; AMCN	0.00549451	0.13736275
X-LINKED EHLERS-DANLOS SYNDROME	0.00549451	0.13736275
ANTLEY-BIXLER SYNDROME	0.00549451	0.13736275
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.00549451	0.13736275
CAT-EYE SYNDROME	0.00549451	0.13736275
STEINERT MYOTONIC DYSTROPHY	0.00549451	0.13736275
PHENYLKETONURIA	0.00549451	0.13736275
ACHONDROGENESIS TYPE 1B	0.00549451	0.13736275
ACALVARIA	0.00549451	0.13736275
CAMPOMELIC DYSPLASIA	0.00549451	0.13736275
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.00549451	0.13736275
NEUROFACIODIGITORENAL SYNDROME	0.00549451	0.13736275
WAARDENBURG SYNDROME TYPE 1	0.00549451	0.13736275
RENAL AGENESIS, BILATERAL	0.00549451	0.13736275
ACHONDROGENESIS TYPE 2	0.00549451	0.13736275
VACTERL ASSOCIATION, X-LINKED, WITH OR WITHOUT HYDROCEPHALUS; VACTERLX	0.00549451	0.13736275
ACHONDROGENESIS	0.00549451	0.13736275
FACIOCARDIOMELIC DYSPLASIA, LETHAL	0.00549451	0.13736275
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.00549451	0.13736275
CAMPOMELIC DYSPLASIA	0.00549451	0.13736275
AUTOSOMAL RECESSIVE OMODYSPLASIA	0.00549451	0.13736275
PSEUDODIASTROPHIC DYSPLASIA	0.00549451	0.13736275
POSTAXIAL ACROFACIAL DYSOSTOSIS	0.00549451	0.13736275
TORIELLO-LACASSIE-DROSTE SYNDROME	0.00549451	0.13736275
CHST3-RELATED SKELETAL DYSPLASIA	0.00549451	0.13736275
TRISOMY 18-LIKE SYNDROME	0.00549451	0.13736275
FRANK-TER HAAR SYNDROME; FTHS	0.00549451	0.13736275
HYDROLETHALUS	0.00549451	0.13736275
AUROCEPHALOSYNDACTYLY	0.00549451	0.13736275
184705 STEINFELD SYNDROME	0.00549451	0.13736275
FEMORAL-FACIAL SYNDROME	0.00549451	0.13736275
CONGENITAL DIAPHRAGMATIC HERNIA	0.00549451	0.13736275
MATTHEW-WOOD SYNDROME	0.00549451	0.13736275
CRANIOSTENOSIS, SAGITTAL, WITH CONGENITAL HEART DISEASE, MENTAL DEFICIENCY, AND MANDIBULAR ANKYLOSIS	0.00549451	0.13736275
MCDONOUGH SYNDROME	0.00549451	0.13736275
THALIDOMIDE EMBRYOPATHY	0.00549451	0.13736275
212135 CARDIOSKELETAL SYNDROME, KUWAITI TYPE	0.00549451	0.13736275
MARSHALL-SMITH SYNDROME	0.00549451	0.13736275
46,XY PARTIAL GONADAL DYSGENESIS	0.00549451	0.13736275
CONGENITAL HEART DEFECT-ROUND FACE-DEVELOPMENTAL DELAY SYNDROME	0.00549451	0.13736275
241800 HYPOTHALAMIC HAMARTOMASCONGENITAL HYPOTHALAMIC HAMARTOMA SYNDROME, INCLUDED; CHHS, INCLUDED	0.00549451	0.13736275
ACROFACIAL DYSOSTOSIS, RODRÍGUEZ TYPE	0.00549451	0.13736275
ACHONDROGENESIS TYPE 1A	0.00549451	0.13736275
VERLOOVE VANHORICK-BRUBAKK SYNDROME	0.00549451	0.13736275
HOLZGREVE SYNDROME	0.00549451	0.13736275
LARYNX ATRESIA	0.00549451	0.13736275
HEART-HAND SYNDROME TYPE 2	0.00549451	0.13736275
CAMPOMELIA, CUMMING TYPE	0.00549451	0.13736275
SHORT RIB-POLYDACTYLY SYNDROME, VERMA-NAUMOFF TYPE	0.00549451	0.13736275
VACTERL WITH HYDROCEPHALUS	0.00549451	0.13736275
FACIOSCAPULOHUMERAL DYSTROPHY	0.00549451	0.13736275
233430 GONADAL DYSGENESIS, XY TYPE, WITH ASSOCIATED ANOMALIES	0.00549451	0.13736275
BEEMER-ERTBRUGGEN SYNDROME	0.00549451	0.13736275
AXENFELD-RIEGER SYNDROME	0.00549451	0.13736275
CAUDAL REGRESSION SEQUENCE	0.00549451	0.13736275
ACQUIRED VON WILLEBRAND SYNDROME	0.00549451	0.13736275
INIENCEPHALY	0.00549451	0.13736275
VACTERL ASSOCIATION WITH HYDROCEPHALUS	0.00549451	0.13736275
15Q26 OVERGROWTH SYNDROME	0.00549451	0.13736275
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.005291683	0.132292075
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.005291683	0.132292075
16P13.2 MICRODELETION SYNDROME	0.005291683	0.132292075
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.005291683	0.132292075
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.005279832999999999	0.13199582499999998
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.005279832999999999	0.13199582499999998
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.005279832999999999	0.13199582499999998
CLASSIC PHENYLKETONURIA	0.005279832999999999	0.13199582499999998
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.005279832999999999	0.13199582499999998
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.005279832999999999	0.13199582499999998
AICARDI-GOUTIÈRES SYNDROME	0.005279832999999999	0.13199582499999998
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.005279832999999999	0.13199582499999998
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.005279832999999999	0.13199582499999998
JABERI-ELAHI SYNDROME; JABELS	0.005279832999999999	0.13199582499999998
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.005279832999999999	0.13199582499999998
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.005279832999999999	0.13199582499999998
GALACTOSEMIA	0.005279832999999999	0.13199582499999998
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.004750264000000001	0.11875660000000002
2P15P16.1 MICRODELETION SYNDROME	0.004750264000000001	0.11875660000000002
RIDDLE SYNDROME	0.004750264000000001	0.11875660000000002
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.004746129	0.118653225
TETRASOMY 18P	0.004746129	0.118653225
WOLCOTT-RALLISON SYNDROME	0.004746129	0.118653225
PELIZAEUS-MERZBACHER DISEASE	0.004746129	0.118653225
PEDIATRIC-ONSET GRAVES DISEASE	0.004738414	0.11846034999999999
AICARDI-GOUTIERES SYNDROME 6	0.004738414	0.11846034999999999
TONNE-KALSCHEUER SYNDROME; TOKAS	0.004738414	0.11846034999999999
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.004734279	0.118356975
TYROSINEMIA TYPE 2	0.004734278999999999	0.11835697499999998
FILIPPI SYNDROME	0.004568203	0.11420507499999999
CHROMOSOME 16P13.3 DELETION SYNDROME	0.004568203	0.11420507499999999
DPAGT1-CDG	0.004568203	0.11420507499999999
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.004568203	0.11420507499999999
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.004568203	0.11420507499999999
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.004568203	0.11420507499999999
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.004568203	0.11420507499999999
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.004568203	0.11420507499999999
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.004568203	0.11420507499999999
COHEN SYNDROME	0.004568203	0.11420507499999999
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.004568203	0.11420507499999999
19P13.12 MICRODELETION SYNDROME	0.004568203	0.11420507499999999
DISTAL MONOSOMY 10Q	0.004568203	0.11420507499999999
20Q11.2 MICRODUPLICATION SYNDROME	0.004568203	0.11420507499999999
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.004568203	0.11420507499999999
RUVALCABA SYNDROME	0.004568203	0.11420507499999999
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.004535253	0.113381325
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.004535253	0.113381325
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.004535253	0.113381325
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.004535253	0.113381325
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.004535253	0.113381325
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.004535253	0.113381325
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.0045352529999999995	0.11338132499999999
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.0045352529999999995	0.11338132499999999
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.0045352529999999995	0.11338132499999999
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.0045352529999999995	0.11338132499999999
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.0045352529999999995	0.11338132499999999
FOIX-CHAVANY-MARIE SYNDROME	0.0045352529999999995	0.11338132499999999
L1 SYNDROME	0.0045352529999999995	0.11338132499999999
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.0045352529999999995	0.11338132499999999
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.0045234030000000005	0.11308507500000001
ADULT-ONSET DYSTONIA-PARKINSONISM	0.0045234030000000005	0.11308507500000001
METHYLMALONIC ACIDURIA, CBLA TYPE	0.0045234030000000005	0.11308507500000001
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.0045234030000000005	0.11308507500000001
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.0045234030000000005	0.11308507500000001
CHÉDIAK-HIGASHI SYNDROME	0.0045234030000000005	0.11308507500000001
SIALIDOSIS TYPE 2	0.0045234030000000005	0.11308507500000001
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.0045234030000000005	0.11308507500000001
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.0045234030000000005	0.11308507500000001
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.0045234030000000005	0.11308507500000001
MENTAL RETARDATION, X-LINKED 104; MRX104	0.0045234030000000005	0.11308507500000001
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.0045234030000000005	0.11308507500000001
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.0045234030000000005	0.11308507500000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.004523403	0.113085075
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.004523403	0.113085075
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.004523403	0.113085075
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.004523403	0.113085075
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.004523403	0.113085075
CITRULLINEMIA TYPE II	0.004523403	0.113085075
MUCOLIPIDOSIS TYPE IV	0.00420471	0.10511775000000001
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 64	0.00420471	0.10511775000000001
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.00420471	0.10511775000000001
SCHWARTZ-JAMPEL SYNDROME	0.00420471	0.10511775000000001
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.00419286	0.10482149999999998
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG	0.00419286	0.10482149999999998
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.00419286	0.10482149999999998
LIG4 SYNDROME	0.004026784	0.10066960000000001
PENTASOMY X	0.004026784	0.10066960000000001
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.004026784	0.10066960000000001
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.004026784	0.10066960000000001
%300712 CRANIOFACIOSKELETAL SYNDROME	0.004026784	0.10066960000000001
EAR-PATELLA-SHORT STATURE SYNDROME	0.004026784	0.10066960000000001
ROIFMAN SYNDROME; RFMN	0.004026784	0.10066960000000001
MIETENS SYNDROME	0.004026784	0.10066960000000001
TRISOMY 9P	0.004026784	0.10066960000000001
TRISOMY 17P	0.004026784	0.10066960000000001
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.004026784	0.10066960000000001
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.004026784	0.10066960000000001
CHARGE SYNDROME	0.004026784	0.10066960000000001
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.004026784	0.10066960000000001
2Q32Q33 MICRODELETION SYNDROME	0.004026784	0.10066960000000001
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.004022649	0.100566225
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.004022649	0.100566225
WIEDEMANN-STEINER SYNDROME	0.004022649	0.100566225
2Q23.1 MICRODELETION SYNDROME	0.004022649	0.100566225
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.004022649	0.100566225
BRANCHIOOCULOFACIAL SYNDROME	0.004022649	0.100566225
DISTAL MONOSOMY 7Q36	0.004022649	0.100566225
DISTAL MONOSOMY 3P	0.004022649	0.100566225
SECKEL SYNDROME 1; SCKL1	0.004022649	0.100566225
RENPENNING SYNDROME	0.004022649	0.100566225
RENPENNING SYNDROME 1; RENS1	0.004022649	0.100566225
RETT SYNDROME	0.004022649	0.100566225
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.003993834	0.09984585
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.003993834	0.09984585
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.003993834	0.09984585
JOUBERT SYNDROME 24	0.003993834	0.09984585
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.003993834	0.09984585
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.003993834	0.09984585
FRIED SYNDROME	0.003993834	0.09984585
SHWACHMAN-DIAMOND SYNDROME	0.003993834	0.09984585
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.003993834	0.09984585
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.003993834	0.09984585
HYDROCEPHALUS, NORMAL-PRESSURE	0.003993834	0.09984585
COHEN-GIBSON SYNDROME; COGIS	0.003993834	0.09984585
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.003989699	0.09974247500000001
CHOREOATHETOSIS, FAMILIAL INVERTED	0.003989699	0.09974247500000001
FAMILIAL DYSAUTONOMIA	0.003989699	0.09974247500000001
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.003989699	0.09974247500000001
METACHROMATIC LEUKODYSTROPHY	0.003989699	0.09974247500000001
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.003989699	0.09974247500000001
PARTINGTON SYNDROME	0.003989699	0.09974247500000001
FAMILIAL COLORECTAL CANCER TYPE X	0.003989699	0.09974247500000001
EPENDYMOMA	0.003989699	0.09974247500000001
DYSEQUILIBRIUM SYNDROME	0.003989699	0.09974247500000001
SUBEPENDYMOMA	0.003989699	0.09974247500000001
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.003989699	0.09974247500000001
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.003989699	0.09974247500000001
CADASIL	0.003989699	0.09974247500000001
HEREDITARY HYPEREKPLEXIA	0.003989699	0.09974247500000001
ALZHEIMER DISEASE 3; AD	0.003989699	0.09974247500000001
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.003989699	0.09974247500000001
TENORIO SYNDROME; TNORS	0.003989699	0.09974247500000001
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.003989699	0.09974247500000001
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.003989699	0.09974247500000001
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.003989699	0.09974247500000001
BEHÇET DISEASE	0.003989699	0.09974247500000001
METACHROMATIC LEUKODYSTROPHY	0.003989699	0.09974247500000001
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.003989699	0.09974247500000001
LYNCH SYNDROME	0.003989699	0.09974247500000001
CENTRONUCLEAR MYOPATHY	0.003989699	0.09974247500000001
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.003989699	0.09974247500000001
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.003989699	0.09974247500000001
MUSCLE-EYE-BRAIN DISEASE	0.003989699	0.09974247500000001
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.003989699	0.09974247500000001
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.003989699	0.09974247500000001
GABRIELE-DE VRIES SYNDROME; GADEVS	0.003981984	0.0995496
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.003981984	0.0995496
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.003981984	0.0995496
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.003981984	0.0995496
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.003981984	0.0995496
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.003981984	0.0995496
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.003981984	0.0995496
PEROXISOME BIOGENESIS DISORDER 5B	0.003981984	0.0995496
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.003981984	0.0995496
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.003981984	0.0995496
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.003981984	0.0995496
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.003981984	0.0995496
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.003981984	0.0995496
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.003977849	0.09944622500000001
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.003977849	0.09944622500000001
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.003977849	0.09944622500000001
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.003977849	0.09944622500000001
CYSTATHIONINURIA	0.003977849	0.09944622500000001
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.003977849	0.09944622500000001
INSULINOMA	0.003977849	0.09944622500000001
CEREBROTENDINOUS XANTHOMATOSIS	0.003977849	0.09944622500000001
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.003977849	0.09944622500000001
SNEDDON SYNDROME	0.003977849	0.09944622500000001
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.003977849	0.09944622500000001
NIPAH VIRUS DISEASE	0.003977849	0.09944622500000001
GM1 GANGLIOSIDOSIS	0.003977849	0.09944622500000001
MERCURY POISONING	0.003977849	0.09944622500000001
INHERITED CREUTZFELDT-JAKOB DISEASE	0.003977849	0.09944622500000001
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.003977849	0.09944622500000001
SNEDDON SYNDROME	0.003977849	0.09944622500000001
SCRUB TYPHUS	0.003977849	0.09944622500000001
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.003977849	0.09944622500000001
CRIGLER-NAJJAR SYNDROME TYPE 1	0.003977849	0.09944622500000001
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.003977849	0.09944622500000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.003977849	0.09944622500000001
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.003977849	0.09944622500000001
ENCEPHALITIS LETHARGICA	0.003977849	0.09944622500000001
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.003977849	0.09944622500000001
TSH-SECRETING PITUITARY ADENOMA	0.003977849	0.09944622500000001
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.003977849	0.09944622500000001
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.003977849	0.09944622500000001
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.003977849	0.09944622500000001
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.003977849	0.09944622500000001
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.003977849	0.09944622500000001
WIEDEMANN-STEINER SYNDROME; WDSTS	0.0038117730000000005	0.09529432500000001
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.0038117730000000005	0.09529432500000001
TETRASOMY 5P	0.0038117730000000005	0.09529432500000001
11Q22.2Q22.3 MICRODELETION SYNDROME	0.0038117730000000005	0.09529432500000001
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.0038117730000000005	0.09529432500000001
TETRASOMY 9P	0.003811773	0.095294325
CATEL-MANZKE SYNDROME; CATMANS	0.003811773	0.095294325
MONOSOMY 22Q13.3	0.003811773	0.095294325
RECOMBINANT 8 SYNDROME	0.003811773	0.095294325
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.003811773	0.095294325
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.003811773	0.095294325
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.003811773	0.095294325
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.003811773	0.095294325
CHROMOSOME 16P13.2 DELETION SYNDROME	0.003811773	0.095294325
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.003811773	0.095294325
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.003811773	0.095294325
MICROCEPHALY 24, PRIMARY, AUTOSOMAL RECESSIVE; MCPH24	0.00348123	0.08703075
X-LINKED INTELLECTUAL DISABILITY, VAN ESCH TYPE	0.00348123	0.08703075
ROIFMAN SYNDROME	0.00348123	0.08703075
X-LINKED INTELLECTUAL DISABILITY, CILLIERS TYPE	0.00348123	0.08703075
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00348123	0.08703075
HYPOSPADIAS-INTELLECTUAL DISABILITY, GOLDBLATT TYPE SYNDROME	0.00348123	0.08703075
MICROTRIPLICATION 11Q24.1	0.00348123	0.08703075
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.00348123	0.08703075
ALOPECIA-CONTRACTURES-DWARFISM-INTELLECTUAL DISABILITY SYNDROME	0.00348123	0.08703075
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.00348123	0.08703075
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.00348123	0.08703075
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.00348123	0.08703075
MENTAL RETARDATION, BUENOS AIRES TYPE	0.00348123	0.08703075
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.00348123	0.08703075
MICROCEPHALY-CARDIOMYOPATHY	0.00348123	0.08703075
ANONYCHIA-MICROCEPHALY SYNDROME	0.00348123	0.08703075
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.00348123	0.08703075
JOHANSON-BLIZZARD SYNDROME; JBS	0.00348123	0.08703075
3MC SYNDROME 1	0.00348123	0.08703075
MONOSOMY 22	0.00348123	0.08703075
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.00348123	0.08703075
MEIER-GORLIN SYNDROME 1; MGORS1	0.00348123	0.08703075
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.00348123	0.08703075
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME	0.00348123	0.08703075
BOWEN-CONRADI SYNDROME	0.00348123	0.08703075
SECKEL SYNDROME 5; SCKL5	0.00348123	0.08703075
JACOBSEN SYNDROME	0.00348123	0.08703075
CRANIOFRONTONASAL DYSPLASIA	0.00348123	0.08703075
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.00348123	0.08703075
RING CHROMOSOME 1 SYNDROME	0.00348123	0.08703075
CEREBROCOSTOMANDIBULAR SYNDROME	0.00348123	0.08703075
AUTOSOMAL DOMINANT STRIATAL NEURODEGENERATION	0.00344828	0.086207
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.00344828	0.086207
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS	0.00344828	0.086207
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2K	0.00344828	0.086207
SPINOCEREBELLAR ATAXIA TYPE 34	0.00344828	0.086207
HUNTINGTON DISEASE-LIKE 2	0.00344828	0.086207
SPASTIC PARAPARESIS-DEAFNESS SYNDROME	0.00344828	0.086207
SPINOCEREBELLAR ATAXIA TYPE 5	0.00344828	0.086207
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4; LGMDD4	0.00344828	0.086207
SPINOCEREBELLAR ATAXIA TYPE 4	0.00344828	0.086207
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.00344828	0.086207
ADULT POLYGLUCOSAN BODY DISEASE	0.00344828	0.086207
CONGENITAL MUSCULAR DYSTROPHY-INFANTILE CATARACT-HYPOGONADISM SYNDROME	0.00344828	0.086207
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.00344828	0.086207
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.00344828	0.086207
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA	0.00344828	0.086207
SPASTIC PARAPLEGIA-FACIAL-CUTANEOUS LESIONS SYNDROME	0.00344828	0.086207
THORACOMELIC DYSPLASIA	0.00344828	0.086207
EARLY-ONSET GENERALIZED LIMB-ONSET DYSTONIA	0.00344828	0.086207
MULTIPLE SYMMETRIC LIPOMATOSIS	0.00344828	0.086207
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.00344828	0.086207
SPONASTRIME DYSPLASIA	0.00344828	0.086207
MYOTONIA FLUCTUANS	0.00344828	0.086207
MYOTONIA PERMANENS	0.00344828	0.086207
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2EE; CMT2EE	0.00344828	0.086207
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.00344828	0.086207
ATAXIA-TAPETORETINAL DEGENERATION SYNDROME	0.00344828	0.086207
CEREBELLAR ATAXIA-ECTODERMAL DYSPLASIA SYNDROME	0.00344828	0.086207
SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT; SPG80	0.00344828	0.086207
ACETAZOLAMIDE-RESPONSIVE MYOTONIA	0.00344828	0.086207
SPINOCEREBELLAR ATAXIA TYPE 17	0.00344828	0.086207
ATAXIA-OCULOMOTOR APRAXIA TYPE 1	0.00344828	0.086207
PROGRESSIVE PSEUDORHEUMATOID ARTHROPATHY OF CHILDHOOD	0.00344828	0.086207
KUSKOKWIM SYNDROME	0.00344828	0.086207
MULTIPLE METAPHYSEAL DYSPLASIA	0.00344828	0.086207
DUCHENNE AND BECKER MUSCULAR DYSTROPHY	0.00344828	0.086207
PALMOPLANTAR KERATODERMA-SPASTIC PARALYSIS SYNDROME	0.00344828	0.086207
HYDROCEPHALY-TALL STATURE-JOINT LAXITY SYNDROME	0.00344828	0.086207
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 26	0.00344828	0.086207
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE	0.00344828	0.086207
SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1	0.00344828	0.086207
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, IRAPA TYPE	0.00344828	0.086207
SPONDYLOEPIMETAPHYSEAL DYSPLASIA CONGENITA, STRUDWICK TYPE	0.00344828	0.086207
MULTIPLE EPIPHYSEAL DYSPLASIA DUE TO COLLAGEN 9 ANOMALY	0.00344828	0.086207
CHARCOT-MARIE-TOOTH DISEASE/HEREDITARY MOTOR AND SENSORY NEUROPATHY	0.00344828	0.086207
MYOPATHY, DISTAL, 1; MPD1	0.00344828	0.086207
INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 1	0.00344828	0.086207
NEUROFERRITINOPATHY	0.00344828	0.086207
SPONDYLOMETAPHYSEAL DYSPLASIA	0.00344828	0.086207
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 1	0.00344828	0.086207
MULTICENTRIC CARPO-TARSAL OSTEOLYSIS WITH OR WITHOUT NEPHROPATHY	0.00344828	0.086207
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 5	0.00344828	0.086207
OSTEOCHONDRITIS DISSECANS	0.00344828	0.086207
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.00344828	0.086207
DOPA-RESPONSIVE DYSTONIA	0.00344828	0.086207
CYSTINOSIS	0.00344828	0.086207
BENIGN HEREDITARY CHOREA	0.00344828	0.086207
SPASTIC ATAXIA-CORNEAL DYSTROPHY SYNDROME	0.00344828	0.086207
RICHARDS-RUNDLE SYNDROME	0.00344828	0.086207
MUTILATING HEREDITARY SENSORY NEUROPATHY WITH SPASTIC PARAPLEGIA	0.00344828	0.086207
LATE-ONSET DISTAL MYOPATHY, MARKESBERY-GRIGGS TYPE	0.00344828	0.086207
ICHTHYOSIS-HEPATOSPLENOMEGALY-CEREBELLAR DEGENERATION SYNDROME	0.00344828	0.086207
POLYNEUROPATHY-INTELLECTUAL DISABILITY-ACROMICRIA-PREMATURE MENOPAUSE SYNDROME	0.00344828	0.086207
EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE; EDMD3	0.00344828	0.086207
IDIOPATHIC JUVENILE OSTEOPOROSIS	0.00344828	0.086207
KENNEDY DISEASE	0.00344828	0.086207
LERI PLEONOSTEOSIS	0.00344828	0.086207
X-LINKED ADRENOLEUKODYSTROPHY	0.00344828	0.086207
NEUROFIBROMATOSIS TYPE 2	0.00344828	0.086207
NONAKA MYOPATHY	0.00344828	0.086207
ABETA AMYLOIDOSIS, IOWA TYPE	0.00344828	0.086207
FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3	0.00344828	0.086207
MAST SYNDROME	0.00344828	0.086207
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.00344828	0.086207
JUVENILE AMYOTROPHIC LATERAL SCLEROSIS	0.00344828	0.086207
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.00344828	0.086207
DEAF BLIND HYPOPIGMENTATION SYNDROME, YEMENITE TYPE	0.00344828	0.086207
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.00344828	0.086207
RHEUMATIC FEVER	0.00344828	0.086207
NEMALINE MYOPATHY 6	0.00344828	0.086207
BARTH SYNDROME; BTHS	0.00344828	0.086207
MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16	0.00344828	0.086207
POTASSIUM-AGGRAVATED MYOTONIA	0.00344828	0.086207
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.00344828	0.086207
BRITTLE CORNEA SYNDROME 2; BCS2	0.00344828	0.086207
VON HIPPEL-LINDAU DISEASE	0.00344828	0.086207
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5	0.00344828	0.086207
LAING EARLY-ONSET DISTAL MYOPATHY	0.00344828	0.086207
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4J	0.00344828	0.086207
MULTIPLE SCLEROSIS-ICHTHYOSIS-FACTOR VIII DEFICIENCY SYNDROME	0.00344828	0.086207
ROUSSY-LÉVY SYNDROME	0.00344828	0.086207
NEMALINE MYOPATHY 7; NEM7	0.00344828	0.086207
MUCOPOLYSACCHARIDOSIS TYPE 4	0.00344828	0.086207
MELNICK-NEEDLES SYNDROME	0.00344828	0.086207
MYASTHENIC SYNDROME, CONGENITAL, 7, PRESYNAPTIC; CMS7	0.00344828	0.086207
BRITTLE CORNEA SYNDROME	0.00344828	0.086207
%271630 BRACHYOLMIA TYPE 1, TOLEDO TYPE;;SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, TOLEDO TYPE;;SED, CHONDROITIN SULFATE TYPE;;PAPS-CHONDROITIN SULFATE SULFOTRANSFERASE DEFICIENCY	0.00344828	0.086207
PELVIC DYSPLASIA-ARTHROGRYPOSIS OF LOWER LIMBS SYNDROME	0.00344828	0.086207
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.00344828	0.086207
CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY	0.00344828	0.086207
GLYCOGEN STORAGE DISEASE DUE TO LAMP-2 DEFICIENCY	0.00344828	0.086207
POLYMYOSITIS	0.00344828	0.086207
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.00344828	0.086207
3-METHYLGLUTACONIC ACIDURIA TYPE 3	0.00344828	0.086207
TRYPTOPHANURIA WITH DWARFISM	0.00344828	0.086207
224550 DYSTONIA WITH RINGBINDEN	0.00344828	0.086207
AMYOTROPHIC LATERAL SCLEROSIS TYPE 4	0.00344828	0.086207
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 5	0.00344828	0.086207
PSEUDOACHONDROPLASIA	0.00344828	0.086207
PSYCHOGENIC MOVEMENT DISORDERS	0.00344828	0.086207
CONGENITAL MYOPATHY WITH MYASTHENIC-LIKE ONSET	0.00344828	0.086207
HYPERKALEMIC PERIODIC PARALYSIS	0.00344828	0.086207
HYPOCALCEMIC VITAMIN D-RESISTANT RICKETS	0.00344828	0.086207
HEREDITARY SPASTIC PARAPLEGIA	0.00344828	0.086207
%300158 ARTHROGRYPOSIS, CONGENITAL, LOWER LIMB, X-LINKED; ACLLX;;ARTHROGRYPOSIS, X-LINKED, TYPE V, FORMERLY; AMCX5, FORMERLY	0.00344828	0.086207
OSTEOGENESIS IMPERFECTA	0.00344828	0.086207
SPASTIC PARAPLEGIA 43, AUTOSOMAL RECESSIVE; SPG43	0.00344828	0.086207
AMISH NEMALINE MYOPATHY	0.00343643	0.08591075
OPTIC ATROPHY 2	0.00343643	0.08591075
HEMIPARKINSONISM-HEMIATROPHY SYNDROME	0.00343643	0.08591075
CEREBELLAR HYPOPLASIA	0.00343643	0.08591075
PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE; PARK14	0.00343643	0.08591075
SPINOCEREBELLAR ATAXIA 43; SCA43	0.00343643	0.08591075
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.00343643	0.08591075
SPASTIC PARAPARESIS AND DEAFNESS	0.00343643	0.08591075
LEUKOENCEPHALOPATHY-SPONDYLOMETAPHYSEAL DYSPLASIA SYNDROME	0.00343643	0.08591075
HUNTINGTON DISEASE-LIKE SYNDROME DUE TO C9ORF72 EXPANSIONS	0.00343643	0.08591075
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.00343643	0.08591075
HYPERMANGANESEMIA WITH DYSTONIA 1; HMNDYT1	0.00343643	0.08591075
NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET	0.00343643	0.08591075
DYSTONIA 3, TORSION, X-LINKED	0.00343643	0.08591075
SPINOCEREBELLAR ATAXIA TYPE 21	0.00343643	0.08591075
EPISODIC ATAXIA WITH SLURRED SPEECH	0.00343643	0.08591075
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.00343643	0.08591075
NON-FUNCTIONING PARAGANGLIOMA	0.00343643	0.08591075
MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO; MSA1	0.00343643	0.08591075
WILSON DISEASE	0.00343643	0.08591075
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	0.00343643	0.08591075
MONOMELIC AMYOTROPHY	0.00343643	0.08591075
PERRY SYNDROME	0.00343643	0.08591075
PARKINSON DISEASE 20, EARLY-ONSET; PARK20	0.00343643	0.08591075
SPINAL MUSCULAR ATROPHY, JOKELA TYPE; SMAJ	0.00343643	0.08591075
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.00343643	0.08591075
OPTIC ATROPHY 3, AUTOSOMAL DOMINANT	0.00343643	0.08591075
SPINOCEREBELLAR ATAXIA 7 OPCA III OPCA WITH RETINAL DEGENERATION OPCA WITH MACULAR DEGENERATION AND EXTERNAL OPHTHALMOPLEGIA AUTOSOMAL DOMINANT CEREBELLAR ATAXIA, TYPE II ADCA, TYPE II	0.00343643	0.08591075
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 16; SCAR16	0.00343643	0.08591075
AUTOSOMAL RECESSIVE MALIGNANT OSTEOPETROSIS	0.00343643	0.08591075
MYOPATHY, SPHEROID BODY	0.00343643	0.08591075
LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP	0.00343643	0.08591075
SENSORINEURAL HEARING LOSS-EARLY GRAYING-ESSENTIAL TREMOR SYNDROME	0.00343643	0.08591075
DYSTONIA 11, MYOCLONIC	0.00343643	0.08591075
SPINOCEREBELLAR ATAXIA 37; SCA37	0.00343643	0.08591075
TETANUS	0.00343643	0.08591075
ADULT-ONSET DISTAL MYOPATHY DUE TO VCP MUTATION	0.00343643	0.08591075
NEUROLEPTIC MALIGNANT SYNDROME	0.00343643	0.08591075
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.00343643	0.08591075
CATARACT-ATAXIA-DEAFNESS SYNDROME	0.00343643	0.08591075
THYROTOXIC PERIODIC PARALYSIS	0.00343643	0.08591075
SPINOCEREBELLAR ATAXIA TYPE 14	0.00343643	0.08591075
PARKINSON DISEASE 21; PARK21	0.00343643	0.08591075
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D	0.00343643	0.08591075
SPINOCEREBELLAR ATAXIA, X-LINKED 4	0.00343643	0.08591075
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.00343643	0.08591075
PARKINSON-DEMENTIA SYNDROMESUPRANUCLEAR PALSY, PROGRESSIVE ATYPICAL, INCLUDED	0.00343643	0.08591075
PARKINSON DISEASE 15, AUTOSOMAL RECESSIVE EARLY-ONSET	0.00343643	0.08591075
PERRY SYNDROME	0.00343643	0.08591075
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21	0.00343643	0.08591075
SÉZARY SYNDROME	0.00343643	0.08591075
SPINOCEREBELLAR ATAXIA 42	0.00343643	0.08591075
MOHR-TRANEBJAERG SYNDROME	0.00343643	0.08591075
MENTAL RETARDATION WITH SPASTIC PARAPLEGIA AND PALMOPLANTAR HYPERKERATOSIS	0.00343643	0.08591075
SPINOCEREBELLAR ATAXIA TYPE 38	0.00343643	0.08591075
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8	0.00343643	0.08591075
HEREDITARY PHEOCHROMOCYTOMA-PARAGANGLIOMA	0.00343643	0.08591075
SPORADIC PHEOCHROMOCYTOMA/SECRETING PARAGANGLIOMA	0.00343643	0.08591075
INFANTILE-ONSET GENERALIZED DYSKINESIA WITH OROFACIAL INVOLVEMENT	0.00343643	0.08591075
INTELLECTUAL DISABILITY-MUSCLE WEAKNESS-SHORT STATURE-FACIAL DYSMORPHISM SYNDROME	0.00343643	0.08591075
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.00343643	0.08591075
SPINOCEREBELLAR ATAXIA TYPE 31	0.00343643	0.08591075
SPINOCEREBELLAR ATAXIA 23; SCA23	0.00343643	0.08591075
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2A	0.00343643	0.08591075
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 3; SCAN3	0.00343643	0.08591075
GLUTATHIONURIA	0.00343643	0.08591075
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.00343643	0.08591075
ACERULOPLASMINEMIA	0.00343643	0.08591075
TYPHOID	0.00343643	0.08591075
SPINOCEREBELLAR ATAXIA 18	0.00343643	0.08591075
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.00343643	0.08591075
PRIMARY DYSTONIA, DYT2 TYPE	0.00343643	0.08591075
DYSTONIA 13, TORSION	0.00343643	0.08591075
LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL	0.00343643	0.08591075
DYSTONIA 2, TORSION, AUTOSOMAL RECESSIVE; DYT2	0.00343643	0.08591075
O'SULLIVAN-MCLEOD SYNDROME	0.00343643	0.08591075
YOUNG-ONSET PARKINSON DISEASE	0.00343643	0.08591075
PRIMARY ORTHOSTATIC TREMOR	0.00343643	0.08591075
COMPLETE ANDROGEN INSENSITIVITY SYNDROME	0.00343643	0.08591075
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.0032703540000000005	0.08175885000000001
TEMTAMY SYNDROME	0.0032703540000000005	0.08175885000000001
2Q23.1 MICRODUPLICATION SYNDROME	0.0032703540000000005	0.08175885000000001
DISTAL MONOSOMY 6P	0.0032703540000000005	0.08175885000000001
17P13.3 MICRODUPLICATION SYNDROME	0.0032703540000000005	0.08175885000000001
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.0032703540000000005	0.08175885000000001
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.0032703540000000005	0.08175885000000001
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.0032703540000000005	0.08175885000000001
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.0032703540000000005	0.08175885000000001
CHAR SYNDROME	0.0032703540000000005	0.08175885000000001
POPOV-CHANG SYNDROME; POPCHAS	0.0032703540000000005	0.08175885000000001
LARSEN-LIKE SYNDROME	0.0032703540000000005	0.08175885000000001
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.0032703540000000005	0.08175885000000001
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.0032703540000000005	0.08175885000000001
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.0032703540000000005	0.08175885000000001
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.0032703540000000005	0.08175885000000001
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.0032703540000000005	0.08175885000000001
ARTERIAL TORTUOSITY SYNDROME	0.0032703540000000005	0.08175885000000001
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.0032703540000000005	0.08175885000000001
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.0032703540000000005	0.08175885000000001
PROTEUS SYNDROME	0.0032662190000000003	0.081655475
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.0032662190000000003	0.081655475
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.0032662190000000003	0.081655475
ZUNICH NEUROECTODERMAL SYNDROME	0.0032662190000000003	0.081655475
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.0032662190000000003	0.081655475
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.0032662190000000003	0.081655475
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.0032662190000000003	0.081655475
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.0032662190000000003	0.081655475
HYPOPLASTIC TIBIAE-POSTAXIAL POLYDACTYLY SYNDROME	0.0027248000000000003	0.06812000000000001
SYNPOLYDACTYLY 1	0.0027248000000000003	0.06812000000000001
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 4	0.0027248000000000003	0.06812000000000001
NIGHT BLINDNESS-SKELETAL ANOMALIES-DYSMORPHISM SYNDROME	0.0027248000000000003	0.06812000000000001
CATEL-MANZKE SYNDROME	0.0027248000000000003	0.06812000000000001
THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME	0.0027248000000000003	0.06812000000000001
SYNDACTYLY, MESOAXIAL SYNOSTOTIC, WITH PHALANGEAL REDUCTION	0.0027248000000000003	0.06812000000000001
TETRALOGY OF FALLOT	0.0027248000000000003	0.06812000000000001
TALONAVICULAR COALITION	0.0027248000000000003	0.06812000000000001
FRANK-TER HAAR SYNDROME	0.0027248000000000003	0.06812000000000001
X-LINKED INTELLECTUAL DISABILITY, STOLL TYPE	0.0027248000000000003	0.06812000000000001
269870 SHORT STATURE-OBESITY SYNDROME; SSOS	0.0027248000000000003	0.06812000000000001
BRACHYDACTYLY TYPE A1	0.0027248000000000003	0.06812000000000001
MOLAR I REINCLUSION	0.0027248000000000003	0.06812000000000001
311895 PIERRE ROBIN SEQUENCE WITH FACIAL AND DIGITAL ANOMALIES	0.0027248000000000003	0.06812000000000001
METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE	0.0027248000000000003	0.06812000000000001
AUTOSOMAL RECESSIVE FACIODIGITOGENITAL SYNDROME	0.0027248000000000003	0.06812000000000001
TETRALOGY OF FALLOT	0.0027248000000000003	0.06812000000000001
NOONAN SYNDROME	0.0027248000000000003	0.06812000000000001
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.0027248000000000003	0.06812000000000001
PROXIMAL SYMPHALANGISM	0.0027248000000000003	0.06812000000000001
LÉRI-WEILL DYSCHONDROSTEOSIS	0.0027248000000000003	0.06812000000000001
ALAGILLE SYNDROME	0.0027248000000000003	0.06812000000000001
BRACHYDACTYLY TYPE C	0.0027248000000000003	0.06812000000000001
WEYERS ACROFACIAL DYSOSTOSIS	0.0027248000000000003	0.06812000000000001
BRACHYDACTYLY-ELBOW WRIST DYSPLASIA SYNDROME	0.0027248000000000003	0.06812000000000001
WILLIAMS-BEUREN SYNDROME; WBS	0.0027248000000000003	0.06812000000000001
WT LIMB-BLOOD SYNDROME	0.0027248000000000003	0.06812000000000001
604381 PATENT DUCTUS ARTERIOSUS AND BICUSPID AORTIC VALVE WITH HAND ANOMALIES	0.0027248000000000003	0.06812000000000001
FIBROCHONDROGENESIS 1; FBCG1	0.0027248000000000003	0.06812000000000001
TRICHORHINOPHALANGEAL SYNDROME TYPE 1 AND 3	0.0027248000000000003	0.06812000000000001
CONDUCTIVE DEAFNESS-PTOSIS-SKELETAL ANOMALIES SYNDROME	0.0027248000000000003	0.06812000000000001
129540 ECTODERMAL DYSPLASIA SYNDROME WITH DISTINCTIVE FACIAL APPEARANCE ANDPREAXIAL POLYDACTYLY OF FEET	0.0027248000000000003	0.06812000000000001
RADIO-ULNAR SYNOSTOSIS-AMEGAKARYOCYTIC THROMBOCYTOPENIA SYNDROME	0.0027248000000000003	0.06812000000000001
PELVIS-SHOULDER DYSPLASIA	0.0027248000000000003	0.06812000000000001
PFEIFFER SYNDROME	0.0027248000000000003	0.06812000000000001
X-LINKED DOMINANT CHONDRODYSPLASIA PUNCTATA	0.0027248000000000003	0.06812000000000001
TEMPLE SYNDROME	0.0027248000000000003	0.06812000000000001
PATENT DUCTUS ARTERIOSUS-BICUSPID AORTIC VALVE-HAND ANOMALIES SYNDROME	0.0027248000000000003	0.06812000000000001
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME; NPLCS	0.0027248000000000003	0.06812000000000001
HYPERTELORISM, TEEBI TYPE	0.0027248000000000003	0.06812000000000001
CRANIOECTODERMAL DYSPLASIA	0.0027248000000000003	0.06812000000000001
PTOSIS-UPPER OCULAR MOVEMENT LIMITATION-ABSENCE OF LACRIMAL PUNCTUM SYNDROME	0.0027248000000000003	0.06812000000000001
PENOSCROTAL TRANSPOSITION	0.0027248000000000003	0.06812000000000001
DEAFNESS, CONDUCTIVE, WITH PTOSIS AND SKELETAL ANOMALIES	0.0027248000000000003	0.06812000000000001
FRONTONASAL DYSPLASIA-BIFID NOSE-UPPER LIMB ANOMALIES SYNDROME	0.0027248000000000003	0.06812000000000001
HAND-FOOT-GENITAL SYNDROME	0.0027248000000000003	0.06812000000000001
SKELETAL DYSPLASIA WITH DELAYED EPIPHYSEAL AND CARPAL BONE OSSIFICATION	0.0027248000000000003	0.06812000000000001
VELO-FACIAL-SKELETAL SYNDROME	0.0027248000000000003	0.06812000000000001
CLEIDORHIZOMELIC SYNDROME	0.0027248000000000003	0.06812000000000001
CLEIDOCRANIAL DYSPLASIA	0.0027248000000000003	0.06812000000000001
BRACHYDACTYLY TYPE A2	0.0027248000000000003	0.06812000000000001
NAIL-PATELLA SYNDROME	0.0027248000000000003	0.06812000000000001
DESBUQUOIS SYNDROME	0.0027248000000000003	0.06812000000000001
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.0027248000000000003	0.06812000000000001
INTELLECTUAL DISABILITY-SHORT STATURE-HYPERTELORISM SYNDROME	0.0027248000000000003	0.06812000000000001
CLEFT LIP/PALATE-INTESTINAL MALROTATION-CARDIOPATHY SYNDROME	0.0027248000000000003	0.06812000000000001
SHORT STATURE-VALVULAR HEART DISEASE-CHARACTERISTIC FACIES SYNDROME	0.0027248000000000003	0.06812000000000001
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.0027248000000000003	0.06812000000000001
CLEIDORHIZOMELIC SYNDROME	0.0027248000000000003	0.06812000000000001
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP	0.0027248000000000003	0.06812000000000001
BANKI SYNDROME	0.0027248000000000003	0.06812000000000001
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE SYNDROME	0.0027248000000000003	0.06812000000000001
CEREBELLAR ATAXIA-HYPOGONADISM SYNDROME	0.0027248000000000003	0.06812000000000001
APLASIA CUTIS CONGENITA-INTESTINAL LYMPHANGIECTASIA SYNDROME	0.0027248000000000003	0.06812000000000001
PERIPHERAL DYSOSTOSIS	0.0027248000000000003	0.06812000000000001
METATROPIC DYSPLASIA	0.0027248000000000003	0.06812000000000001
KERATOSIS PALMARIS ET PLANTARIS WITH CLINODACTYLY	0.0027248000000000003	0.06812000000000001
FRAXE INTELLECTUAL DISABILITY	0.0027248000000000003	0.06812000000000001
KERATOSIS PALMARIS ET PLANTARIS-CLINODACTYLY SYNDROME	0.0027248000000000003	0.06812000000000001
MOEBIUS SYNDROME	0.0027248000000000003	0.06812000000000001
SUMMITT SYNDROME	0.0027248000000000003	0.06812000000000001
HAND-FOOT-GENITAL SYNDROME; HFG	0.0027248000000000003	0.06812000000000001
EXTERNAL AUDITORY CANAL ATRESIA-VERTICAL TALUS-HYPERTELORISM SYNDROME	0.0027248000000000003	0.06812000000000001
BRACHYDACTYLY, TYPE A3	0.0027248000000000003	0.06812000000000001
INTELLECTUAL DISABILITY-SPASTICITY-ECTRODACTYLY SYNDROME	0.0027248000000000003	0.06812000000000001
ACROFACIAL DYSOSTOSIS, WEYERS TYPE	0.0027248000000000003	0.06812000000000001
BRACHYDACTYLY, TYPE A1, D	0.0027248000000000003	0.06812000000000001
DENTAL ANKYLOSIS	0.0027248000000000003	0.06812000000000001
3M SYNDROME	0.0027248000000000003	0.06812000000000001
FETAL MINOXIDIL SYNDROME	0.0027248000000000003	0.06812000000000001
ROBIN SEQUENCE-OLIGODACTYLY SYNDROME	0.0027248000000000003	0.06812000000000001
MESOMELIC DYSPLASIA, NIEVERGELT TYPE	0.0027248000000000003	0.06812000000000001
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.0027248000000000003	0.06812000000000001
LACRIMOAURICULODENTODIGITAL SYNDROME; LADD	0.0027248000000000003	0.06812000000000001
HALLUX VARUS-PREAXIAL POLYSYNDACTYLY SYNDROME	0.0027248000000000003	0.06812000000000001
DIAPHRAGMATIC DEFECT-LIMB DEFICIENCY-SKULL DEFECT SYNDROME	0.0027248000000000003	0.06812000000000001
OSLAM SYNDROME	0.0027248000000000003	0.06812000000000001
EPIPHYSEAL DYSPLASIA, BAUMANN TYPE	0.0027248000000000003	0.06812000000000001
FLOATING-HARBOR SYNDROME	0.0027248000000000003	0.06812000000000001
GORDON SYNDROME	0.0027248000000000003	0.06812000000000001
MESOMELIC DYSPLASIA, KANTAPUTRA TYPE	0.0027248000000000003	0.06812000000000001
RFT1-CDG	0.001843403	0.046085074999999996
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.001843403	0.046085074999999996
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.001843403	0.046085074999999996
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.001843403	0.046085074999999996
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.001843403	0.046085074999999996
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.001843403	0.046085074999999996
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.001843403	0.046085074999999996
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.001843403	0.046085074999999996
XQ28 (MECP2) DUPLICATION	0.001843403	0.046085074999999996
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.001843403	0.046085074999999996
EMANUEL SYNDROME	0.001843403	0.046085074999999996
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.001843403	0.046085074999999996
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.001843403	0.046085074999999996
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.001843403	0.046085074999999996
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.001843403	0.046085074999999996
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.001843403	0.046085074999999996
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.001843403	0.046085074999999996
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.001843403	0.046085074999999996
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.001843403	0.046085074999999996
CHROMOSOME 19P13.13 DELETION SYNDROME	0.001843403	0.046085074999999996
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.001843403	0.046085074999999996
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.001843403	0.046085074999999996
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.001843403	0.046085074999999996
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.001843403	0.046085074999999996
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.001843403	0.046085074999999996
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.001843403	0.046085074999999996
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.001843403	0.046085074999999996
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.001843403	0.046085074999999996
MONOSOMY 18Q	0.001843403	0.046085074999999996
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.001843403	0.046085074999999996
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.001843403	0.046085074999999996
22Q11.2 DELETION SYNDROME	0.001843403	0.046085074999999996
GALLOWAY-MOWAT SYNDROME	0.001843403	0.046085074999999996
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.001843403	0.046085074999999996
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.001843403	0.046085074999999996
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.001843403	0.046085074999999996
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.001843403	0.046085074999999996
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.001843403	0.046085074999999996
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.001843403	0.046085074999999996
MULTIPLE SULFATASE DEFICIENCY	0.001843403	0.046085074999999996
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.001843403	0.046085074999999996
8P23.1 MICRODELETION SYNDROME	0.001843403	0.046085074999999996
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.001843403	0.046085074999999996
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.001843403	0.046085074999999996
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.001843403	0.046085074999999996
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.001843403	0.046085074999999996
STT3A-CDG	0.001843403	0.046085074999999996
STT3B-CDG	0.001843403	0.046085074999999996
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.001843403	0.046085074999999996
PHACE SYNDROME	0.001843403	0.046085074999999996
SSR4-CDG	0.001843403	0.046085074999999996
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.001843403	0.046085074999999996
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.001843403	0.046085074999999996
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.001843403	0.046085074999999996
ADAMS-OLIVER SYNDROME 2; AOS2	0.001843403	0.046085074999999996
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.001843403	0.046085074999999996
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.001843403	0.046085074999999996
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.001843403	0.046085074999999996
22Q11.2 MICRODUPLICATION SYNDROME	0.001843403	0.046085074999999996
COFFIN-SIRIS SYNDROME 1; CSS1	0.001843403	0.046085074999999996
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.001843403	0.046085074999999996
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.001843403	0.046085074999999996
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.001843403	0.046085074999999996
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001843403	0.046085074999999996
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.001843403	0.046085074999999996
CEDNIK SYNDROME	0.001843403	0.046085074999999996
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.001843403	0.046085074999999996
GLASS SYNDROME	0.001843403	0.046085074999999996
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.001843403	0.046085074999999996
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.001843403	0.046085074999999996
DISTAL MONOSOMY 1Q	0.001843403	0.046085074999999996
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.001843403	0.046085074999999996
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.001843403	0.046085074999999996
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.001843403	0.046085074999999996
CK SYNDROME	0.001843403	0.046085074999999996
LISSENCEPHALY 4	0.001843403	0.046085074999999996
MICRO SYNDROME	0.001843403	0.046085074999999996
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.001843403	0.046085074999999996
HOLOPROSENCEPHALY 2; HPE2	0.001843403	0.046085074999999996
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.001843403	0.046085074999999996
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.001843403	0.046085074999999996
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.001843403	0.046085074999999996
N-ACETYLASPARTATE DEFICIENCY; NACED	0.001843403	0.046085074999999996
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.001843403	0.046085074999999996
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.001843403	0.046085074999999996
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.001843403	0.046085074999999996
WIEACKER-WOLFF SYNDROME	0.001843403	0.046085074999999996
HOLOPROSENCEPHALY	0.001843403	0.046085074999999996
KABUKI SYNDROME 1	0.001843403	0.046085074999999996
8P11.2 DELETION SYNDROME	0.001843403	0.046085074999999996
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.001843403	0.046085074999999996
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.001843403	0.046085074999999996
GENITOPATELLAR SYNDROME	0.001843403	0.046085074999999996
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.001843403	0.046085074999999996
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.001843403	0.046085074999999996
MACDERMOT-WINTER SYNDROME	0.001843403	0.046085074999999996
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.001843403	0.046085074999999996
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.001843403	0.046085074999999996
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.001843403	0.046085074999999996
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.001843403	0.046085074999999996
LISSENCEPHALY 8; LIS8	0.001843403	0.046085074999999996
BARAITSER-WINTER SYNDROME 1; BRWS1	0.001843403	0.046085074999999996
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.001843403	0.046085074999999996
VICI SYNDROME; VICIS	0.001843403	0.046085074999999996
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.001843403	0.046085074999999996
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.001843403	0.046085074999999996
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.001843403	0.046085074999999996
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.001843403	0.046085074999999996
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.001843403	0.046085074999999996
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.001843403	0.046085074999999996
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.001843403	0.046085074999999996
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.001843403	0.046085074999999996
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.001843403	0.046085074999999996
ALG3-CDG	0.001843403	0.046085074999999996
ALG1-CDG	0.001843403	0.046085074999999996
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.001843403	0.046085074999999996
KLEEFSTRA SYNDROME	0.001843403	0.046085074999999996
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.001843403	0.046085074999999996
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.001843403	0.046085074999999996
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.001843403	0.046085074999999996
HEART AND BRAIN MALFORMATION SYNDROME	0.001843403	0.046085074999999996
COFFIN-SIRIS SYNDROME 5	0.001843403	0.046085074999999996
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.001843403	0.046085074999999996
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.001843403	0.046085074999999996
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.001843403	0.046085074999999996
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.001843403	0.046085074999999996
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.001843403	0.046085074999999996
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.001843403	0.046085074999999996
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.001843403	0.046085074999999996
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.001843403	0.046085074999999996
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.001843403	0.046085074999999996
MEVALONIC ACIDURIA	0.001843403	0.046085074999999996
ALG11-CDG	0.001843403	0.046085074999999996
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.001843403	0.046085074999999996
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.001843403	0.046085074999999996
CHROMOSOME 1P35 DELETION SYNDROME	0.001843403	0.046085074999999996
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.001843403	0.046085074999999996
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.001843403	0.046085074999999996
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.001843403	0.046085074999999996
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.001843403	0.046085074999999996
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.001843403	0.046085074999999996
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.001843403	0.046085074999999996
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.001843403	0.046085074999999996
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.001843403	0.046085074999999996
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.001843403	0.046085074999999996
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.001843403	0.046085074999999996
KLEEFSTRA SYNDROME 2; KLEFS2	0.001843403	0.046085074999999996
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.001843403	0.046085074999999996
CONGENITAL TOXOPLASMOSIS	0.001843403	0.046085074999999996
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.001843403	0.046085074999999996
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.001843403	0.046085074999999996
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.001843403	0.046085074999999996
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.001843403	0.046085074999999996
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.001843403	0.046085074999999996
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.001843403	0.046085074999999996
HOLOPROSENCEPHALY 1; HPE1	0.001843403	0.046085074999999996
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.001843403	0.046085074999999996
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.001843403	0.046085074999999996
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.001843403	0.046085074999999996
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.001843403	0.046085074999999996
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.001843403	0.046085074999999996
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.001843403	0.046085074999999996
10Q22.3Q23.3 MICRODELETION SYNDROME	0.001843403	0.046085074999999996
WALKER-WARBURG SYNDROME	0.001843403	0.046085074999999996
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.001843403	0.046085074999999996
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.001843403	0.046085074999999996
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.001843403	0.046085074999999996
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.001843403	0.046085074999999996
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.001843403	0.046085074999999996
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.001843403	0.046085074999999996
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.001843403	0.046085074999999996
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.001843403	0.046085074999999996
EMANUEL SYNDROME	0.001843403	0.046085074999999996
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.001843403	0.046085074999999996
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.001843403	0.046085074999999996
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.001843403	0.046085074999999996
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.001843403	0.046085074999999996
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.001843403	0.046085074999999996
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.001843403	0.046085074999999996
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.001843403	0.046085074999999996
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.001843403	0.046085074999999996
15Q14 MICRODELETION SYNDROME	0.001843403	0.046085074999999996
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.001843403	0.046085074999999996
AICARDI-GOUTIERES SYNDROME 7	0.001843403	0.046085074999999996
KOOLEN-DE VRIES SYNDROME	0.001843403	0.046085074999999996
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.001843403	0.046085074999999996
17Q11.2 MICRODUPLICATION SYNDROME	0.001843403	0.046085074999999996
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.001843403	0.046085074999999996
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.001843403	0.046085074999999996
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.001843403	0.046085074999999996
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.001843403	0.046085074999999996
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.001843403	0.046085074999999996
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.001843403	0.046085074999999996
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.001843403	0.046085074999999996
MEHMO SYNDROME; MEHMO	0.001843403	0.046085074999999996
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.001843403	0.046085074999999996
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.001843403	0.046085074999999996
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.001843403	0.046085074999999996
INFANTILE LIVER FAILURE SYNDROME 1	0.001843403	0.046085074999999996
DISTAL TRISOMY 17Q	0.001843403	0.046085074999999996
OROFACIODIGITAL SYNDROME TYPE 14	0.001301984	0.0325496
HOLOPROSENCEPHALY 11	0.001301984	0.0325496
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.001301984	0.0325496
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.001301984	0.0325496
BARATELA-SCOTT SYNDROME	0.001301984	0.0325496
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.001301984	0.0325496
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.001301984	0.0325496
OGDEN SYNDROME; OGDNS	0.001301984	0.0325496
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.001301984	0.0325496
OROFACIODIGITAL SYNDROME XIV; OFD14	0.001301984	0.0325496
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.001301984	0.0325496
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.001301984	0.0325496
OKAMOTO SYNDROME	0.001301984	0.0325496
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.001301984	0.0325496
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.001301984	0.0325496
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.001301984	0.0325496
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.001301984	0.0325496
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.001301984	0.0325496
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.001301984	0.0325496
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.001301984	0.0325496
OCULO-PALATO-CEREBRAL SYNDROME	0.001301984	0.0325496
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.001301984	0.0325496
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.001301984	0.0325496
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.001301984	0.0325496
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.001301984	0.0325496
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.001301984	0.0325496
OPTIC ATROPHY 11; OPA11	0.001301984	0.0325496
AL-RAQAD SYNDROME; ARS	0.001301984	0.0325496
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.001301984	0.0325496
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.001301984	0.0325496
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.001301984	0.0325496
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.001301984	0.0325496
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.001301984	0.0325496
HYPERTRICHOSIS CUBITI	0.001301984	0.0325496
LIG4 SYNDROME	0.001301984	0.0325496
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.001301984	0.0325496
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.001301984	0.0325496
CRANIOTELENCEPHALIC DYSPLASIA	0.001301984	0.0325496
SECKEL SYNDROME 8; SCKL8	0.001301984	0.0325496
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.001301984	0.0325496
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.001301984	0.0325496
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.001301984	0.0325496
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.001301984	0.0325496
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.001301984	0.0325496
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.001301984	0.0325496
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.001301984	0.0325496
GENITOPATELLAR SYNDROME; GTPTS	0.001301984	0.0325496
ALAZAMI SYNDROME; ALAZS	0.001301984	0.0325496
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.001301984	0.0325496
HOLOPROSENCEPHALY 5; HPE5	0.001301984	0.0325496
DESBUQUOIS DYSPLASIA 2; DBQD2	0.001301984	0.0325496
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.001301984	0.0325496
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.001301984	0.0325496
MEVALONIC ACIDURIA; MEVA	0.001301984	0.0325496
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.001301984	0.0325496
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.001301984	0.0325496
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.001301984	0.0325496
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.001301984	0.0325496
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.001301984	0.0325496
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.001301984	0.0325496
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.001301984	0.0325496
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.001301984	0.0325496
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.001301984	0.0325496
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.001301984	0.0325496
CONGENITAL VARICELLA SYNDROME	0.001301984	0.0325496
DYSTONIA 28, CHILDHOOD-ONSET	0.001301984	0.0325496
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.001301984	0.0325496
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.001301984	0.0325496
SAY-BARBER-MILLER SYNDROME	0.001301984	0.0325496
MUCOLIPIDOSIS IV; ML4	0.001301984	0.0325496
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.001301984	0.0325496
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.001301984	0.0325496
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.001301984	0.0325496
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.001301984	0.0325496
DUPLICATION OF THE PITUITARY GLAND	0.001301984	0.0325496
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.001301984	0.0325496
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.001301984	0.0325496
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.001301984	0.0325496
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.001301984	0.0325496
HOYERAAL-HREIDARSSON SYNDROME	0.001301984	0.0325496
FETAL TRIMETHADIONE SYNDROME	0.001301984	0.0325496
FETAL ALCOHOL SYNDROME	0.001301984	0.0325496
PHENOBARBITAL EMBRYOPATHY	0.001301984	0.0325496
MONOSOMY 13Q34	0.001301984	0.0325496
TOLUENE EMBRYOPATHY	0.001301984	0.0325496
FORSYTHE-WAKELING SYNDROME; FWS	0.001301984	0.0325496
HOLMES-GANG SYNDROME	0.001301984	0.0325496
SECKEL SYNDROME 9; SCKL9	0.001301984	0.0325496
MICROPHTHALMIA, SYNDROMIC 3	0.001301984	0.0325496
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.001301984	0.0325496
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.001301984	0.0325496
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.001301984	0.0325496
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.001301984	0.0325496
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.001301984	0.0325496
CRANIOSYNOSTOSIS 6; CRS6	0.001301984	0.0325496
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.001301984	0.0325496
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.001301984	0.0325496
RAINE SYNDROME	0.001301984	0.0325496
8Q22.1 MICRODELETION SYNDROME	0.001301984	0.0325496
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.001301984	0.0325496
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.001301984	0.0325496
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.001301984	0.0325496
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.001301984	0.0325496
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.001301984	0.0325496
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.001301984	0.0325496
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.001301984	0.0325496
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.001301984	0.0325496
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.001301984	0.0325496
HOLOPROSENCEPHALY 3; HPE3	0.001301984	0.0325496
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.001301984	0.0325496
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.001301984	0.0325496
LOWRY-MACLEAN SYNDROME	0.001301984	0.0325496
MARDEN-WALKER SYNDROME	0.001301984	0.0325496
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.001301984	0.0325496
ISOLATED COMPLEX I DEFICIENCY	0.001301984	0.0325496
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.001301984	0.0325496
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.001301984	0.0325496
AICARDI-GOUTIERES SYNDROME 5	0.001301984	0.0325496
ROTHMUND-THOMSON SYNDROME	0.001301984	0.0325496
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.001301984	0.0325496
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.001301984	0.0325496
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.001301984	0.0325496
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.001301984	0.0325496
CEREBELLOFACIODENTAL SYNDROME	0.001301984	0.0325496
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.001301984	0.0325496
BRESEK SYNDROME	0.001301984	0.0325496
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.001301984	0.0325496
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.001301984	0.0325496
ALAZAMI-YUAN SYNDROME	0.001301984	0.0325496
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.001301984	0.0325496
MARINESCO-SJOGREN SYNDROME; MSS	0.001301984	0.0325496
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.001301984	0.0325496
HADZISELIMOVIC SYNDROME	0.001301984	0.0325496
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.001301984	0.0325496
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.001301984	0.0325496
MENTAL RETARDATION, X-LINKED 106; MRX106	0.001301984	0.0325496
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.001301984	0.0325496
KABUKI SYNDROME	0.001297849	0.032446225
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.001297849	0.032446225
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.001297849	0.032446225
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.001297849	0.032446225
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.001297849	0.032446225
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.001297849	0.032446225
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.001297849	0.032446225
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.001297849	0.032446225
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.001297849	0.032446225
5Q35 MICRODUPLICATION SYNDROME	0.001297849	0.032446225
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.001297849	0.032446225
XERODERMA PIGMENTOSUM	0.001297849	0.032446225
MICROFORM HOLOPROSENCEPHALY	0.001297849	0.032446225
SANJAD-SAKATI SYNDROME	0.001297849	0.032446225
14Q12 MICRODELETION SYNDROME	0.001297849	0.032446225
LEUKOCYTE ADHESION DEFICIENCY	0.001297849	0.032446225
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.001297849	0.032446225
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.001297849	0.032446225
MOYNAHAN SYNDROME	0.001297849	0.032446225
MENKES DISEASE	0.001297849	0.032446225
PRIMARY CUTIS VERTICIS GYRATA	0.001297849	0.032446225
RENIER-GABREELS-JASPER SYNDROME	0.001297849	0.032446225
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.001297849	0.032446225
9Q33.3Q34.11 MICRODELETION SYNDROME	0.001297849	0.032446225
CAMOS SYNDROME	0.001297849	0.032446225
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.001297849	0.032446225
ANGELMAN SYNDROME	0.001297849	0.032446225
TRIPLE A SYNDROME	0.001297849	0.032446225
3-HYDROXYISOBUTYRIC ACIDURIA	0.001297849	0.032446225
CONGENITAL RUBELLA SYNDROME	0.001297849	0.032446225
WORSTER-DROUGHT SYNDROME	0.001297849	0.032446225
SJÖGREN-LARSSON SYNDROME	0.001297849	0.032446225
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.001297849	0.032446225
NORRIE DISEASE	0.001297849	0.032446225
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.001297849	0.032446225
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.001297849	0.032446225
WOLF-HIRSCHHORN SYNDROME	0.001297849	0.032446225
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.001297849	0.032446225
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.001297849	0.032446225
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.001297849	0.032446225
KLEEFSTRA SYNDROME	0.001297849	0.032446225
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.001297849	0.032446225
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.001297849	0.032446225
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.001297849	0.032446225
GAUCHER DISEASE, PERINATAL LETHAL	0.001297849	0.032446225
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.001297849	0.032446225
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.001297849	0.032446225
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.001297849	0.032446225
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.001297849	0.032446225
KEARNS-SAYRE SYNDROME; KSS	0.001297849	0.032446225
CYCLIC VOMITING SYNDROME	0.001297849	0.032446225
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.001297849	0.032446225
INCONTINENTIA PIGMENTI; IP	0.001297849	0.032446225
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.001297849	0.032446225
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.001297849	0.032446225
COFFIN-LOWRY SYNDROME; CLS	0.001297849	0.032446225
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.001297849	0.032446225
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.001297849	0.032446225
MENTAL RETARDATION, X-LINKED 102	0.001297849	0.032446225
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.001297849	0.032446225
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.001297849	0.032446225
XYLOSIDASE DEFICIENCY	0.001297849	0.032446225
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.001297849	0.032446225
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.001297849	0.032446225
PHENYLKETONURIA	0.001297849	0.032446225
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.001297849	0.032446225
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.001297849	0.032446225
SYMMETRICAL THALAMIC CALCIFICATIONS	0.001297849	0.032446225
LISSENCEPHALY 3; LIS3	0.001297849	0.032446225
BRANCHIOSKELETOGENITAL SYNDROME	0.001297849	0.032446225
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.001297849	0.032446225
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.001297849	0.032446225
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.001297849	0.032446225
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.001297849	0.032446225
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.001297849	0.032446225
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.001297849	0.032446225
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.001297849	0.032446225
PSEUDO-TORCH SYNDROME 2	0.001297849	0.032446225
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.001297849	0.032446225
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.001297849	0.032446225
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.001297849	0.032446225
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.001297849	0.032446225
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.001297849	0.032446225
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.001297849	0.032446225
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.001297849	0.032446225
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.001297849	0.032446225
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.001297849	0.032446225
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.001297849	0.032446225
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.001297849	0.032446225
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.001297849	0.032446225
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.001297849	0.032446225
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.001297849	0.032446225
PERRAULT SYNDROME 3	0.001297849	0.032446225
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.001297849	0.032446225
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.001297849	0.032446225
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.001297849	0.032446225
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.001297849	0.032446225
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.001297849	0.032446225
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.001297849	0.032446225
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.001297849	0.032446225
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.001297849	0.032446225
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.001297849	0.032446225
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.001297849	0.032446225
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.001297849	0.032446225
ASPARTYLGLUCOSAMINURIA; AGU	0.001297849	0.032446225
MOWAT-WILSON SYNDROME; MOWS	0.001297849	0.032446225
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.001297849	0.032446225
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.001297849	0.032446225
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.001297849	0.032446225
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.001297849	0.032446225
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.001297849	0.032446225
MOWAT-WILSON SYNDROME	0.001297849	0.032446225
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.001297849	0.032446225
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.001297849	0.032446225
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.001297849	0.032446225
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.001297849	0.032446225
COHEN SYNDROME	0.001297849	0.032446225
MARDEN-WALKER SYNDROME	0.001297849	0.032446225
HARROD SYNDROME	0.001297849	0.032446225
ANGELMAN SYNDROME (TYPE 1)	0.001297849	0.032446225
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.001297849	0.032446225
SUPRABULBAR PARESIS, CONGENITAL	0.001297849	0.032446225
ANGELMAN SYNDROME (TYPE 2)	0.001297849	0.032446225
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.001086973	0.027174325
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.001086973	0.027174325
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.001086973	0.027174325
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.001086973	0.027174325
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.001086973	0.027174325
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.001086973	0.027174325
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.001086973	0.027174325
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.001086973	0.027174325
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.001086973	0.027174325
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.001086973	0.027174325
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.001086973	0.027174325
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.001086973	0.027174325
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.001086973	0.027174325
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.001086973	0.027174325
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.001086973	0.027174325
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.001086973	0.027174325
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.001086973	0.027174325
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.001086973	0.027174325
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.001086973	0.027174325
FUCOSIDOSIS	0.001086973	0.027174325
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.001086973	0.027174325
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.001086973	0.027174325
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.001086973	0.027174325
WILSON-TURNER SYNDROME	0.001086973	0.027174325
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.001086973	0.027174325
FG SYNDROME TYPE 1	0.001086973	0.027174325
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.001086973	0.027174325
GRISCELLI SYNDROME	0.001086973	0.027174325
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.001086973	0.027174325
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.001086973	0.027174325
POTOCKI-SHAFFER SYNDROME	0.001086973	0.027174325
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.001086973	0.027174325
SOTOS SYNDROME	0.001086973	0.027174325
DYSTONIA-APHONIA SYNDROME	0.001086973	0.027174325
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.001086973	0.027174325
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.001086973	0.027174325
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.001086973	0.027174325
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.001086973	0.027174325
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.001086973	0.027174325
ISOLATED GLYCEROL KINASE DEFICIENCY	0.001086973	0.027174325
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.001086973	0.027174325
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.001086973	0.027174325
GRISCELLI SYNDROME, TYPE 1	0.001086973	0.027174325
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.001086973	0.027174325
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.001086973	0.027174325
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.001086973	0.027174325
PRADER-WILLI-LIKE SYNDROME	0.001086973	0.027174325
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.001086973	0.027174325
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.001086973	0.027174325
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.001086973	0.027174325
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.001086973	0.027174325
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.001086973	0.027174325
CHROMOSOME 5Q12 DELETION SYNDROME	0.001086973	0.027174325
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.001086973	0.027174325
SHASHI-PENA SYNDROME; SHAPNS	0.001086973	0.027174325
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.001086973	0.027174325
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.001086973	0.027174325
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.001086973	0.027174325
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.001086973	0.027174325
DISTAL MONOSOMY 19P13.3	0.001086973	0.027174325
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.001086973	0.027174325
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.001086973	0.027174325
MIRAGE SYNDROME; MIRAGE	0.001086973	0.027174325
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.001086973	0.027174325
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.001086973	0.027174325
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.001086973	0.027174325
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.001086973	0.027174325
LUSCAN-LUMISH SYNDROME; LLS	0.001086973	0.027174325
JOUBERT SYNDROME 30; JBTS30	0.001086973	0.027174325
IMMUNODEFICIENCY 49; IMD49	0.001086973	0.027174325
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.001086973	0.027174325
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.001086973	0.027174325
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.001086973	0.027174325
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.001086973	0.027174325
DIGEORGE SYNDROME; DGS	0.001086973	0.027174325
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.001086973	0.027174325
11P15.4 MICRODUPLICATION SYNDROME	0.001086973	0.027174325
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.001086973	0.027174325
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.001086973	0.027174325
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.001086973	0.027174325
SEVERE CANAVAN DISEASE	0.001086973	0.027174325
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.001086973	0.027174325
ISOVALERIC ACIDEMIA	0.001086973	0.027174325
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.001086973	0.027174325
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.001086973	0.027174325
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.001086973	0.027174325
HELSMOORTEL-VAN DER AA SYNDROME	0.001086973	0.027174325
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.001086973	0.027174325
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.001086973	0.027174325
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.001086973	0.027174325
ARGININOSUCCINIC ACIDURIA	0.001086973	0.027174325
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.001086973	0.027174325
PITUITARY STALK INTERRUPTION SYNDROME	0.001086973	0.027174325
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.001086973	0.027174325
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.001086973	0.027174325
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.001086973	0.027174325
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.001086973	0.027174325
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.001086973	0.027174325
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.001086973	0.027174325
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.001086973	0.027174325
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.001086973	0.027174325
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.001086973	0.027174325
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.001086973	0.027174325
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.001086973	0.027174325
DESANTO-SHINAWI SYNDROME	0.001086973	0.027174325
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.001086973	0.027174325
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.001086973	0.027174325
CITRULLINEMIA, CLASSIC	0.001086973	0.027174325
TEMTAMY SYNDROME; TEMTYS	0.001086973	0.027174325
611961 STEVENSON-CAREY SYNDROME	0.001086973	0.027174325
NARP SYNDROME	0.001086973	0.027174325
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.001086973	0.027174325
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.001086973	0.027174325
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.001086973	0.027174325
MENTAL RETARDATION, X-LINKED 90	0.001086973	0.027174325
MENTAL RETARDATION, X-LINKED 88	0.001086973	0.027174325
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.001086973	0.027174325
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.001086973	0.027174325
MENTAL RETARDATION, X-LINKED 101; MRX101	0.001086973	0.027174325
LEBER CONGENITAL AMAUROSIS	0.001086973	0.027174325
KEUTEL SYNDROME	0.001086973	0.027174325
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.001086973	0.027174325
XQ25 DUPLICATION SYNDROME	0.001086973	0.027174325
MENTAL RETARDATION, X-LINKED 103	0.001086973	0.027174325
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.001086973	0.027174325
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.001086973	0.027174325
ALSTRÖM SYNDROME	0.001086973	0.027174325
SHUKLA-VERNON SYNDROME; SHUVER	0.001086973	0.027174325
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.001086973	0.027174325
NETHERTON SYNDROME	0.001086973	0.027174325
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.001086973	0.027174325
LANDAU-KLEFFNER SYNDROME	0.001086973	0.027174325
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.001086973	0.027174325
KETOADIPICACIDURIA	0.001086973	0.027174325
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.001086973	0.027174325
PETTIGREW SYNDROME	0.001086973	0.027174325
GLYCEROL KINASE DEFICIENCY; GKD	0.001086973	0.027174325
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.001086973	0.027174325
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.001086973	0.027174325
MUCOPOLYSACCHARIDOSIS TYPE 2	0.001086973	0.027174325
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.001086973	0.027174325
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.001086973	0.027174325
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.001086973	0.027174325
SCHIZENCEPHALY	0.001086973	0.027174325
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.001086973	0.027174325
LEIGH SYNDROME; LS	0.001086973	0.027174325
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.001086973	0.027174325
ELEJALDE DISEASE	0.001086973	0.027174325
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.001086973	0.027174325
PMM2-CDG	0.001086973	0.027174325
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.001086973	0.027174325
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.001086973	0.027174325
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.001086973	0.027174325
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.001086973	0.027174325
MENTAL RETARDATION, X-LINKED 72	0.001086973	0.027174325
MELANOSIS, NEUROCUTANEOUS; NCMS	0.001086973	0.027174325
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.001086973	0.027174325
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.001086973	0.027174325
PYRUVATE CARBOXYLASE DEFICIENCY	0.001086973	0.027174325
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.001086973	0.027174325
MONOSOMY 9Q22.3	0.001086973	0.027174325
INFANTILE REFSUM DISEASE	0.001086973	0.027174325
SULFOCYSTEINURIA	0.001086973	0.027174325
GM2-GANGLIOSIDOSIS, AB VARIANT	0.001086973	0.027174325
TAY-SACHS DISEASE	0.001086973	0.027174325
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.001086973	0.027174325
RAYNAUD-CLAES SYNDROME; MRXSRC	0.001086973	0.027174325
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.001086973	0.027174325
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.001086973	0.027174325
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.001086973	0.027174325
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.001086973	0.027174325
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.001086973	0.027174325
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.001086973	0.027174325
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.001086973	0.027174325
NIEMANN-PICK DISEASE, TYPE C2	0.001086973	0.027174325
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.001086973	0.027174325
HEREDITARY FOLATE MALABSORPTION	0.001086973	0.027174325
KAGAMI-OGATA SYNDROME	0.001086973	0.027174325
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.001086973	0.027174325
GAUCHER DISEASE, TYPE II	0.001086973	0.027174325
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.001086973	0.027174325
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.001086973	0.027174325
FOLATE MALABSORPTION, HEREDITARY	0.001086973	0.027174325
SCHINDLER DISEASE, TYPE I	0.001086973	0.027174325
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.001086973	0.027174325
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.001086973	0.027174325
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.001086973	0.027174325
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.001086973	0.027174325
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.001086973	0.027174325
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.001086973	0.027174325
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.001086973	0.027174325
HOLOPROSENCEPHALY 7	0.001086973	0.027174325
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.001086973	0.027174325
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.001086973	0.027174325
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.001086973	0.027174325
TEMPLE-BARAITSER SYNDROME; TMBTS	0.001086973	0.027174325
COACH SYNDROME	0.001086973	0.027174325
PHACE ASSOCIATION	0.001086973	0.027174325
HYPEREKPLEXIA 4; HKPX4	0.001086973	0.027174325
MENTAL RETARDATION, X-LINKED 9	0.001086973	0.027174325
HARTNUP DISORDER	0.001086973	0.027174325
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.001086973	0.027174325
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.001086973	0.027174325
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.001086973	0.027174325
CRANIOPHARYNGIOMA	0.001086973	0.027174325
WYBURN-MASON SYNDROME	0.001086973	0.027174325
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.001086973	0.027174325
OCULOECTODERMAL SYNDROME; OES	0.001086973	0.027174325
CODAS SYNDROME	0.001086973	0.027174325
CHROMOSOME 2Q37 DELETION SYNDROME	0.001086973	0.027174325
XQ25 MICRODUPLICATION SYNDROME	0.001086973	0.027174325
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.001086973	0.027174325
MAPLE SYRUP URINE DISEASE	0.001086973	0.027174325
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.001086973	0.027174325
PROPIONIC ACIDEMIA	0.001086973	0.027174325
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.001086973	0.027174325
ARGININEMIA	0.001086973	0.027174325
GRACILE BONE DYSPLASIA; GCLEB	0.001086973	0.027174325
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.001086973	0.027174325
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.001086973	0.027174325
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.001086973	0.027174325
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.001086973	0.027174325
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.001086973	0.027174325
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.001086973	0.027174325
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.001086973	0.027174325
SALLA DISEASE	0.001086973	0.027174325
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.001086973	0.027174325
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.001086973	0.027174325
GABA-TRANSAMINASE DEFICIENCY	0.001086973	0.027174325
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.001086973	0.027174325
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.001086973	0.027174325
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.001086973	0.027174325
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.001086973	0.027174325
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.001086973	0.027174325
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.001086973	0.027174325
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.001086973	0.027174325
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.001086973	0.027174325
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.001086973	0.027174325
MULTIPLE CARBOXYLASE DEFICIENCY	0.001086973	0.027174325
VICI SYNDROME	0.001086973	0.027174325
CONGENITAL DISORDER OF GLYCOSYLATION	0.001086973	0.027174325
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.001086973	0.027174325
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.001086973	0.027174325
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.001086973	0.027174325
ACROMELIC FRONTONASAL DYSPLASIA	0.001086973	0.027174325
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.001086973	0.027174325
1Q21.1 MICRODUPLICATION SYNDROME	0.001086973	0.027174325
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.001086973	0.027174325
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.001086973	0.027174325
DISTAL 16P11.2 MICRODELETION SYNDROME	0.001086973	0.027174325
17Q12 MICRODELETION SYNDROME	0.001086973	0.027174325
HARTNUP DISEASE	0.001086973	0.027174325
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.001086973	0.027174325
20P12.3 MICRODELETION SYNDROME	0.001086973	0.027174325
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.001086973	0.027174325
2P21 MICRODELETION SYNDROME	0.001086973	0.027174325
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.001086973	0.027174325
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.001086973	0.027174325
DONNAI-BARROW SYNDROME	0.001086973	0.027174325
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.001086973	0.027174325
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.001086973	0.027174325
OPTIC PATHWAY GLIOMA	0.001086973	0.027174325
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.001086973	0.027174325
COWDEN SYNDROME	0.001086973	0.027174325
CANAVAN DISEASE	0.001086973	0.027174325
EAST SYNDROME	0.001086973	0.027174325
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.001086973	0.027174325
CENTRAL BILATERAL MACROGYRIA	0.001086973	0.027174325
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.001086973	0.027174325
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.001086973	0.027174325
XQ21 MICRODELETION SYNDROME	0.001086973	0.027174325
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.001086973	0.027174325
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.001086973	0.027174325
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.001086973	0.027174325
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.001086973	0.027174325
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.001086973	0.027174325
NEPHROGENIC DIABETES INSIPIDUS	0.001086973	0.027174325
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.001086973	0.027174325
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.001086973	0.027174325
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.001086973	0.027174325
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.001086973	0.027174325
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.001086973	0.027174325
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.001086973	0.027174325
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.001086973	0.027174325
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.001086973	0.027174325
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.001086973	0.027174325
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.001086973	0.027174325
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.00075643	0.01891075
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.00075643	0.01891075
CHROMOSOME 1Q21.1 DELETION SYNDROME, 1.35-MB	0.00075643	0.01891075
SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	0.00075643	0.01891075
MITOCHONDRIAL MYOPATHY AND SIDEROBLASTIC ANEMIA	0.00075643	0.01891075
CARDIAC LIPIDOSIS, FAMILIAL	0.00075643	0.01891075
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.00075643	0.01891075
JUNG SYNDROME	0.00075643	0.01891075
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.00075643	0.01891075
ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME; ANES	0.00075643	0.01891075
PRIMARY HYPERGONADOTROPIC HYPOGONADISM-PARTIAL ALOPECIA SYNDROME	0.00075643	0.01891075
BLOOM SYNDROME	0.00075643	0.01891075
BONNEMANN-MEINECKE-REICH SYNDROME	0.00075643	0.01891075
CATARACT-INTELLECTUAL DISABILITY-HYPOGONADISM SYNDROME	0.00075643	0.01891075
608432 CRANIOSYNOSTOSIS, CALCIFICATION OF BASAL GANGLIA, AND FACIAL DYSMORPHISM	0.00075643	0.01891075
MARTSOLF SYNDROME	0.00075643	0.01891075
JOHANSON-BLIZZARD SYNDROME	0.00075643	0.01891075
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.00075643	0.01891075
AICARDI-GOUTIERES SYNDROME 2; AGS2	0.00075643	0.01891075
JOHNSON NEUROECTODERMAL SYNDROME	0.00075643	0.01891075
MECKEL SYNDROME, TYPE 4; MKS4	0.00075643	0.01891075
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.00075643	0.01891075
XFE PROGEROID SYNDROME; XFEPS	0.00075643	0.01891075
CHARGE SYNDROME	0.00075643	0.01891075
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 2	0.00075643	0.01891075
SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS	0.00075643	0.01891075
CAREY-FINEMAN-ZITER SYNDROME	0.00075643	0.01891075
LETHAL HEMOLYTIC ANEMIA-GENITAL ANOMALIES SYNDROME	0.00075643	0.01891075
MICROCEPHALY 7, PRIMARY, AUTOSOMAL RECESSIVE	0.00075643	0.01891075
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 2; CEMCOX2	0.00075643	0.01891075
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	0.00075643	0.01891075
SEVERE MOTOR AND INTELLECTUAL DISABILITIES-SENSORINEURAL DEAFNESS-DYSTONIA SYNDROME	0.00075643	0.01891075
TRIGLYCERIDE STORAGE DISEASE, TYPE I	0.00075643	0.01891075
RING CHROMOSOME 13 SYNDROME	0.00075643	0.01891075
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.00075643	0.01891075
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00075643	0.01891075
SAY SYNDROME	0.00075643	0.01891075
RUVALCABA SYNDROME	0.00075643	0.01891075
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.00075643	0.01891075
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.00075643	0.01891075
FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ	0.00075643	0.01891075
ABSENT EYEBROWS AND EYELASHES WITH MENTAL RETARDATION	0.00075643	0.01891075
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.00075643	0.01891075
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA-MYOPATHY-EMACIATION SYNDROME	0.00075643	0.01891075
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.00075643	0.01891075
XK APROSENCEPHALY SYNDROME	0.00075643	0.01891075
WEAVER-WILLIAMS SYNDROME	0.00075643	0.01891075
MMEP SYNDROME	0.00075643	0.01891075
MICROCEPHALY-BRACHYDACTYLY-KYPHOSCOLIOSIS SYNDROME	0.00075643	0.01891075
ATAXIA-PANCYTOPENIA SYNDROME	0.00075643	0.01891075
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.00075643	0.01891075
156620 MICROCEPHALY-DEAFNESS SYNDROME	0.00075643	0.01891075
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.00075643	0.01891075
ACHALASIA-MICROCEPHALY SYNDROME	0.00075643	0.01891075
207790 ARACHNOID CYSTS, INTRACRANIAL	0.00075643	0.01891075
SECKEL SYNDROME 4	0.00075643	0.01891075
FACIOCARDIOMELIC SYNDROME	0.00075643	0.01891075
X-LINKED MANDIBULOFACIAL DYSOSTOSIS	0.00075643	0.01891075
ALANINURIA WITH MICROCEPHALY, DWARFISM, ENAMEL HYPOPLASIA, AND DIABETES MELLITUS	0.00075643	0.01891075
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.00075643	0.01891075
FRONTONASAL DYSPLASIA 2; FND2	0.00075643	0.01891075
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.01891075
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.00075643	0.01891075
PRIMARY PULMONARY HYPOPLASIA	0.00075643	0.01891075
ADDUCTED THUMBS SYNDROME	0.00075643	0.01891075
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.00075643	0.01891075
OCULOAURICULOFRONTONASAL SYNDROME	0.00075643	0.01891075
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 28	0.00075643	0.01891075
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.00075643	0.01891075
MEIER-GORLIN SYNDROME 2; MGORS2	0.00075643	0.01891075
MEIER-GORLIN SYNDROME 3; MGORS3	0.00075643	0.01891075
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.00075643	0.01891075
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.00075643	0.01891075
DISTAL TRISOMY 5Q	0.00075643	0.01891075
CONGENITAL MUSCULAR DYSTROPHY WITHOUT INTELLECTUAL DISABILITY	0.00075643	0.01891075
FEINGOLD SYNDROME 2; FGLDS2	0.00075643	0.01891075
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 30	0.00075643	0.01891075
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00075643	0.01891075
OTOMANDIBULAR SYNDROME	0.00075643	0.01891075
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.00075643	0.01891075
KERATOSIS FOLLICULARIS-DWARFISM-CEREBRAL ATROPHY SYNDROME	0.00075643	0.01891075
LETHAL INTRAUTERINE GROWTH RESTRICTION-CORTICAL MALFORMATION-CONGENITAL CONTRACTURES SYNDROME	0.00075643	0.01891075
MÜLLERIAN DUCT ANOMALIES-LIMB ANOMALIES SYNDROME	0.00075643	0.01891075
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.00075643	0.01891075
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.00075643	0.01891075
DE SANCTIS-CACCHIONE SYNDROME	0.00075643	0.01891075
FETAL METHYLMERCURY SYNDROME	0.00075643	0.01891075
AMINOPTERIN/METHOTREXATE EMBRYOFETOPATHY	0.00075643	0.01891075
MENTAL RETARDATION, X-LINKED 63	0.00075643	0.01891075
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.00075643	0.01891075
STROMME SYNDROME; STROMS	0.00075643	0.01891075
HYPOSPADIAS-MENTAL RETARDATION SYNDROME	0.00075643	0.01891075
HEREDITARY BULLOUS DYSTROPHY, MACULAR TYPE	0.00075643	0.01891075
X-LINKED INTELLECTUAL DISABILITY, SHRIMPTON TYPE	0.00075643	0.01891075
GMS SYNDROME	0.00075643	0.01891075
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.00075643	0.01891075
CHROMOSOME XP11.3 DELETION SYNDROME	0.00075643	0.01891075
HYPOGONADISM WITH LOW-GRADE MENTAL DEFICIENCY AND MICROCEPHALY	0.00075643	0.01891075
SEVERE COMBINED IMMUNODEFICIENCY	0.00075643	0.01891075
LETHAL OSTEOSCLEROTIC BONE DYSPLASIA	0.00075643	0.01891075
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.00075643	0.01891075
LOWRY-WOOD SYNDROME	0.00075643	0.01891075
LISSENCEPHALY TYPE 3-METACARPAL BONE DYSPLASIA SYNDROME	0.00075643	0.01891075
GROWTH HORMONE INSENSITIVITY SYNDROME	0.00075643	0.01891075
DYSOSTOSIS, STANESCU TYPE	0.00075643	0.01891075
LACTIC ACIDURIA DUE TO D-LACTIC ACID	0.00075643	0.01891075
LAMBOTTE SYNDROME	0.00075643	0.01891075
DIABETIC EMBRYOPATHY	0.00075643	0.01891075
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00075643	0.01891075
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.00075643	0.01891075
HYPO- AND HYPERMELANOTIC CUTANEOUS MACULES-RETARDED GROWTH-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.01891075
46,XX GONADAL DYSGENESIS	0.00075643	0.01891075
SHPRINTZEN-GOLDBERG SYNDROME	0.00075643	0.01891075
NIJMEGEN BREAKAGE SYNDROME	0.00075643	0.01891075
MICROCEPHALY WITH CERVICAL SPINE FUSION ANOMALIES	0.00075643	0.01891075
MICROCEPHALY WITH CHEMOTACTIC DEFECT AND TRANSIENT HYPOGAMMAGLOBULINEMIA	0.00075643	0.01891075
OCULOPALATOCEREBRAL SYNDROME	0.00075643	0.01891075
OSTEOGENESIS IMPERFECTA CONGENITA, MICROCEPHALY, AND CATARACTS	0.00075643	0.01891075
EXTRASYSTOLES-SHORT STATURE-HYPERPIGMENTATION-MICROCEPHALY SYNDROME	0.00075643	0.01891075
FRYNS-SMEETS-THIRY SYNDROME	0.00075643	0.01891075
X-LINKED INTELLECTUAL DISABILITY, ABIDI TYPE	0.00075643	0.01891075
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.00075643	0.01891075
248760 MARFANOID HABITUS WITH MICROCEPHALY AND GLOMERULONEPHRITIS	0.00075643	0.01891075
GENITOPALATOCARDIAC SYNDROME	0.00075643	0.01891075
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.00075643	0.01891075
MICROCEPHALIC OSTEODYSPLASTIC DYSPLASIA, SAUL-WILSON TYPE	0.00075643	0.01891075
RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	0.00075643	0.01891075
RHIZOMELIC SYNDROME	0.00075643	0.01891075
AURICULAR ABNORMALITIES-CLEFT LIP WITH OR WITHOUT CLEFT PALATE-OCULAR ABNORMALITIES SYNDROME	0.00075643	0.01891075
%270750 SPASTIC PARAPLEGIA 23; SPG23;;SPASTIC PARAPLEGIA WITH PIGMENTARY ABNORMALITIES;;SPASTIC PARAPARESIS, VITILIGO, PREMATURE GRAYING, CHARACTERISTIC FACIES;;LISON SYNDROME	0.00075643	0.01891075
SPINAL MUSCULAR ATROPHY WITH MICROCEPHALY AND MENTAL SUBNORMALITY	0.00075643	0.01891075
NIJMEGEN BREAKAGE SYNDROME	0.00075643	0.01891075
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00075643	0.01891075
%236795 3-@HYDROXYISOBUTYRIC ACIDURIA	0.00075643	0.01891075
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.00075643	0.01891075
LARYNGEAL ABDUCTOR PARALYSIS-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.01891075
EPIPHYSEAL DYSPLASIA, MICROCEPHALY, AND NYSTAGMUS	0.00075643	0.01891075
MICROPHTHALMIA, SYNDROMIC 8; MCOPS8	0.00075643	0.01891075
DUANE ANOMALY-MYOPATHY-SCOLIOSIS SYNDROME	0.00075643	0.01891075
601453 TRICHODENTAL DYSPLASIA	0.00075643	0.01891075
LEPRECHAUNISM	0.00075643	0.01891075
ENCEPHALOMALACIA, MULTILOCULAR	0.00075643	0.01891075
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.00075643	0.01891075
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.00075643	0.01891075
ACHALASIA-MICROCEPHALY SYNDROME	0.00075643	0.01891075
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1; DKCB1	0.00075643	0.01891075
MICROCEPHALY-FACIAL DYSMORPHISM-OCULAR ANOMALIES-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00075643	0.01891075
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.00075643	0.01891075
223540 DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY;;MOLLICA SYNDROME	0.00075643	0.01891075
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, OHDO TYPE	0.00075643	0.01891075
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.00075643	0.01891075
RING CHROMOSOME 6 SYNDROME	0.00075643	0.01891075
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.00075643	0.01891075
HOLOPROSENCEPHALY-POSTAXIAL POLYDACTYLY SYNDROME	0.00075643	0.01891075
FANCONI ANEMIA, COMPLEMENTATION GROUP D1	0.00075643	0.01891075
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.00075643	0.01891075
CHONDRODYSPLASIA-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00075643	0.01891075
MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1	0.00075643	0.01891075
MICROCEPHALY-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.01891075
NON-DISTAL TRISOMY 13Q	0.00075643	0.01891075
MICROCEPHALY-CARDIAC DEFECT-LUNG MALSEGMENTATION SYNDROME	0.00075643	0.01891075
CERNUNNOS-XLF DEFICIENCY	0.00075643	0.01891075
HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY	0.00075643	0.01891075
MICROCEPHALY-ALBINISM-DIGITAL ANOMALIES SYNDROME	0.00075643	0.01891075
ISOLATED OSTEOPOIKILOSIS	0.00075643	0.01891075
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.00075643	0.01891075
BULLOUS DYSTROPHY, HEREDITARY MACULAR TYPE	0.00075643	0.01891075
MASA SYNDROME	0.00075643	0.01891075
AUTOSOMAL DOMINANT PRIMARY MICROCEPHALY	0.00075643	0.01891075
HOLOPROSENCEPHALY WITH FETAL AKINESIA/HYPOKINESIA SEQUENCE	0.00075643	0.01891075
WAGR SYNDROME	0.00075643	0.01891075
KERATOSIS FOLLICULARIS, DWARFISM, AND CEREBRAL ATROPHY	0.00075643	0.01891075
MICROCEPHALY-MICROCORNEA SYNDROME, SEEMANOVA TYPE	0.00075643	0.01891075
WAARDENBURG SYNDROME TYPE 3	0.00075643	0.01891075
GERODERMA OSTEODYSPLASTICUM; GO	0.00075643	0.01891075
MECKEL SYNDROME	0.00075643	0.01891075
DISTAL MONOSOMY 13Q	0.00075643	0.01891075
CHONDRODYSPLASIA-PSEUDOHERMAPHRODITISM SYNDROME	0.00075643	0.01891075
MICROCEPHALY-CERVICAL SPINE FUSION ANOMALIES SYNDROME	0.00075643	0.01891075
WARBURG MICRO SYNDROME 1	0.00075643	0.01891075
KLIPPEL-TRÉNAUNAY SYNDROME	0.00075643	0.01891075
MICROCEPHALY-BRAIN DEFECT-SPASTICITY-HYPERNATREMIA SYNDROME	0.00075643	0.01891075
ANE SYNDROME	0.00075643	0.01891075
MICROCEPHALY, AUTOSOMAL DOMINANT	0.00075643	0.01891075
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.00075643	0.01891075
ACROOTOOCULAR SYNDROME	0.00075643	0.01891075
PAGOD SYNDROME	0.00075643	0.01891075
AORTIC ARCH ANOMALY WITH PECULIAR FACIES AND MENTAL RETARDATION	0.00075643	0.01891075
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO ZNF335 DEFICIENCY	0.00075643	0.01891075
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 53	0.00075643	0.01891075
X-LINKED INTELLECTUAL DISABILITY-PLAGIOCEPHALY SYNDROME	0.00075643	0.01891075
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.00075643	0.01891075
MEIER-GORLIN SYNDROME 8; MGORS8	0.00075643	0.01891075
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.00075643	0.01891075
FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW	0.00075643	0.01891075
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.00075643	0.01891075
SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI	0.00075643	0.01891075
FANCONI ANEMIA, COMPLEMENTATION GROUP V	0.00075643	0.01891075
FANCONI ANEMIA, COMPLEMENTATION GROUP R	0.00075643	0.01891075
HOLOPROSENCEPHALY-RADIAL HEART RENAL ANOMALIES SYNDROME	0.00075643	0.01891075
FANCONI ANEMIA, COMPLEMENTATION GROUP U	0.00075643	0.01891075
PONTOCEREBELLAR HYPOPLASIA, TYPE 12; PCH12	0.00075643	0.01891075
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00075643	0.01891075
PSEUDOPROGERIA SYNDROME	0.00075643	0.01891075
RHIZOMELIC SYNDROME, URBACH TYPE	0.00075643	0.01891075
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.00075643	0.01891075
LARYNGEAL ABDUCTOR PARALYSIS	0.00075643	0.01891075
ARTHROGRYPOSIS, DISTAL, TYPE 2E	0.00075643	0.01891075
9Q SUBTELOMERIC DELETION SYNDROME	0.00075643	0.01891075
STIMMLER SYNDROME	0.00075643	0.01891075
VENTRICULAR EXTRASYSTOLES WITH SYNCOPAL EPISODES-PERODACTYLY-ROBIN SEQUENCE SYNDROME	0.00075643	0.01891075
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.00075643	0.01891075
CONGENITAL HERPES SIMPLEX VIRUS INFECTION	0.00075643	0.01891075
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.00075643	0.01891075
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.00075643	0.01891075
CONGENITAL OSTEOGENESIS IMPERFECTA-MICROCEPHALY-CATARACTS SYNDROME	0.00075643	0.01891075
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.00075643	0.01891075
BARDET-BIEDL SYNDROME 20	0.00075643	0.01891075
ISOLATED GROWTH HORMONE DEFICIENCY, TYPE V; IGHD5	0.00075643	0.01891075
OROFACIODIGITAL SYNDROME TYPE 5	0.00075643	0.01891075
MECKEL SYNDROME 12; MKS12	0.00075643	0.01891075
HUMERO-RADIAL SYNOSTOSIS	0.00075643	0.01891075
RENAL TUBULAR DYSGENESIS	0.00075643	0.01891075
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.00075643	0.01891075
HYPERREFLEXIA	0.00075643	0.01891075
IMMUNODEFICIENCY 55; IMD55	0.00075643	0.01891075
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00075643	0.01891075
SATOYOSHI SYNDROME	0.00075643	0.01891075
CRI DU CHAT SYNDROME (5P DELETION)	0.00075643	0.01891075
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00075643	0.01891075
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.00075643	0.01891075
NEU-LAXOVA SYNDROME 2; NLS2	0.00075643	0.01891075
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 50; MRT50	0.00075643	0.01891075
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00075643	0.01891075
PIEBALDISM	0.00075643	0.01891075
MILLER-DIEKER SYNDROME (MDS)	0.00075643	0.01891075
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00075643	0.01891075
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.00075643	0.01891075
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.00075643	0.01891075
RECURRENT 16P12.1 MICRODELETION (NEURODEVELOPMENTAL SUSCEPTIBILITY LOCUS)	0.00075643	0.01891075
TETRAPLOIDY	0.00075643	0.01891075
WHITE MATTER HYPOPLASIA-CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.01891075
2P15-16.1 MICRODELETION SYNDROME	0.00075643	0.01891075
133750 EXTRASYSTOLES, MULTIFORM VENTRICULAR, WITH SHORT STATURE, HYPERPIGMENTATIONAND MICROCEPHALY	0.00075643	0.01891075
OSTEOPOROSIS-MACROCEPHALY-BLINDNESS-JOINT HYPERLAXITY SYNDROME	0.00075643	0.01891075
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.00075643	0.01891075
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.00075643	0.01891075
DIAMOND-BLACKFAN ANEMIA 1	0.00075643	0.01891075
SECKEL SYNDROME 10; SCKL10	0.00075643	0.01891075
MEIER-GORLIN SYNDROME 6; MGORS6	0.00075643	0.01891075
MICROCEPHALY 18, PRIMARY, AUTOSOMAL DOMINANT; MCPH18	0.00075643	0.01891075
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00075643	0.01891075
MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21	0.00075643	0.01891075
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.00075643	0.01891075
MICROCEPHALY 12, PRIMARY, AUTOSOMAL RECESSIVE; MCPH12	0.00075643	0.01891075
1Q21.1 RECURRENT MICRODELETION (SUSCEPTIBILITY LOCUS FOR NEURODEVELOPMENTAL DISORDERS)	0.00075643	0.01891075
MICROCEPHALY 23, PRIMARY, AUTOSOMAL RECESSIVE; MCPH23	0.00075643	0.01891075
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000545554	0.01363885
LATERAL MENINGOCELE SYNDROME	0.000545554	0.01363885
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.000545554	0.01363885
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.000545554	0.01363885
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000545554	0.01363885
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.000545554	0.01363885
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.000545554	0.01363885
HYPERTRYPTOPHANEMIA; HYPTRP	0.000545554	0.01363885
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.000545554	0.01363885
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.000545554	0.01363885
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.000545554	0.01363885
BARDET-BIEDL SYNDROME 3; BBS3	0.000545554	0.01363885
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.01363885
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.000545554	0.01363885
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.000545554	0.01363885
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.01363885
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000545554	0.01363885
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.000545554	0.01363885
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.000545554	0.01363885
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.000545554	0.01363885
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000545554	0.01363885
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000545554	0.01363885
ATELOSTEOGENESIS TYPE III	0.000545554	0.01363885
OTOPALATODIGITAL SYNDROME TYPE 2	0.000545554	0.01363885
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.01363885
CDAGS SYNDROME	0.000545554	0.01363885
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.000545554	0.01363885
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000545554	0.01363885
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.000545554	0.01363885
FARBER DISEASE	0.000545554	0.01363885
CHROMOSOME 15Q14 DELETION SYNDROME	0.000545554	0.01363885
HYPOTONIA-CYSTINURIA SYNDROME	0.000545554	0.01363885
ZECHI-CEIDE SYNDROME	0.000545554	0.01363885
CREE MENTAL RETARDATION SYNDROME	0.000545554	0.01363885
HURLER SYNDROME	0.000545554	0.01363885
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000545554	0.01363885
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.01363885
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000545554	0.01363885
COSTELLO SYNDROME; CSTLO	0.000545554	0.01363885
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.000545554	0.01363885
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.000545554	0.01363885
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000545554	0.01363885
7P22.1 MICRODUPLICATION SYNDROME	0.000545554	0.01363885
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.000545554	0.01363885
DIAPHANOSPONDYLODYSOSTOSIS	0.000545554	0.01363885
PSEUDOAMINOPTERIN SYNDROME	0.000545554	0.01363885
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.000545554	0.01363885
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.000545554	0.01363885
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000545554	0.01363885
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.000545554	0.01363885
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.000545554	0.01363885
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.000545554	0.01363885
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.000545554	0.01363885
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.000545554	0.01363885
JOUBERT SYNDROME 28	0.000545554	0.01363885
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.000545554	0.01363885
JOUBERT SYNDROME 27	0.000545554	0.01363885
ROSSELLI-GULIENETTI SYNDROME	0.000545554	0.01363885
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.000545554	0.01363885
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.000545554	0.01363885
48,XYYY SYNDROME	0.000545554	0.01363885
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.000545554	0.01363885
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.000545554	0.01363885
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.000545554	0.01363885
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.000545554	0.01363885
THAUVIN-ROBINET-FAIVRE SYNDROME	0.000545554	0.01363885
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.000545554	0.01363885
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.000545554	0.01363885
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000545554	0.01363885
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000545554	0.01363885
CODAS SYNDROME	0.000545554	0.01363885
CINCA SYNDROME	0.000545554	0.01363885
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.000545554	0.01363885
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.000545554	0.01363885
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000545554	0.01363885
TRANSKETOLASE DEFICIENCY	0.000545554	0.01363885
NOONAN SYNDROME 2; NS2	0.000545554	0.01363885
MACROCEPHALY/AUTISM SYNDROME	0.000545554	0.01363885
FRONTOOCULAR SYNDROME	0.000545554	0.01363885
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.000545554	0.01363885
PEROXISOME BIOGENESIS DISORDER 10B	0.000545554	0.01363885
HEREDITARY OROTIC ACIDURIA	0.000545554	0.01363885
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.000545554	0.01363885
GERMAN SYNDROME	0.000545554	0.01363885
3MC SYNDROME 2	0.000545554	0.01363885
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000545554	0.01363885
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.000545554	0.01363885
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.000545554	0.01363885
PEROXISOME BIOGENESIS DISORDER 3B	0.000545554	0.01363885
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.000545554	0.01363885
SAUL-WILSON SYNDROME; SWILS	0.000545554	0.01363885
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.000545554	0.01363885
REVESZ SYNDROME	0.000545554	0.01363885
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000545554	0.01363885
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.000545554	0.01363885
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.000545554	0.01363885
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000545554	0.01363885
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.000545554	0.01363885
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.000545554	0.01363885
GERODERMA OSTEODYSPLASTICA	0.000545554	0.01363885
RETINITIS PIGMENTOSA 80; RP80	0.000545554	0.01363885
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.000545554	0.01363885
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.000545554	0.01363885
RABSON-MENDENHALL SYNDROME	0.000545554	0.01363885
JOUBERT SYNDROME 33; JBTS33	0.000545554	0.01363885
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.000545554	0.01363885
JOUBERT SYNDROME 31; JBTS31	0.000545554	0.01363885
JOUBERT SYNDROME 32; JBTS32	0.000545554	0.01363885
HYDROXYKYNURENINURIA	0.000545554	0.01363885
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000545554	0.01363885
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.000545554	0.01363885
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.000545554	0.01363885
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.000545554	0.01363885
NETHERTON SYNDROME; NETH	0.000545554	0.01363885
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.000545554	0.01363885
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.000545554	0.01363885
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000545554	0.01363885
NAVAJO NEUROHEPATOPATHY	0.000545554	0.01363885
NIEMANN-PICK DISEASE, TYPE A	0.000545554	0.01363885
METHYLMALONIC ACIDURIA, CBLB TYPE	0.000545554	0.01363885
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.01363885
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000545554	0.01363885
ALG6-CDG	0.000545554	0.01363885
OCCIPITAL HORN SYNDROME	0.000545554	0.01363885
SYNDROMIC DIARRHEA	0.000545554	0.01363885
OROTIC ACIDURIA	0.000545554	0.01363885
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.000545554	0.01363885
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.000545554	0.01363885
VASCULAR EHLERS-DANLOS SYNDROME	0.000545554	0.01363885
COLE-CARPENTER SYNDROME	0.000545554	0.01363885
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000545554	0.01363885
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.000545554	0.01363885
PELLAGRA-LIKE SYNDROME	0.000545554	0.01363885
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.000545554	0.01363885
MCKUSICK-KAUFMAN SYNDROME	0.000545554	0.01363885
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.01363885
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.01363885
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.000545554	0.01363885
SWEENEY-COX SYNDROME; SWCOS	0.000545554	0.01363885
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000545554	0.01363885
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000545554	0.01363885
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000545554	0.01363885
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.000545554	0.01363885
TREACHER-COLLINS SYNDROME	0.000545554	0.01363885
OROFACIODIGITAL SYNDROME XVI; OFD16	0.000545554	0.01363885
MENTAL RETARDATION, X-LINKED 99	0.000545554	0.01363885
MECKEL SYNDROME 13; MKS13	0.000545554	0.01363885
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000545554	0.01363885
RAHMAN SYNDROME	0.000545554	0.01363885
DYSKERATOSIS CONGENITA	0.000545554	0.01363885
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000545554	0.01363885
EVEN-PLUS SYNDROME	0.000545554	0.01363885
WOLMAN DISEASE	0.000545554	0.01363885
INFANTILE DYSTONIA-PARKINSONISM	0.000545554	0.01363885
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.000545554	0.01363885
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000545554	0.01363885
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.000545554	0.01363885
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.000545554	0.01363885
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.000545554	0.01363885
ALPHA-MANNOSIDOSIS	0.000545554	0.01363885
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.000545554	0.01363885
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.000545554	0.01363885
OTOFACIOCERVICAL SYNDROME	0.000545554	0.01363885
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.000545554	0.01363885
ICF SYNDROME	0.000545554	0.01363885
JOUBERT SYNDROME 10	0.000545554	0.01363885
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.000545554	0.01363885
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.000545554	0.01363885
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000545554	0.01363885
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.000545554	0.01363885
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.000545554	0.01363885
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.000545554	0.01363885
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.01363885
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.000545554	0.01363885
WAARDENBURG-SHAH SYNDROME	0.000545554	0.01363885
JOUBERT SYNDROME 35; JBTS35	0.000545554	0.01363885
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.01363885
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.000545554	0.01363885
RICHARDS-RUNDLE SYNDROME; RRNS	0.000545554	0.01363885
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.000545554	0.01363885
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.000545554	0.01363885
ARIMA SYNDROME	0.000545554	0.01363885
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.000545554	0.01363885
CUTIS LAXA	0.000545554	0.01363885
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.000545554	0.01363885
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.000545554	0.01363885
1P21.3 MICRODELETION SYNDROME	0.000545554	0.01363885
3C SYNDROME	0.000545554	0.01363885
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.000545554	0.01363885
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.000545554	0.01363885
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.000545554	0.01363885
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.000545554	0.01363885
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.000545554	0.01363885
LYMPHEDEMA, HEREDITARY, III	0.000545554	0.01363885
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.000545554	0.01363885
CHOPS SYNDROME; CHOPS	0.000545554	0.01363885
CHROMOSOME 15Q25 DELETION SYNDROME	0.000545554	0.01363885
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.000545554	0.01363885
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.000545554	0.01363885
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000545554	0.01363885
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.000545554	0.01363885
ABETAL34V AMYLOIDOSIS	0.000545554	0.01363885
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.000545554	0.01363885
JOUBERT SYNDROME 14	0.000545554	0.01363885
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.000545554	0.01363885
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.000545554	0.01363885
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.000545554	0.01363885
JOUBERT SYNDROME 15	0.000545554	0.01363885
PERMANENT CONGENITAL HYPOTHYROIDISM	0.000545554	0.01363885
OBESITY DUE TO SIM1 DEFICIENCY	0.000545554	0.01363885
PRIMARY CONGENITAL HYPOTHYROIDISM	0.000545554	0.01363885
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.000545554	0.01363885
CHROMOSOME 16Q22 DELETION SYNDROME	0.000545554	0.01363885
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.000545554	0.01363885
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.000545554	0.01363885
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000545554	0.01363885
THANATOPHORIC DYSPLASIA, TYPE I	0.000545554	0.01363885
8Q12 MICRODUPLICATION SYNDROME	0.000545554	0.01363885
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.000545554	0.01363885
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.000545554	0.01363885
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000545554	0.01363885
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.000545554	0.01363885
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000545554	0.01363885
MICROVILLUS INCLUSION DISEASE	0.000545554	0.01363885
THYROID HYPOPLASIA	0.000545554	0.01363885
THYROID ECTOPIA	0.000545554	0.01363885
CHROMOSOME 4Q21 DELETION SYNDROME	0.000545554	0.01363885
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.000545554	0.01363885
NEPHRONOPHTHISIS 11; NPHP11	0.000545554	0.01363885
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.000545554	0.01363885
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.000545554	0.01363885
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.000545554	0.01363885
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000545554	0.01363885
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000545554	0.01363885
JOUBERT SYNDROME 23; JBTS23	0.000545554	0.01363885
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.000545554	0.01363885
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.000545554	0.01363885
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.000545554	0.01363885
ATHYREOSIS	0.000545554	0.01363885
AURICULOCONDYLAR SYNDROME	0.000545554	0.01363885
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.000545554	0.01363885
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.000545554	0.01363885
CHROMOSOME 17P13.1 DELETION SYNDROME	0.000545554	0.01363885
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.000545554	0.01363885
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.000545554	0.01363885
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000545554	0.01363885
FAMILIAL THYROID DYSHORMONOGENESIS	0.000545554	0.01363885
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.000545554	0.01363885
THYROID HEMIAGENESIS	0.000545554	0.01363885
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000545554	0.01363885
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000545554	0.01363885
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.000545554	0.01363885
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.000545554	0.01363885
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.000545554	0.01363885
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.000545554	0.01363885
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000545554	0.01363885
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000545554	0.01363885
JOUBERT SYNDROME 21	0.000545554	0.01363885
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.000545554	0.01363885
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.000545554	0.01363885
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000545554	0.01363885
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000545554	0.01363885
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.000545554	0.01363885
PERIPHERAL HYPOTHYROIDISM	0.000545554	0.01363885
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000545554	0.01363885
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000545554	0.01363885
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.000545554	0.01363885
IMMUNODEFICIENCY 23; IMD23	0.000545554	0.01363885
CHROMOSOME 9P DELETION SYNDROME	0.000545554	0.01363885
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.000545554	0.01363885
XIA-GIBBS SYNDROME	0.000545554	0.01363885
CULLER-JONES SYNDROME; CJS	0.000545554	0.01363885
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000545554	0.01363885
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.000545554	0.01363885
BARDET-BIEDL SYNDROME 17; BBS17	0.000545554	0.01363885
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.000545554	0.01363885
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.000545554	0.01363885
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000545554	0.01363885
BARDET-BIEDL SYNDROME 16; BBS16	0.000545554	0.01363885
BARDET-BIEDL SYNDROME 2	0.000545554	0.01363885
BARDET-BIEDL SYNDROME 8; BBS8	0.000545554	0.01363885
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.01363885
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.01363885
PROPIONIC ACIDEMIA	0.000545554	0.01363885
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.000545554	0.01363885
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.000545554	0.01363885
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.01363885
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.000545554	0.01363885
SEPTOOPTIC DYSPLASIA	0.000545554	0.01363885
NOONAN SYNDROME 11; NS11	0.000545554	0.01363885
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.000545554	0.01363885
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.000545554	0.01363885
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.000545554	0.01363885
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.000545554	0.01363885
TYSHCHENKO SYNDROME	0.000545554	0.01363885
ALDH18A1-RELATED DE BARSY SYNDROME	0.000545554	0.01363885
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.000545554	0.01363885
STEEL SYNDROME; STLS	0.000545554	0.01363885
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.000545554	0.01363885
ISOLATED PLAGIOCEPHALY	0.000545554	0.01363885
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.000545554	0.01363885
CURRARINO SYNDROME	0.000545554	0.01363885
LIGNEOUS CONJUNCTIVITIS	0.000545554	0.01363885
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000545554	0.01363885
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000545554	0.01363885
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000545554	0.01363885
OPITZ G/BBB SYNDROME	0.000545554	0.01363885
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000545554	0.01363885
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.000545554	0.01363885
ZEBRA BODY MYOPATHY	0.000545554	0.01363885
OCULOSKELETODENTAL SYNDROME; OCSKD	0.000545554	0.01363885
RIGID SPINE SYNDROME	0.000545554	0.01363885
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.000545554	0.01363885
TRANSALDOLASE DEFICIENCY	0.000545554	0.01363885
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.000545554	0.01363885
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.000545554	0.01363885
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.000545554	0.01363885
JOUBERT SYNDROME 8	0.000545554	0.01363885
AUSTRALIA ANTIGEN	0.000545554	0.01363885
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.000545554	0.01363885
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.000545554	0.01363885
HURLER SYNDROME	0.000545554	0.01363885
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.000545554	0.01363885
DIAMOND-BLACKFAN ANEMIA 5	0.000545554	0.01363885
CARDIOFACIOCUTANEOUS SYNDROME	0.000545554	0.01363885
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.000545554	0.01363885
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.000545554	0.01363885
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.000545554	0.01363885
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.000545554	0.01363885
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.000545554	0.01363885
JOUBERT SYNDROME 25	0.000545554	0.01363885
SENIOR-LOKEN SYNDROME	0.000545554	0.01363885
NOONAN SYNDROME 3; NS3	0.000545554	0.01363885
N SYNDROME	0.000545554	0.01363885
NOONAN SYNDROME 9; NS9	0.000545554	0.01363885
AU-KLINE SYNDROME; AUKS	0.000545554	0.01363885
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000545554	0.01363885
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.01363885
JOUBERT SYNDROME 7	0.000545554	0.01363885
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000545554	0.01363885
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.000545554	0.01363885
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.01363885
16P13.11 MICRODUPLICATION SYNDROME	0.000545554	0.01363885
CONGENITAL HYPOTHYROIDISM	0.000545554	0.01363885
LYSOSOMAL ACID LIPASE DEFICIENCY	0.000545554	0.01363885
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.000545554	0.01363885
USHER SYNDROME TYPE 1	0.000545554	0.01363885
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.000545554	0.01363885
ELSAHY-WATERS SYNDROME; ESWS	0.000545554	0.01363885
SENIOR-LOKEN SYNDROME 9	0.000545554	0.01363885
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.000545554	0.01363885
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.000545554	0.01363885
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.000545554	0.01363885
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.000545554	0.01363885
JOUBERT SYNDROME 6	0.000545554	0.01363885
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.01363885
JOUBERT SYNDROME 26	0.000545554	0.01363885
NOONAN SYNDROME 5; NS5	0.000545554	0.01363885
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.000545554	0.01363885
NOONAN SYNDROME 6; NS6	0.000545554	0.01363885
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.000545554	0.01363885
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.000545554	0.01363885
XQ27.3Q28 DUPLICATION SYNDROME	0.000545554	0.01363885
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.01363885
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000545554	0.01363885
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.000545554	0.01363885
DUCHENNE MUSCULAR DYSTROPHY	0.000545554	0.01363885
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.000545554	0.01363885
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000545554	0.01363885
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.01363885
SPINOCEREBELLAR ATAXIA TYPE 7	0.000545554	0.01363885
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.000545554	0.01363885
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.000545554	0.01363885
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.000545554	0.01363885
FRIAS SYNDROME	0.000545554	0.01363885
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.000545554	0.01363885
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.000545554	0.01363885
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.000545554	0.01363885
MIXED CONNECTIVE TISSUE DISEASE	0.000541419	0.013535475
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.000541419	0.013535475
ENDOCARDIAL FIBROELASTOSIS	0.000541419	0.013535475
1P36 MICRODELETION SYNDROME	0.000541419	0.013535475
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000541419	0.013535475
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.000541419	0.013535475
CROUZON SYNDROME	0.000541419	0.013535475
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000541419	0.013535475
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.000541419	0.013535475
HYPOMAGNESEMIA 2, RENAL	0.000541419	0.013535475
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.000541419	0.013535475
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.000541419	0.013535475
DARIER-WHITE DISEASE; DAR	0.000541419	0.013535475
THANATOPHORIC DYSPLASIA TYPE 2	0.000541419	0.013535475
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.000541419	0.013535475
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.000541419	0.013535475
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.000541419	0.013535475
FETAL GAUCHER DISEASE	0.000541419	0.013535475
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.000541419	0.013535475
SECONDARY SYRINGOMYELIA	0.000541419	0.013535475
DIAMINOPENTANURIA	0.000541419	0.013535475
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.000541419	0.013535475
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000541419	0.013535475
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.000541419	0.013535475
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000541419	0.013535475
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.000541419	0.013535475
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.000541419	0.013535475
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000541419	0.013535475
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.000541419	0.013535475
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.000541419	0.013535475
MEGALENCEPHALY WITH DYSMYELINATION	0.000541419	0.013535475
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.013535475
ADAMS-OLIVER SYNDROME	0.000541419	0.013535475
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.000541419	0.013535475
CRIGLER-NAJJAR SYNDROME	0.000541419	0.013535475
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.000541419	0.013535475
2Q33.1 DELETION SYNDROME	0.000541419	0.013535475
PARIETAL FORAMINA	0.000541419	0.013535475
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.000541419	0.013535475
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.000541419	0.013535475
CEREBELLOPARENCHYMAL DISORDER II	0.000541419	0.013535475
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000541419	0.013535475
NEUROFIBROMATOSIS, TYPE I	0.000541419	0.013535475
ADDISON DISEASE	0.000541419	0.013535475
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.013535475
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000541419	0.013535475
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.000541419	0.013535475
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000541419	0.013535475
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.000541419	0.013535475
MAPLE SYRUP URINE DISEASE; MSUD	0.000541419	0.013535475
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.000541419	0.013535475
PULMONARY ARTERIOVENOUS MALFORMATION	0.000541419	0.013535475
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.000541419	0.013535475
CONGENITAL HYDROCEPHALUS	0.000541419	0.013535475
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.000541419	0.013535475
224250 DYSMYELINATION WITH JAUNDICE	0.000541419	0.013535475
HUNTINGTON DISEASE; HD	0.000541419	0.013535475
FRAGILE X SYNDROME	0.000541419	0.013535475
JERVELL AND LANGE-NIELSEN SYNDROME	0.000541419	0.013535475
ALEXANDER DISEASE	0.000541419	0.013535475
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.000541419	0.013535475
HADDAD SYNDROME	0.000541419	0.013535475
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.000541419	0.013535475
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.000541419	0.013535475
DERMOTRICHIC SYNDROME	0.000541419	0.013535475
ZIMMERMANN-LABAND SYNDROME 1	0.000541419	0.013535475
FOUNTAIN SYNDROME	0.000541419	0.013535475
FLYNN-AIRD SYNDROME	0.000541419	0.013535475
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.000541419	0.013535475
VISCERAL STEATOSIS, CONGENITAL	0.000541419	0.013535475
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.000541419	0.013535475
ACTH DEFICIENCY, ISOLATED; IAD	0.000541419	0.013535475
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000541419	0.013535475
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.000541419	0.013535475
HYPER-BETA-ALANINEMIA	0.000541419	0.013535475
HYPERLEUCINE-ISOLEUCINEMIA	0.000541419	0.013535475
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000541419	0.013535475
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.000541419	0.013535475
EPILEPSY, READING	0.000541419	0.013535475
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.013535475
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000541419	0.013535475
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.000541419	0.013535475
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.000541419	0.013535475
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.000541419	0.013535475
GRANULOMATOSIS WITH POLYANGIITIS	0.000541419	0.013535475
LISSENCEPHALY TYPE 1 DUE TO DOUBLECORTIN GENE MUTATION	0.000541419	0.013535475
SYSTEMIC SCLEROSIS	0.000541419	0.013535475
GAUCHER DISEASE, TYPE IIIC	0.000541419	0.013535475
GAPO SYNDROME; GAPOS	0.000541419	0.013535475
BERNARD-SOULIER SYNDROME	0.000541419	0.013535475
ACUTE ADRENAL INSUFFICIENCY	0.000541419	0.013535475
GLUTARIC ACIDEMIA I; GA1	0.000541419	0.013535475
NEUROFIBROMATOSIS, TYPE II	0.000541419	0.013535475
EPILEPSY, BENIGN OCCIPITAL	0.000541419	0.013535475
SCLERODERMA	0.000541419	0.013535475
FRYNS SYNDROME; FRNS	0.000541419	0.013535475
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.000541419	0.013535475
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.000541419	0.013535475
HYPERLYSINEMIA, TYPE I	0.000541419	0.013535475
KRABBE DISEASE	0.000541419	0.013535475
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.000541419	0.013535475
ASPARTYLGLUCOSAMINURIA	0.000541419	0.013535475
PAPILLORENAL SYNDROME	0.000541419	0.013535475
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.000541419	0.013535475
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000541419	0.013535475
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.000541419	0.013535475
DYSOSTEOSCLEROSIS	0.000541419	0.013535475
KAPUR-TORIELLO SYNDROME	0.000541419	0.013535475
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.000541419	0.013535475
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.000541419	0.013535475
NON-FUNCTIONING PITUITARY ADENOMA	0.000541419	0.013535475
STURGE-WEBER SYNDROME	0.000541419	0.013535475
NODULAR NEURONAL HETEROTOPIA	0.000541419	0.013535475
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.000541419	0.013535475
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.000541419	0.013535475
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000541419	0.013535475
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.000541419	0.013535475
KEUTEL SYNDROME; KTLS	0.000541419	0.013535475
KIFAFA SEIZURE DISORDER	0.000541419	0.013535475
AUTISM	0.000541419	0.013535475
PREECLAMPSIA/ECLAMPSIA 1	0.000541419	0.013535475
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.000541419	0.013535475
HYPOPHOSPHATASIA, CHILDHOOD	0.000541419	0.013535475
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.000541419	0.013535475
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.000541419	0.013535475
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000541419	0.013535475
7Q11.23 MICRODUPLICATION SYNDROME	0.000541419	0.013535475
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.000541419	0.013535475
HYPERPROLINEMIA, TYPE II	0.000541419	0.013535475
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.000541419	0.013535475
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.000541419	0.013535475
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000541419	0.013535475
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.000541419	0.013535475
EPILEPSY-TELANGIECTASIA	0.000541419	0.013535475
MENTAL RETARDATION, FRA12A TYPE	0.000541419	0.013535475
X-LINKED INTELLECTUAL DISABILITY-ATAXIA-APRAXIA SYNDROME	0.000541419	0.013535475
EPISODIC ATAXIA TYPE 6	0.000541419	0.013535475
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.000541419	0.013535475
HYPOPHOSPHATASIA, INFANTILE	0.000541419	0.013535475
LASSA FEVER	0.000541419	0.013535475
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.000541419	0.013535475
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.000541419	0.013535475
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.000541419	0.013535475
ROMANO-WARD SYNDROME	0.000541419	0.013535475
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000541419	0.013535475
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.000541419	0.013535475
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.000541419	0.013535475
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000541419	0.013535475
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000541419	0.013535475
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.000541419	0.013535475
MECKEL SYNDROME, TYPE 10; MKS10	0.000541419	0.013535475
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.000541419	0.013535475
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.000541419	0.013535475
CLASSIC HOMOCYSTINURIA	0.000541419	0.013535475
RETINITIS PIGMENTOSA 59; RP59	0.000541419	0.013535475
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000541419	0.013535475
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.000541419	0.013535475
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.000541419	0.013535475
NOONAN SYNDROME 7; NS7	0.000541419	0.013535475
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.000541419	0.013535475
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.000541419	0.013535475
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.000541419	0.013535475
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.000541419	0.013535475
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.000541419	0.013535475
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.000541419	0.013535475
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.000541419	0.013535475
AUTISM, SUSCEPTIBILITY TO, 18	0.000541419	0.013535475
THANATOPHORIC DYSPLASIA	0.000541419	0.013535475
GLIOBLASTOMA	0.000541419	0.013535475
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.000541419	0.013535475
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.000541419	0.013535475
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.000541419	0.013535475
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000541419	0.013535475
ADIPOSIS DOLOROSA	0.000541419	0.013535475
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.000541419	0.013535475
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.000541419	0.013535475
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.000541419	0.013535475
ABETA AMYLOIDOSIS, DUTCH TYPE	0.000541419	0.013535475
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.000541419	0.013535475
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.013535475
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.000541419	0.013535475
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.013535475
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.000541419	0.013535475
PACHYGYRIA, FRONTOTEMPORAL	0.000541419	0.013535475
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000541419	0.013535475
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000541419	0.013535475
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.000541419	0.013535475
LINEAR NEVUS SEBACEUS SYNDROME	0.000541419	0.013535475
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000541419	0.013535475
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.000541419	0.013535475
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000541419	0.013535475
BETA-KETOTHIOLASE DEFICIENCY	0.000541419	0.013535475
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.000541419	0.013535475
HISTIOCYTOID CARDIOMYOPATHY	0.000541419	0.013535475
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000541419	0.013535475
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.000541419	0.013535475
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.000541419	0.013535475
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.000541419	0.013535475
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.000541419	0.013535475
PAROXYSMAL EXTREME PAIN DISORDER	0.000541419	0.013535475
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.000541419	0.013535475
16Q24.3 MICRODELETION SYNDROME	0.000541419	0.013535475
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.013535475
HYPOPHOSPHATASIA	0.000541419	0.013535475
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.000541419	0.013535475
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000541419	0.013535475
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.000541419	0.013535475
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.000541419	0.013535475
BETA-MANNOSIDOSIS	0.000541419	0.013535475
SPASTIC ATAXIA WITH CONGENITAL MIOSIS	0.000541419	0.013535475
GYRATE ATROPHY OF CHOROID AND RETINA	0.000541419	0.013535475
HYPERPROLINEMIA TYPE 1	0.000541419	0.013535475
MALAN OVERGROWTH SYNDROME	0.000541419	0.013535475
EPISODIC ATAXIA, TYPE 6	0.000541419	0.013535475
PROGRESSIVE HEMIFACIAL ATROPHY	0.000541419	0.013535475
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.000541419	0.013535475
20Q13.33 MICRODELETION SYNDROME	0.000541419	0.013535475
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.000541419	0.013535475
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000541419	0.013535475
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.000541419	0.013535475
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.000541419	0.013535475
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.000541419	0.013535475
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000541419	0.013535475
HEMIDYSTONIA-HEMIATROPHY SYNDROME	0.000541419	0.013535475
SUDDEN CARDIAC FAILURE, INFANTILE	0.000541419	0.013535475
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.000541419	0.013535475
NASU-HAKOLA DISEASE	0.000541419	0.013535475
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000541419	0.013535475
GM2 GANGLIOSIDOSIS, AB VARIANT	0.000541419	0.013535475
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.000541419	0.013535475
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.000541419	0.013535475
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.000541419	0.013535475
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.000541419	0.013535475
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.000541419	0.013535475
NOCARDIOSIS	0.000541419	0.013535475
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.000541419	0.013535475
SMITH-KINGSMORE SYNDROME; SKS	0.000541419	0.013535475
LUJO HEMORRHAGIC FEVER	0.000541419	0.013535475
EBOLA HEMORRHAGIC FEVER	0.000541419	0.013535475
FADD-RELATED IMMUNODEFICIENCY	0.000541419	0.013535475
BENIGN FAMILIAL INFANTILE EPILEPSY	0.000541419	0.013535475
X-LINKED INTELLECTUAL DISABILITY-SEIZURES-PSORIASIS SYNDROME	0.000541419	0.013535475
ISOLATED BILIARY ATRESIA	0.000541419	0.013535475
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.000541419	0.013535475
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.000541419	0.013535475
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.000541419	0.013535475
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000541419	0.013535475
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000541419	0.013535475
PHAKOMATOSIS PIGMENTOVASCULARIS	0.000541419	0.013535475
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.000541419	0.013535475
CRONKHITE-CANADA SYNDROME	0.000541419	0.013535475
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.013535475
PORENCEPHALY	0.000541419	0.013535475
PROLACTINOMA	0.000541419	0.013535475
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.000541419	0.013535475
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.000541419	0.013535475
RAMON SYNDROME	0.000541419	0.013535475
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.000541419	0.013535475
RIFT VALLEY FEVER	0.000541419	0.013535475
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000541419	0.013535475
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.000541419	0.013535475
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.000541419	0.013535475
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000541419	0.013535475
THYROCEREBRORENAL SYNDROME	0.000541419	0.013535475
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.000541419	0.013535475
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.000541419	0.013535475
COFFIN-SIRIS SYNDROME 8; CSS8	0.000541419	0.013535475
VIRAL HEMORRHAGIC FEVER	0.000541419	0.013535475
FAMILIAL MEDITERRANEAN FEVER	0.000541419	0.013535475
WHIPPLE DISEASE	0.000541419	0.013535475
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.000541419	0.013535475
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.000541419	0.013535475
WOLFRAM SYNDROME	0.000541419	0.013535475
CHIME SYNDROME	0.000541419	0.013535475
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.013535475
INFANTILE NEUROAXONAL DYSTROPHY	0.000541419	0.013535475
GALACTOSIALIDOSIS	0.000541419	0.013535475
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000541419	0.013535475
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.000541419	0.013535475
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.000541419	0.013535475
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.000541419	0.013535475
IMMUNODEFICIENCY 37; IMD37	0.000541419	0.013535475
STURGE-WEBER SYNDROME	0.000541419	0.013535475
INFANTILE LIVER FAILURE SYNDROME 2	0.000541419	0.013535475
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.000541419	0.013535475
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000541419	0.013535475
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.000541419	0.013535475
EARLY-ONSET LAFORA BODY DISEASE	0.000541419	0.013535475
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.000541419	0.013535475
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.000541419	0.013535475
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000541419	0.013535475
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.000541419	0.013535475
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.000541419	0.013535475
PERRAULT SYNDROME 5; PRLTS5	0.000541419	0.013535475
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000541419	0.013535475
TAKAYASU ARTERITIS	0.000541419	0.013535475
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.000541419	0.013535475
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.000541419	0.013535475
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.000541419	0.013535475
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.000541419	0.013535475
PRADER-WILLI SYNDROME	0.000541419	0.013535475
MENTAL RETARDATION, X-LINKED 21	0.000541419	0.013535475
FAMILIAL THROMBOCYTOSIS	0.000541419	0.013535475
ADRENOLEUKODYSTROPHY	0.000541419	0.013535475
LISSENCEPHALY, X-LINKED, 1; LISX1	0.000541419	0.013535475
MENTAL RETARDATION, X-LINKED 14	0.000541419	0.013535475
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.000541419	0.013535475
PORPHYRIA	0.000541419	0.013535475
THYROCEREBRORETINAL SYNDROME	0.000541419	0.013535475
SJOGREN-LARSSON SYNDROME; SLS	0.000541419	0.013535475
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.000541419	0.013535475
THREONINEMIA	0.000541419	0.013535475
TAY-SACHS DISEASE; TSD	0.000541419	0.013535475
IMMUNOGLOBULIN A VASCULITIS	0.000541419	0.013535475
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.000541419	0.013535475
JUVENILE HUNTINGTON DISEASE	0.000541419	0.013535475
RABIES	0.000541419	0.013535475
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.000541419	0.013535475
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.000541419	0.013535475
EDINBURGH MALFORMATION SYNDROME	0.000541419	0.013535475
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000541419	0.013535475
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.000541419	0.013535475
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.000541419	0.013535475
AICA-RIBOSIDURIA	0.000541419	0.013535475
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000541419	0.013535475
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000541419	0.013535475
CLARK-BARAITSER SYNDROME	0.000541419	0.013535475
MALIGNANT ATROPHIC PAPULOSIS	0.000541419	0.013535475
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000541419	0.013535475
MENTAL RETARDATION, X-LINKED 82	0.000541419	0.013535475
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.000541419	0.013535475
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.000541419	0.013535475
THANATOPHORIC DYSPLASIA TYPE 1	0.000541419	0.013535475
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.000541419	0.013535475
ATKIN-FLAITZ SYNDROME	0.000541419	0.013535475
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.000541419	0.013535475
NEUROCUTANEOUS MELANOCYTOSIS	0.000541419	0.013535475
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.000541419	0.013535475
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.000541419	0.013535475
MOGS-CDG	0.000541419	0.013535475
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.000541419	0.013535475
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.000541419	0.013535475
L-2-HYDROXYGLUTARIC ACIDURIA	0.000541419	0.013535475
FAMILIAL MULTIPLE LIPOMATOSIS	0.000541419	0.013535475
MPDU1-CDG	0.000541419	0.013535475
ALG2-CDG	0.000541419	0.013535475
ALG9-CDG	0.000541419	0.013535475
ECTODERMAL DYSPLASIA SYNDROME	0.000541419	0.013535475
FRONTAL ENCEPHALOCELE	0.000541419	0.013535475
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.000541419	0.013535475
NEURAMINIDASE DEFICIENCY	0.000541419	0.013535475
PORPHYRIA VARIEGATA	0.000541419	0.013535475
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.000541419	0.013535475
GRISCELLI SYNDROME TYPE 2	0.000541419	0.013535475
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.000541419	0.013535475
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.000541419	0.013535475
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.000541419	0.013535475
ACUTE INTERMITTENT PORPHYRIA	0.000541419	0.013535475
HEREDITARY COPROPORPHYRIA	0.000541419	0.013535475
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.013535475
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.000541419	0.013535475
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.000541419	0.013535475
KNOBLOCH SYNDROME 1; KNO1	0.000541419	0.013535475
ACQUIRED PARTIAL LIPODYSTROPHY	0.000541419	0.013535475
RETINAL DEGENERATION AND EPILEPSY	0.000541419	0.013535475
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.000541419	0.013535475
RAMON SYNDROME	0.000541419	0.013535475
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.000541419	0.013535475
EPISODIC ATAXIA TYPE 3	0.000541419	0.013535475
GITELMAN SYNDROME	0.000541419	0.013535475
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000541419	0.013535475
CITRULLINEMIA TYPE I	0.000541419	0.013535475
BENIGN FAMILIAL NEONATAL EPILEPSY	0.000541419	0.013535475
EPILEPSY-TELANGIECTASIA SYNDROME	0.000541419	0.013535475
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.000541419	0.013535475
ONDINE SYNDROME	0.000541419	0.013535475
MENTAL RETARDATION, X-LINKED 100	0.000541419	0.013535475
ACQUIRED METHEMOGLOBINEMIA	0.000541419	0.013535475
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000541419	0.013535475
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.000541419	0.013535475
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.000541419	0.013535475
MICROSPORIDIOSIS	0.000541419	0.013535475
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000541419	0.013535475
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.000541419	0.013535475
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000541419	0.013535475
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.000541419	0.013535475
CRISPONI SYNDROME	0.000541419	0.013535475
WHIM SYNDROME	0.000541419	0.013535475
CRYPTOCOCCOSIS	0.000541419	0.013535475
FAMILIAL BENIGN COPPER DEFICIENCY	0.000541419	0.013535475
POTOCKI-SHAFFER SYNDROME	0.000541419	0.013535475
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000541419	0.013535475
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.000541419	0.013535475
GURRIERI SYNDROME	0.000541419	0.013535475
AYME-GRIPP SYNDROME; AYGRP	0.000541419	0.013535475
CRANIOSYNOSTOSIS 2	0.000541419	0.013535475
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000541419	0.013535475
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.000541419	0.013535475
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000541419	0.013535475
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.000541419	0.013535475
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.000541419	0.013535475
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.000541419	0.013535475
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.000541419	0.013535475
GRISCELLI SYNDROME, TYPE 2; GS2	0.000541419	0.013535475
MOYAMOYA DISEASE	0.000541419	0.013535475
HEREDITARY FRUCTOSE INTOLERANCE	0.000541419	0.013535475
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.000541419	0.013535475
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.000541419	0.013535475
FAMILIAL CALCIUM PYROPHOSPHATE DEPOSITION	0.000541419	0.013535475
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.000541419	0.013535475
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.000541419	0.013535475
MOMO SYNDROME	0.000541419	0.013535475
RING CHROMOSOME 10 SYNDROME	0.000541419	0.013535475
GLYCINE ENCEPHALOPATHY; GCE	0.000541419	0.013535475
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.000541419	0.013535475
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.000541419	0.013535475
LHERMITTE-DUCLOS DISEASE	0.000541419	0.013535475
LARGE CONGENITAL MELANOCYTIC NEVUS	0.000541419	0.013535475
MUCOPOLYSACCHARIDOSIS TYPE 3	0.000541419	0.013535475
ICHTHYOSIS AND MALE HYPOGONADISM	0.000541419	0.013535475
MYASTHENIA GRAVIS	0.000541419	0.013535475
HYPOPARATHYROIDISM, X-LINKED	0.000541419	0.013535475
CONGENITAL MYASTHENIC SYNDROME	0.000541419	0.013535475
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.013535475
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.000541419	0.013535475
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.013535475
KNOBLOCH SYNDROME	0.000541419	0.013535475
CHILDHOOD DISINTEGRATIVE DISORDER	0.000541419	0.013535475
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.000541419	0.013535475
CENTRAL DIABETES INSIPIDUS	0.000541419	0.013535475
RECURRENT ACUTE PANCREATITIS	0.000541419	0.013535475
IMMUNODEFICIENCY 47	0.000541419	0.013535475
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.000541419	0.013535475
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.000541419	0.013535475
LOWE OCULOCEREBRORENAL SYNDROME	0.000541419	0.013535475
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000541419	0.013535475
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.000541419	0.013535475
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.000541419	0.013535475
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.000541419	0.013535475
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.000541419	0.013535475
ACUTE BILIRUBIN ENCEPHALOPATHY	0.000541419	0.013535475
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.000541419	0.013535475
17Q24.2 MICRODELETION SYNDROME	0.000541419	0.013535475
LIPOID PROTEINOSIS	0.000541419	0.013535475
9Q21.13 MICRODELETION SYNDROME	0.000541419	0.013535475
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.000541419	0.013535475
OCULOCEREBRORENAL SYNDROME OF LOWE	0.000541419	0.013535475
LYMPHANGIOLEIOMYOMATOSIS	0.000541419	0.013535475
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.000541419	0.013535475
ROSAÏ-DORFMAN DISEASE	0.000541419	0.013535475
PINEOBLASTOMA	0.000541419	0.013535475
MUCOPOLYSACCHARIDOSIS, TYPE II	0.000541419	0.013535475
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.000541419	0.013535475
ATYPICAL TERATOID RHABDOID TUMOR	0.000541419	0.013535475
